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ABSTRACT  
The prevalence of food allergy is increasing in westernized countries, 
affecting 5-8% of children and 1-3% of adults. Although innumerous proteins are 
encountered in normal diets, only few proteins are commonly implicated as food 
allergens. In this vein, the major focus in allergy studies falls into intrinsic 
features of allergens; however, it is known that extrinsic factors can play a role in 
allergic processes. The allergenicity of Ber e 1, the major allergen from Brazil 
nuts, is well established and it has been shown that natural lipids from Brazil nuts 
are essential for the development of an immune response towards Ber e 1. The 
present study aimed to characterize the humoral response induced by 
recombinant (r)Ber e 1 alone or in the presence of lipids, and to investigate the 
mechanism(s) by which natural lipids influence the development of an immune 
response. BALB/c mice were sensitised intraperitoneally with rBer e 1 alone or in 
the presence of different lipid fractions. It was found that rBer e 1 alone did not 
induce an immune response and only one specific fraction of Brazil nut lipids 
(SPC fraction C), composed of a mixture of lipid classes, was able to induce a 
Th2-type humoral response, with the presence of Ber-specific anaphylactic 
antibodies, high levels of Ber-specific IgG1, and low levels of Ber-specific IgG2a. 
CD1-restricted natural killer (NK)T cells recognize lipids and therefore to test the 
hypothesis that NKT cells may be involved in the response, the sensitisation 
protocol with rBer e 1 and SPC lipid fraction C was tested in mice lacking these 
cells (JD18 KO mice). These animals presented significantly lower titers of Ber-
specific anaphylactic antibodies, Ber-specific IgG1, and total IgE than sensitised 
wild type mice, indicating that one of the pathways by which lipids triggered an 
immune response involved NKT cells. In conclusion, the present work found 
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that lipids from Brazil nuts were essential for the development of a Th2-type 
humoral response to rBer e 1 and that the immune response induced by lipids 
involved NKT cells.  
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ABBREVIATIONS 
 
AHR: Airway hyper-reactivity 
AP-1: Activating protein-1 
APC: Antigen presenting cells 
ASG: acylsterylglycosides  
BAL: Bronchoalveolar lavage 
BHT: Butylated hydroxytoluene  
BSA: Bovine serum albumin  
CER: Cerebroside 
DC: Dendritic cell 
DGDG: digalactosyldiacylglycerol  
DPG: diphosphatidylglycerol 
 dsRNA: double strand RNA  
ESG: Esterified steryl-glucoside 
ELISA: Enzyme-linked immune sorbent assay 
GALT: Gut associated lymphoid tissue  
IEC: Intestinal epithelial cells  
IFN: Interferon 
Ig: Immunoglobulin 
IL: Interleukin  
ITAM: Immunoreceptor tyrosine-based activation motifs  
ITIM: Immunoreceptor tyrosine-based inhibitory motifs  
LBP: LPS-binding protein  
LPE: Lyso-phosphatidylethanolamine 
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LPI: Lyso-phosphatidylinositol 
LPS: lipopolysaccharide 
Lps: Lyso-phosphtidylserine 
M: Microfold cells  
MAL: MyD88-adaptor-like  
MD: myeloid differentiation 
MGDG: Monogalactosyldiacylglycerols  
MHC: Major histocompatibility complex  
MUFA: Monounsaturated fatty acids  
MyD88: Myeloid differentiation primary response gene 88  
NF: Nuclear factor 
NKT: Natural killer T cells  
NMR: Nuclear magnetic resonance 
PA: Phosphatidic acid 
PBS: Phosphate buffered saline 
PC: Phosphatidylcholine  
PCA: Passive cutaneous anaphylaxis 
PE: Phosphatidylethanolamine  
PG: Phosphatidylglycerol 
PI: Phosphatidylinositol 
PS: Phosphatidylserine 
PUFA: Polyunsaturated fatty acid 
S: Sterols 
SFA: Saturated fatty acid 
SE: Sterol esters 
SG: Sterylglycosides 
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SL: Sulpholipid 
SPC: Solid-phase chromatography 
SQDG: Sulfoquinovosyldiacylglycerol  
ssRNA: single strand RNA 
TICAM-1: TIR-domain containing adaptor molecule 
TIR: Toll/interleukin-1 receptor  
TIRAP: TIR domain-containing adaptor protein  
TG: Triacylglycerol or triglycerides 
TLC: Thin layer chromatography 
TLR: Toll-like receptors 
TRAM: TRIF-related adaptor molecule  
TRIF: TIR domain containing adaptor inducing IFN-Ƣ 
TSFA: total saturated fatty acids  
WE: Wax esters  
D-GalCer: alpha-galactosylceramide 
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MAIN HYPOTHESIS 
 
The presence of natural lipids from Brazil nuts is essential for the in vivo 
sensitisation to Ber e 1, the major allergen in Brazil nuts. 
 
OBJECTIVES 
 
1. To extract and fractionate lipids from Brazil nuts; 
 
2. To identify fraction(s) of Brazil nut lipids able to induce 
anaphylactic antibody synthesis in an animal model of 
sensitisation; 
 
3. To investigate mechanism(s) involved in the lipid-protein 
induction of a Th2-humoral response. 
 
 CHAPTER 1 
 
 
 
 
GENERAL INTRODUCTION 
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1. Allergy 
The term allergy was created by Clemens von Pirquet in 1906 from the 
Greek allos meaning "other" and ergon meaning "reaction" (Silverstein, 2000). 
Allergy is a significant health problem in developed countries and its prevalence 
is continually on the increase.  Today, it is estimated that 10-25% of the 
population is affected by allergic diseases (Nouri-Aria e Durham, 2008; 
Niederberger, 2009).  
Allergy, referring to type-I hypersensitivity reaction, occurs when an 
immunologically sensitised individual has a further contact with the antigen, 
known as allergen, leading to a secondary boosting of the immune system (Roitt, 
1998). This reaction is usually mediated by Immunoglobulin E (IgE) and involves 
diverse cells and molecules from the immune system. 
Allergens are usually harmless proteins and the most common allergens 
that drive an IgE-mediated type-I response originate from food, pollens, mites, 
drugs, latex and insect venom. The development of allergic reactions by allergens 
depends on numerous factors such as environment, genetic predisposition, age, 
dose and route of sensitisation, structure and physicochemical properties of the 
allergen (Dearman e Kimber, 2001; Breiteneder, H. e Mills, E. N., 2005; 
Cochrane, Beyer et al., 2009).  
Different types of allergies are described depending upon the organ 
system affected, such as allergic rhinitis, conjunctivitis, asthma, dermatitis and 
food allergies. The symptoms observed range from skin, gastrointestinal and 
respiratory reactions to life threatening anaphylactic reactions.  
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1.1. Mechanisms of allergy  
The elucidation of mechanisms involved in the pathogenesis of allergic 
responses initiated in 1879, when Ehrlich described two new cellular types: mast 
cells and eosinophils (Larche, Akdis et al., 2006). In 1921, Prausnitz and Kustner 
first described the passive transfer of antigen-specific hypersensitivity by means 
of serum from an atopic donor to a normal individual; the factor responsible for 
this reaction was named reagin (Prausnitz e Kustner, 1921; Mittal, Saha et al., 
1971). This factor was later identified as IgE by two independent research groups 
(Ishizaka, Ishizaka et al., 1966; Johansson e Bennich, 1967). Based on these 
findings, allergic responses started to be associated with the inflammation caused 
by the degranulation of mast cells which, in turn, is caused by the linking of the 
antigen to IgE molecules attached to the membrane of mast cells.  
An allergic process is initiated when antigen presenting cells (APCs) 
capture the allergen, migrate to the draining lymph nodes and, in the context of 
class II MHC (Major Histocompatibility Complex) molecules, present peptides 
from the allergen to naive T lymphocytes. These T lymphocytes then 
differentiate into CD4+ Th2 cells and produce specific cytokines, such as 
interleukin (IL)-4, IL-5, and IL-13 (Gould e Sutton, 2008). In this scenario, 
antigen-specific B cells are also activated and, in the presence of Th2 cytokines, 
produce antigen-specific IgE. This antibody binds to high-DIILQLW\ )Fƥ5, DQG
ORZ DIILQLW\ )Fƥ5,, UHFHSWRUV H[SUHVVHG on the surface of mast cells and 
basophils. These events characterize the sensitisation phase of the type-I-
hypersensitivity (Bischoff, 2007; Gould e Sutton, 2008). In a subsequent contact 
with the allergen, the allergen binds to specific-IgE on the surface of immune 
cells and the consequent release of potent biologically active mediators and their 
combined effects on various target organs are responsible for the symptoms 
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observed in the acute elicitation phase of an allergic process (Sampson, 2000; 
Cianferoni e Spergel, 2009).  
High-affinity FFƥ5, UHFHSWRUV DUH H[SUHVVHG PDLQO\ RQ WKH VXUIDFH RI
mast cells, basophils, dendritic cells, Langerhans cells and monocytes (Sihra, Kon 
et al., 1997). %LQGLQJRI DQWLJHQV WR VSHFLILF ,J(PROHFXOHVRFFXS\LQJ)Fƥ5,RQ
circulating basophils and tissue-resident mast cells is an initial step in the process 
RI DQ DOOHUJLF UHDFWLRQ 2Q WKHVH FHOOV )Fƥ5, KDV D KHWHURWHWUDPHULF IRUP DQG
consists of one D subunit, one E subunit and two disulphide-linked ƣ FKDLQV
(Kinet, 1999; Gould, Sutton et al., 2003). )Fƥ5,ơ LV WKH UHFHSWRU VXEXQLW
UHVSRQVLEOHIRUWKH,J(ELQGLQJDQGWKHUHPDLQLQJ)Fƥ5,VXEXQLWVDUHUHVSRQVLEOH
for signaO WUDQVGXFWLRQ DFURVV WKH FHOO PHPEUDQH )Fƥ5,ơ KDV WZR H[WUDFHOOXODU
immunoglobulin-like domains, a transmembrane hydrophobic region, and a 
positively-FKDUJHGF\WRSODVPLFWDLO)Fƥ5,ƢKDVIRXUWUDQVPHPEUDQHGRPDLQVDQG
WZR F\WRSODVPLF WDLOV )Fƥ5,ƣ KDV D single transmembrane domain and a 
F\WRSODVPDWLF WDLO ,QWUDFHOOXODU FRPSRQHQWV RI )Fƥ5, XQGHUJR SURWHLQ
phosphorylation upon signalling at the immunoreceptor tyrosine-based activation 
motifs (ITAM), culminating with cell activation (Kinet, 1999; Gould, Sutton et al., 
2003). IgE-activated mast cells secret preformed granular mediators such as 
histamine and proteases; lipid mediators synthesized from membrane 
phospholipids, and cytokines. Basophils are also activated by IgE-)Fƥ5, FURVV-
linking, releasing preformed granule mediators such as proteases and histamine 
but also secrete large quantities of Th2 cytokines such as IL-4. The role of these 
cells is gaining attention  in allergic diseases (Falcone, Haas et al., 2000; Mukai, 
Obata et al., 2009). 
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Low affinity FcHRII receptors (CD23) are present on the surface of 
macrophages, monocytes, lymphocytes and platelets. The exact function of 
FcHRII remains poorly understood (Rosenwasser e Meng, 2005; Zhang, Murphy 
et al., 2007); however, the role of these receptors has been reported to be 
involved in allergic diseases by enhancing IgE-antigen complex presentation, 
regulating IgE synthesis, influencing cell differentiation and growth of both B- 
and T-cells, and stimulating production of pro-inflammatory mediators from 
immune cells, such as monocytes, macrophages and eosinophils (Rosenwasser e 
Meng, 2005). 
Moreover, it is important to mention that the involvement of IgG and 
its receptors is also well established in murine allergic processes (Hazenbos, 
Gessner et al., 1996; Miyajima, Dombrowicz et al., 1997; Ravetch e Bolland, 2001; 
Strait, Morris et al., 2006). The role of IgG, particularly IgG1, is critical for the 
induction of systemic anaphylaxis (Dombrowicz, Flamand et al., 1997; Miyajima, 
Dombrowicz et al., 1997) and this event occurs through the binding of IgG1 to 
its activation FcJRIII receptors present in mast cells and basophils and the 
consequent release of inflammatory mediators (Miyajima, Dombrowicz et al., 
1997; Nimmerjahn, Bruhns et al., 2005; Mukai, Obata et al., 2009). 
The humoral response is essential for the manifestation of type 1 
allergic reactions; however, they are also largely dependent upon preceding 
cellular mechanisms. The description of the different population of T 
lymphocytes, Th1 and Th2 significantly elucidated mechanisms of allergy (Del 
Prete, Maggi et al., 1988; Mosmann e Coffman, 1989). Activated allergen-specific 
Th2 lymphocytes play an essential role in the induction and maintenance of 
allergic processes, producing cytokines such as IL-4, IL-5, and IL-13 (so called 
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Th2 cytokines ) (Leung, 1998; Romagnani, 2000; Woodfolk, 2007). IL-4 is 
involved with the production of IgE and IgG1 by B cells (Del Prete, Maggi et al., 
1988; Bacharier e Geha, 2000; Faquim-Mauro e Macedo, 2000); IL-5 is essential 
for the development, differentiation, recruitment and activation of eosinophils 
(Lopez, Sanderson et al., 1988; Sanderson, 1990); and IL-13 regulates mucus 
secretion (Zhu, Homer et al., 1999; Mattes, Yang et al., 2001). Therefore, the 
differentiation of naive T lymphocytes into the Th2 phenotype is a critical step 
for the development of allergic responses.  
 
2. Food allergy 
The occurrence of food allergies is on the rise in westernized countries 
and the condition affects approximately 6% of young children and 3% of adults 
(Sicherer e Sampson, 2009). The individual food allergy varies by culture and 
population but globally the most common food allergies are milk, egg, peanut, 
soy, wheat, tree nuts, fish, shellfish and fruits (Eriksson, Moller et al., 2004; Vierk, 
Koehler et al., 2007; Imamura, Kanagawa et al., 2008; Fernandez Rivas, 2009). 
Food allergy is an immunological reaction against a food that occurs in 
susceptible individuals. Based on immunological mechanisms, food allergies can 
be classified in IgE-mediated, which are mediated by immunoglobulin E (IgE); 
cell-mediated, in which immune cells are responsible for the allergic process and, 
overlap, when both IgE and immune cells are involved in the reaction (Lee e 
Burks, 2006; Nowak-Wegrzyn e Sampson, 2006). The different symptoms 
observed in each of these immune-mediated food reactions are described in the 
table below (Metcalfe, 2005; Lee e Burks, 2006; Nowak-Wegrzyn e Sampson, 
2006; Cianferoni e Spergel, 2009). 
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Table 1.1.: Immune-mediated adverse reaction to foods 
 
 
 
IgE-mediated (immediate) 
 
x Urticaria and angioedema 
x Rhinoconjunctivitis, rhinitis, asthma 
x Oral allergy syndrome 
x Nausea, colic, vomiting, diarrhea  
x Anaphylactic shock 
 
Non-IgE-mediated (delayed) 
 
x Food induced enterocolitic 
syndromes 
x Celiac disease 
 
Overlap 
x Atopic dermatitis 
x Allergic eosinophilic gastroenteritis  
 
The best-characterized food allergy reactions are IgE mediated and the 
symptoms involved with this pathology include urticaria, asthma, oral allergy 
syndrome, digestive system symptoms and anaphylactic shock. These responses 
occur after the release of chemical mediators from mast cells and basophils as a 
result of interactions between food proteins and specific IgE molecules on the 
surfaces of these effector cells (Metcalfe, 2005; Lee e Burks, 2006). Under normal 
circumstances in most individuals, ingested proteins are not allergenic and; thus, 
do not elicit allergic immune responses. However, genetic alterations in the 
mechanisms that regulate the immune recognition of foreign proteins can 
predispose certain individuals to develop allergy (Metcalfe, 2005). 
Mucosal surfaces represent the intersection between the organism and 
the environment. The gut associated lymphoid tissue (GALT) in mammals is the 
largest lymphoid organ in the body. The intestinal mucosa of an adult presents 
300 m2 of area (Moog, 1981) and it is estimated that adults ingest in average 30 kg 
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of proteins per year (Mestecky, 1987). Despite the extent of protein exposure, 
very few individuals develop food allergies due to the induction of oral tolerance. 
Different immune cells participate in oral tolerance, with regulatory T cells being 
the most important. Disturbances at different steps in the path to oral tolerance, 
antigen- or host-related, can trigger an allergic response (Chehade e Mayer, 2005).  
Once proteins contact the intestinal surface, they are sampled by 
different cells and, depending on their characteristics, result in different 
responses. Antigens might be taken up by epithelial cells, Microfold (M) cells 
overlying Peyer's patches or DCs (Chehade e Mayer, 2005). Intestinal epithelial 
cells (IEC) express CD23 (FcHRII) following allergic stimulation and it was 
demonstrated that CD23 is involved in the rapid transepithelial transport of 
intact allergens in sensitised animals, increasing the uptake of IgE/allergen 
complexes (Bevilacqua, Montagnac et al., 2004). It was recently shown that 
digested peanuts allergens are exclusively transported across the epithelium by 
specialized antigen-sampling M cells and delivered to the lymphoid tissue of 
Peyer's patch. These conditions  favour strongly the induction of immune 
responses rather than oral tolerance (Chambers, Wickham et al., 2004). The role 
of intestinal DCs in allergic processes is not entirely understood, but it was 
shown that DCs open the tight junctions between epithelial cells, send dendrites 
outside the epithelium and can directly sample antigens in the intestinal lumen 
(Rescigno, Urbano et al., 2001).  
 
3. Animal models of allergy  
Animal models play a valuable role in increasing our understanding of 
the complex immunological and pathophysiological mechanisms involved in the 
 23 
development of food allergic responses (Finkelman, 2007). Such systems can also 
help on the identification of truly novel proteins, which have not been 
experienced previously in the diet, being useful to estimate the allergenic 
potential of proteins. 
Food allergy is a complex disease, influenced by genetic predisposition, 
allergen properties, environmental factors and exposure conditions. Therefore, 
the ideal animal model should mimic all aspects of a clinical situation in humans, 
including sensitisation and challenge using the oral route, lack of requirement for 
adjuvants, selected responses for known allergens, induction of IgE antibody, 
identification of similar IgE epitopes to those observed in human sera, 
production of clinically relevant symptoms on challenge and presenting 
reproducible results. Although it is unlikely that a single method using 
experimental animals will be able to assess all aspects of food allergy, the main 
objective of animal experimental models is to provide reliable information to be 
used conjunctly with relevant results obtained from other techniques. 
Several animal models of food allergy are described in the literature 
using mice, rats, dogs or neonatal swine (Knippels, Houben et al., 1999; Li, 
Serebrisky et al., 2000; Teuber, Del Val et al., 2002; Rupa, Hamilton et al., 2008). 
The most commonly used species is mouse, due to the accessibility of a great 
range of antibodies and reagents as well as transgenic animals in which genes of 
immune interest are deleted or over expressed. It is also generally accepted that 
man and mouse share similar mechanisms of immune regulation (Griffiths, 
Dearman et al., 2005; Maizels, 2005).  
The main drawback of animal models of food allergy is the difficulty of 
sensitizing animals by the oral route, as would reflect the process of allergen 
sensitisation in humans. The oral administration of allergens in the absence of 
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adjuvants promotes tolerance rather than sensitisation (Keller, Mucida et al., 2006; 
Sun, Czerkinsky et al., 2010). The few models able to achieve appropriate oral 
sensitisation imply long protocols, in the presence of mucosal adjuvants, such as 
cholera toxin (Van Wijk, Nierkens et al., 2007; Perrier, Thierry et al., 2009). In 
order to circumvent this aspect, numerous models of food allergy animal apply 
different routes of sensitisation such as intra-peritoneal and transdermal 
(Birmingham, Parvataneni et al., 2007; Dearman, Alcocer et al., 2007). There are 
several mouse strains used to study IgE-mediated processes, BALB/c mice, for 
instance, are more susceptible to develop allergic diseases than other strains, such 
as C57BL/6, which is considered more resistant (Drazen, Arm et al., 1996; 
Alcorn, Ckless et al., 2010). There are also transgenic strains of mice that develop 
exacerbated Th2/IgE responses. These animals bear monoclonal populations of 
T and B lymphocytes towards one specific antigen (e.g. DO11.10, specific for 
OVA) and are useful for IgE-mediated studies (Curotto De Lafaille, Muriglan et 
al., 2001; Mucida, Kutchukhidze et al., 2005).    
In animal models of food allergy, the parameters usually evaluated to 
characterize the molecular and cellular mechanisms involved in the allergic 
process are mainly: levels of IgE and IgG1, anaphylactic activity of antibodies, 
splenocytes proliferation and cytokine secretion profile, histological aspects of 
gastro-intestinal mucosa, and clinical symptoms of anaphylaxis (Li, Serebrisky et 
al., 2000; Morafo, Srivastava et al., 2003; Adel-Patient, Bernard et al., 2005; 
Cardoso, Teixeira et al., 2008; Proust, Astier et al., 2008).  
4. Anaphylaxis in animal models of allergy 
Anaphylactic reactions have been widely used in the last few decades for 
experimental investigations of allergy (Inagaki, Goto et al., 1986; Fung-Leung, De 
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Sousa-Hitzler et al., 1996; Kennedy Norton, Barnstein et al., 2008; Inagaki e 
Nagai, 2009; Pushparaj, Tay et al., 2009). In animal models, anaphylaxis can be 
actively or passively induced. Active anaphylactic reactions can be systemic or 
cutaneous, both being provoked in sensitised animals, by challenging them with 
the antigen. Active systemic anaphylaxis uses intravenous challenge and the 
parameters evaluated are body temperature, heart rate, mortality rate and other 
(Miyajima, Dombrowicz et al., 1997; Strait, Morris et al., 2002). Active cutaneous 
anaphylaxis challenges the animal via intra-dermal, evaluating the vascular 
permeability in the skin by dye extravasation (Woo, Kim et al., 2006; Nonaka, 
Izumo et al., 2008). Passive anaphylactic reactions can also be systemically or 
cutaneously performed. For passive systemic anaphylaxis, animals are passively 
transferred with serum or antibodies intravenously and then challenged with the 
antigen (Miyajima, Dombrowicz et al., 1997). The parameters evaluated are the 
same as those used for active systemic anaphylaxis. In passive cutaneous 
anaphylactic reactions, serum or antibodies are intradermally injected and the 
animals are challenged via intravenous with the antigen (Ovary, 1982; Inagaki, 
Goto et al., 1986).     
Due to is reliability and simplicity, a widely used protocol for an 
anaphylactic response is the passive cutaneous anaphylactic reaction for which 
the term PCA (Passive Cutaneous Anaphylaxis) was created  (Ovary, 1950). PCA 
is a simple in vivo model to identify antigen-specific anaphylactic antibodies in 
experimental allergy in animals. Although other in vitro techniques for 
determining antibody concentration such as RAST (radioallergosorbent 
immunoassay test), ELISA (Enzyme-linked immuno sorbent assay) and 
microarrays are regarded as more sensitive (Eriksson e Ahlstedt, 1977; Wiese, 
Belosludtsev et al., 2001; Lebrun, Petchpud et al., 2005; Harwanegg e Hiller, 
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2006), PCA is still utilized because, by partially mimicking an immediate allergic 
process, it is able to assess the biological function of antibodies (Miyajima, 
Dombrowicz et al. 1997; Woo, Kim et al. 2006; Nonaka, Izumo et al. 2008). 
PCA relies on one of the fundamental characteristics of an immediate 
allergic reaction, namely the liberation of vasoactive substances and their action 
on increasing the permeability of capillaries in the skin. The most well known 
mechanism responsible for this process involves mast cell activation. Mast cells 
present multiple cell-surface receptors (Hallgren e Gurish, 2007; Hakim-Rad, 
Metz et al., 2009), but the main players in the mast cell activation for anaphylactic 
processes are the immunoglobulin receptors.  
 
4.1. Mast cell activation 
Tissue mast cells are central players in the initiation of PCA reactions. 
Mast cells are widely distributed in the connective tissues of mammals and other 
vertebrates, being located around blood vessels in mucosal and epithelial 
interfaces that are exposed to the external environment, such as those of the 
respiratory and gastrointestinal tract and skin (Galli, Zsebo et al., 1994; Galli, 
Maurer et al., 1999). Mast cell activation leads to the release of a plethora of 
inflammatory mediators. These include preformed granular mediators, lipid 
mediators synthesized from membrane phospholipids, and cytokines (Bochner e 
Lichtenstein, 1991; Ryan, Kashyap et al., 2007).  
The  widely accepted concept for mast cell activation involves the cross-
linking activation of the high-DIILQLW\ )Fƥ5, UHFHSWRUV E\ ,J( DW  WKH PDVW FHOO
surface (Bochner e Lichtenstein, 1991). Stimulation of IgE-sensitised mast cells 
with antigen induces )Fƥ5, receptor cross-linking and this procedure leads to the 
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DFWLYDWLRQ RI Ƣ VXEXQLW-associated LYN, a SRC family protein tyrosine kinase. 
Activated LYN phosphorylates tyrosine residues in the immunoreceptor 
tyrosine-based activation motifs (ITAMs), present in the cytoplasmic regions of 
FcH5,ƢDQGƣVXEXQLWV7KLV W\URVLQHSKRVSKRU\ODWLRQKDSSHQVZLWKLQ WKHILUVW
15 seconds following Fcƥ5,DJJUHJDWLRQE\DQWLJHQRQPDVWFHOOV(Paolini, Jouvin 
et al., 1991).  3KRVSKRU\ODWHGƢDQGƣ,7$0VUHFUXLW/<1DQG6<.UHVSHFWLYHO\
(Benhamou e Siraganian, 1992). The tethering of SYK allows phosphorilation of 
its catalytic domain, as well as phosphorylation by LYN, thereby increasing its 
catalytic activity. SYK binds to phosphorylated ITAMS and is activated on 
binding. The subsequent SYK- and/or LYN-mediated tyrosine phosphorylation 
of the transmembrane adaptor molecule LAT (linker for activation of T cells) is 
crucial for coordination of the downstream signaling pathways that are required 
for the degranulation of pro-inflammatory mediators such as histamine, 
serotonin (5-hydroxytryptamine), leukotrienes, prostaglandins, nucleotides as well 
as the for the production of cytokine and chemokine molecules (Gilfillan e 
Tkaczyk, 2006; Rivera e Gilfillan, 2006). These biologically active compounds 
released from activated mast cells are responsible for the immediate increasing on 
vascular permeability observed in anaphylactic reactions as well as for the 
modulation of innate and adaptive immune responses (Galli, Nakae et al., 2005).  
The high affinity receptor for IgE, FcHRI, is the most thoroughly 
studied mediator of mast cell function (Bochner e Lichtenstein, 1991; Gould, 
Sutton et al., 2003; Chang e Shiung, 2006; Prussin e Metcalfe, 2006; Matsuda, 
Okayama et al., 2008; Carroll-Portillo, Spendier et al., 2009). However, recent 
studies have emphasized the importance of the IgG Fc receptors present not 
only in mast cells, but also on monocytes, macrophages and neutrophils 
(Oettgen, Martin et al., 1994; Hazenbos, Gessner et al., 1996; Miyajima, 
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Dombrowicz et al., 1997).  There are two distinct classes of murine IgG FcRs, 
one for activation and an other for inhibitory activity. Activation receptors 
LQFOXGH WKH KLJK DIILQLW\ )Fƣ5, DQG WKH ORZ DIILQLW\ )Fƣ5,,, $JJUHJDWLRQ RI
)Fƣ5, RU )Fƣ5,,, FDQ PHGLDWH D YDULHW\ RI LQIODPPDWRU\ SURFHVVes, amongst 
them mast cell degranulation (Daeron, 1997; Ravetch e Bolland, 2001). Both 
high- and low-affinity constant region binding receptors (FcR) trigger cell 
responses with equal efficiency. The difference bears on the order of the events 
which, in both cases, result in FcR aggregation. In general, high-affinity FcRs 
bind non-complexed monomeric immunoglobulins before these antibodies are 
complexed by multivalent antigens and low-affinity FcRs bind aggregated 
immunoglobulins already complexed to multivalent antigens (Daeron, 1997). 
Similar to FcH receptors, signal transduction through these receptors is mediated 
by immunoreceptor tyrosine-based activation motifs (ITAMs) in the cytoplasmic 
GRPDLQV RI WKH )F UHFHSWRU ƣ FKDLQ WKURXJK UHFUXLWPHQW DQG DFWLYDWLRQ RI
tyrosine kinases such as LYN and SYK (Daeron, 1997; Ravetch e Bolland, 2001). 
7KH LQKLELWRU\ UHFHSWRU LV QDPHG )Fƣ5,,E DQG LW PHGLDWHV LQKLELWRU\ ,J*
signaling through immunoreceptor tyrosine-based inhibitory motifs (ITIMs), 
which preferentially interact with tyrosine and inositol phosphatases. 
&URVVOLQNDJHRI)Fƣ5,,EZLWKDQDFWLYDWLRQUHFHSWRUVXFKDVWKH)FH5,)Fƣ5,RU
)Fƣ5,,,FDQLQKLELWSUR-inflammatory signalling (Daeron, Latour et al., 1995). The 
FRQWUDVWLQJ IXQFWLRQV RI )Fƣ5,,E DQG )Fƣ5,,, ZKLFK SUHVHQW LGHQWLFDO OLJDQG
binding properties and co-expression on mast cells allow control of IgG-
mediated signalling (Daeron, 1997; Ravetch e Bolland, 2001; Chong, Andrew 
Bouton et al., 2003).  
The involvement of IgG and FcJ receptors in mouse mast cell 
degranulation was demonstrated several decades ago using an in vitro model of 
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anaphylaxis (Vaz, Vaz et al., 1970). Some years later, it was shown that in vivo 
anaphylaxis (PCA reactions) could be induced by defined IgG antibody 
subclasses and that the response was species specific. Mouse mast cells, for 
instance, were activated and degranulated through IgG1, but not through IgG2 
or IgG3 (Ovary, 1982). Differently, studies in rats showed that FcJR does not 
trigger degranulation on rat mast cells (Bocek, Draberova et al., 1995). This study 
also demonstrated that FcHRI saturation by IgE on rat mast cells completely 
blocks their response to IgG immune complexes (Bocek, Draberova et al., 1995). 
Other studies demonstrated that IgG1 antibodies are exclusively dependent on 
FcJRIII, a low-affinity activation receptor (Nimmerjahn, Bruhns et al., 2005). 
Currently, it is well established in rodent models that antigen cross-linking of 
IgG1 bound to FcJRIII on mast cells and basophils is able to elicit anaphylactic 
reactions in a similar way to those induced through IgE-FcHRI (Hazenbos, 
Gessner et al., 1996; Dombrowicz, Flamand et al., 1997; Miyajima, Dombrowicz et 
al., 1997; Wakayama, Hasegawa et al., 1998; Strait, Morris et al., 2002). Passive 
systemic anaphylaxis induced by IgG1 was attenuated in FcJRIII-deficient mice 
(Miyajima, Dombrowicz et al., 1997), and, moreover, it was demonstrated that 
IgE is not essential for anaphylaxis since IgE null mice expressed fatal active 
anaphylaxis responses (Oettgen, Martin et al., 1994).  
Further, the existence of two biologically different mouse IgG1 was 
suggested, differing in their affinity for protein A and in their PCA activity (Mota 
e Perini, 1982). More recent studies better described these two functionally 
distinct IgG1 types, demonstrating that one type of IgG1 (anaphylactic IgG1) has 
anaphylactic activity and is synthesised in an IL-4-dependent environment, being 
inhibited by IL-12 or IFN-J. The non-anaphylactic IgG1 lacks this activity and its 
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synthesis is stimulated by IL-12 or IFN-gamma (Faquim-Mauro, Coffman et al., 
1999). It was also shown that the production of these two types of antibodies, 
anaphylactic- and non-anaphylactic-type IgG1, can be modulated by different 
adjuvants (Faquim-Mauro e Macedo, 2000). As expected, the ability of 
anaphylactic IgG1 to mediate anaphylaxis is directly related to their binding to 
FcJRIII expressed on mast cells and that this ability is related with its N-linked 
oligosaccharide chain (Faquim-Mauro, Jacysyn et al., 2003). Several studies in 
mice have confirmed that anaphylaxis can be induced by IgG1 
immunocomplexes (Alber, Kent et al., 1992; Hazenbos, Gessner et al., 1996; 
Hochreiter, Ferreira et al., 2003; Tsujimura, Obata et al., 2008). Recently, the 
glycan composition of IgG1 antibodies was investigated and it was demonstrated 
that the anaphylactic IgG1 presents more sialic acid and fucose residues than the 
non-anaphylactic type. Moreover, the removal of the terminal sialic acid residues 
in anaphylactic IgG1 resulted in loss of the ability to trigger mast cell 
degranulation and in vivo anaphylactic reaction (Faquim-Mauro, Coffman et al., 
1999; Faquim-Mauro, Jacysyn et al., 2003; Silva, Casabuono et al., 2008). 
The differentiation between IgG1 or IgE-mediated PCA reactions is 
usually performed by heating-inactivation, since IgE is described as a heat-labile 
immunoglobulin whereas IgG1s are heat-stable (Lehrer e Vaughan, 1976; 
Faquim-Mauro e Macedo, 2000). An additional property used to differentiate 
these two classes of immunoglobulins is the reaction duration, short intervals 
between sensitisation and antigen-challenge (2h) are used to identify IgG1 
anaphylaxis and longer intervals are used to identify IgE anaphylaxis (48h) 
(Lehrer e Vaughan, 1976; Faquim-Mauro e Macedo, 2000). Furthermore, a 
comparative study of IgE and IgG1 eliciting PCA reactions in mice showed that 
the alteration of skin mast cells is smaller in IgG1 antibody than in IgE antibody 
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(Inagaki, Nagai et al., 1988) and it has also been demonstrated that the amount of 
antibodies required to elicit PCA reactions is higher for IgG1 (500 ng/mL) than 
for IgE (15 ng/mL) (Ovary, 1982). 
Therefore, since IgE and IgG1 are the only known immunoglobulin 
isotypes that can elicit active and passive anaphylactic reactions in mice (Mota, 
Wong et al., 1968; Becker, 1971; Lehrer e Vaughan, 1976; Dombrowicz, Flamand 
et al., 1997; Blaikie e Basketter, 1999; Ryan, Kashyap et al., 2007), all 
considerations regarding IgE and IgG1 are essential for investigations on mouse 
models of anaphylaxis. 
 
4.2. PCA technique 
One way of performing PCA technique is by injecting serum from 
sensitised or non-sensitised mice into the dermis of naïve recipient mice dermis. 
A period of 48 hours is allowed for the possible antibodies present in the donor 
serum samples to bind to the receptors located on the mast cell surfaces of the 
recipient. Then, recipient animals are intravenously challenged with the relevant 
protein (which the experimental donor mice were sensitised to), with the addition 
of Evans blue dye. If the serum injected into the recipient mouse dermis contains 
protein-specific anaphylactic antibodies which bind to their receptors on mast 
cells, the contact with the antigen (the relevant protein injected intra-venously) 
will provoke a cross-linking reaction (antigen-antibody-mast cell receptor) 
causing mast cells degranulation. The liberation of vasoactive substances 
increases the vascular permeability in the skin and the extravasation of Evans 
blue dye from blood vessels is visible to the naked eye. This process starts within 
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seconds after the injection of protein and after thirty minutes following the 
challenge the diameter of the cutaneous reaction is measured.  
A brief description of the technique is represented in the Figure 1.1. and 
examples of PCA results are showed in the Figure 1.2. (Ovary, 1950; Mota e 
Perini, 1982). 
 
Figure 1.1.: The serum to be tested is injected via intra-dermal (i.d.) in the ears of 
naive recipient mice. 48 hours later an intra-venous (i.v.) injection containing the 
allergen and Evans blue dye is performed. The local extravasation of Evans blue 
dye in the tissue is visible within minutes after antigen injection and the diameter 
of the blue circle represents the PCA results (expressed in mm). 
 
 
Figure 1.2.:  Examples of PCA results obtained 30 minutes following the i.v. 
challenge. Reactions resulting in diameters smaller than 3 mm are considered 
negative and diameters measuring 3 mm or more are considered positive PCA 
reactions. 
 
5. Food allergens 
Despite the fact that innumerous proteins are encountered in normal 
diets, only a few specific protein families are commonly implicated as food 
48 h
i.v. injection
(antigen + Evans blue 
dye + PBS)
Diameter measured
30  min
i.d. injection
(serum)
Fc R
FcR+ Ig Antigens
Blood vessels
0 mm                     2mm                       4mm      6mm                       8mm
Negative reactions Positive reactions
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allergens (Bush e Hefle, 1996). The majority of plant allergens, for instance, are 
grouped into just 4 families (Radauer e Breiteneder, 2007), indicating that certain 
conserved characteristcs are determinants for the development of allergic 
responses. The classification of plant food allergens into families and 
superfamilies is based on their structural and functional properties (Breiteneder e 
Radauer, 2004).These families are the prolamin superfamily, the cupin 
superfamily, the profilins and proteins related to the major birch pollen allergen 
Bet v 1. The prolamin superfamily contains the 2S albumin seed storage proteins, 
the nonspecific lipid transfer proteins, protease inhibitors and cereal prolamins 
present in legumes, tree nuts, cereals, fruits, and vegetables. The cupin 
superfamily contains the vicilin and legumin-type seed storage globulins present 
in soybeans, peanuts and nut trees. The allergenic profilins are present in 
flowering plants, although non-allergenic profilins are present in all eukaryotic 
cells. Bet v 1 superfamily contains several types of proteins but the only allergenic 
are the pathogenesis-related proteins 10 family members (Radauer e Breiteneder, 
2007).  
The prolamin superfamily is the most prominent of all protein families 
that contain allergenic members. Prolamins are proline- and glutamine-rich D-
helical proteins with a conserved skeleton of 8 cysteine residues that serve several 
biologic functions. The allergenic prolamins include members of the nonspecific 
lipid transfer protein family (Breiteneder, H. e Mills, C., 2005), the 2S albumin 
storage proteins (Pastorello, Pompei et al., 2001) WKH FHUHDO ơ-amylase/trypsin 
inhibitors (Pastorello, Farioli et al., 2007), and the soybean hydrophobic protein 
(Baud, Pebay-Peyroula et al., 1993). These protein families have little sequence 
homology to each other apart from the cysteine skeleton, but they have highly 
VLPLODU ơ-helical structures. This structure is highly stable to both thermal and 
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proteolytic denaturation, which might contribute to the allergenicity of these 
proteins (Breiteneder, H. e Mills, E. N., 2005).  
  
 
Figure 1.3. Phylogenetic tree showing the relationship of members from the 
prolamin superfamily. Allergens and families that contain allergens are shaded. AI, 
ơ-Amylase inhibitor;Ace-AMP1, Allium cepa antimicrobial protein 1; DAI, dimeric 
amylase inhibitor; ExtLP, extensin-like protein; GSP, grain softness 
protein; HyPRP, hybrid proline²rich protein;LDI, limit dextrinase 
inhibitor; LMW, low molecular weight; MAI, monomeric amylase inhibitor; MTI, 
monomeric trypsin inhibitor; nsLTP, nonspecific lipid transfer protein; PRP, 
proline-rich protein; SFA-8, sunflower albumin 8; TAI-CM, 
chloroform/methanol soluble tetrameric amylase inhibitor; TI, trypsin 
inhibitor; WCI, wheat chymotrypsin inhibitor;XyLP, xylogen-like protein. 
Diagram extracted from (Radauer e Breiteneder, 2007).  
 
Therefore, it is clear that some proteins are intrinsically more allergenic 
than others. However, the membership in one of a limited number of protein 
families in itself is not sufficient to determine allergenic activity.  Amongst the 
intrinsic protein features that have been reported to contribute to the 
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phenomenon of allergenicity are: size, solubility, glycosylation status, resistance to 
proteolytic digestion, heat stability, ligand bindings, disulfide bonds, number of 
IgE-binding sites, potential interaction with cell membranes and lipid structures, 
and biological function such as enzymatic activity and storage proteins 
(Breiteneder, H. e Mills, E. N., 2005; Thomas, Macintosh et al., 2009; Traidl-
Hoffmann, Jakob et al., 2009).  
The more common food allergens are generally water-soluble, with a 
reasonable degree of glycosylation and have molecular weight varying from 10 to 
70 kDa (Taylor e Lehrer, 1996). Food allergens also tend to be stable and 
resistant to heat and digestive processes (Wal, 1998), i.e. they are able to retain 
their original, native, 3-dimension structure after these chemical or physical 
treatments. This stability is important particularly for oral allergens as it implies 
on their survival of cooking and gastric digestion; increasing the probability of 
being uptaken in the gut and recognised by the immune system. The biological 
function of protein is also reported to be related to protein allergenicity. Proteins 
with enzymatic activity, such as might enhance sensitisation by disrupting tight 
junctions in mucosal tissues. A well studied example is the house dust mite 
allergen, Der p 1, able to disrupt bronchial epithelium tight junctions (Herbert, 
King et al., 1995). Moreover, many of the known food allergens are classified as 
pathogenesis-related proteins. This class of proteins is more abundant in 
situations of environmental stress and they exhibit functions such as antifungal 
activity, antibacterial activity, and proteinase inhibition (Breiteneder e Ebner, 
2000; Metcalfe, 2005). 
Despite these general commonalities of known allergens, it is important 
to highlight that not all stable proteins are allergens. Allergens from apples and 
milk, for example, have been shown to be labile (Wal, 1998; Huby, Dearman et 
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al., 2000). Hundreds of proteins have been identified as allergens, having their 
amino acid sequences characterized and incorporated into comprehensive 
allergen databases (Goodman, Hefle et al., 2005); however, the precise features 
that make a protein allergenic remain elusive. The potential allergenicity of novel 
foods is still assessed by comparison to that of existing allergens (Esch, 2006). 
Therefore, there is considerable interest in defining the characteristics that confer 
sensitizing potential on the proteins that can provoke the quality of immune 
response necessary for the acquisition of allergic sensitisation. This has assumed 
increased importance with the need to identify and characterize potential food 
allergens as an essential part of food safety assessment (Goodman, Hefle et al., 
2005; Thomas, Macintosh et al., 2009; Traidl-Hoffmann, Jakob et al., 2009). 
 
6. Brazil nuts 
The Brazil nut (Bertholletia excelsa or Bertholletia excels) is a South American 
tree from the family Lecythidaceae and also the name of the tree's commercially 
harvested edible seed. The Brazil nut tree is native to the Guianas, Venezuela, 
Colombia, Peru, Bolivia, and Brazil. The Brazil nut tree is a large tree, reaching 
30²50 metres of height and 1²2 metres of trunk diameter. It may live for 500 
years or more. Betholletia excelsa is distinguished from all other species of 
Lecythidaceae by the oblong leaves with a whitish cast on the abaxial surface 
caused by microscopic cuticular papillae; a two-lobed calyx at anthesis; woody 
fruits that fall to the ground with the seeds inside; and seeds with a boney testa 
and no apparent cotyledons (Mori, 2006 onward-b). Brazil nuts, the seeds of the 
Brazil nut tree, are one of the most widely exploited tropical nuts. They are 
harvested almost entirely from wild trees during a five to six month period in the 
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rainy season. There is an average of 200 fruits per tree and a mean seed number 
per fruit of 15-20 (Mori, 2006 onward-b).  
 
Figure 1.4.: Photographs of the tree, fruit and seeds of Bertholletia excelsa (Mori, 
2006 onward-a). 
 
The protein content of Brazil nuts is approximately 14.3% of dried 
weight (USDA, 2009). Brazil nuts are probably one of the richest food sources of 
the sulphur-containing amino acids; the total seed protein is reported to contain 
about 8.3% methionine and cysteine by weight (Sun, Altenbach et al., 1987). The 
total protein of Brazil nuts can be fractionated into three size classes of proteins, 
the 11 S, 7 S, and 2 S proteins. The water-soluble 2S albumin comprises about 
30% of the total protein and is exceptionally rich in the sulfur amino acids; about 
30% methionine and cysteine (Sun, Altenbach et al., 1987). The detailed 
composition of Brazil nuts is presented in the Appendix 1.   
 38 
The 2S albumin family is part of the prolamin superfamily and are 
present in seeds of several dicotyledonous and monocotyledonous species. The 2 
S albumins are generally D-helical proteins (10 to 15 kDa) composed of one small 
and one large subunit linked by two conserved disulphide bridges in a distinctive 
right-handed fold (Breiteneder e Radauer, 2004; Mills, Jenkins et al., 2004). 2S 
albumins include several important food allergens, such as Ber e 1 from Brazil 
nuts, Jug r 1 from the English walnuts, Ses i 2 from sesame seeds, Sin a 1 from 
yellow mustard and others (Teuber, Dandekar et al., 1998; Pastorello, Pompei et 
al., 2001; Pastorello, Varin et al., 2001). 
 
6.1. Brazil nut allergy 
Allergies to nuts are amongst the most common food allergies, affecting 
approximately 1% of the general population in the UK and the USA (Crespo, 
James et al., 2006).  Allergy to Brazil nuts was first reported in 1983, in a study 
describing 4 children with allergic reactions to Brazil nuts (Hide, 1983), and a 
further study reported 12 cases of Brazil nut allergy (Arshad, Malmberg et al., 
1991). However, the allergenic potential of Brazil nut became notable when its 2 
S albumin proteins, rich in cysteine and methionine, were used for genetic 
engineering in order to improve the nutritional value of soybean. This approach 
was unsuccessful due to the potential passage of allergenic properties of the 2 S 
albumin protein of Brazil nuts to the transgenic soybean (Nordlee, Taylor et al., 
1996).   
The first direct correlation of the sensitisation to the Brazil nut major 
allergen, Ber e 1, with the clinical expression of allergy to this seed was shown in 
a study in which sera from Brazil nut allergic and non-allergic individuals were 
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compared. All sera from symptomatic patients recognized Ber e 1, whereas no 
sera from asymptomatic subjects showed IgE binding to Ber e 1 (Pastorello, 
Farioli et al., 1998).  
The structural IgE epitope of Ber e 1 has been mapped to a single helix-
loop-helix region, through the use of a chimaeric protein microarray system 
together with sera from well-characterised Brazil nut allergic subjects (Alcocer, 
Murtagh et al., 2004). Corroborating with these findings, the same structural 
region has been reported as the immunodominant region in related food 
allergens by different techniques (Karisola, Alenius et al., 2002). 
 
6.2. Ber e 1 
Allergens are named using the first 3 letters of the genus, followed by a 
single letter for the species and a number indicating the chronologic order of 
allergen purification. Therefore, Ber e 1 was the first purified allergen from 
Bertholletia excelsa. As a member of the 2 S albumin protein family, the major 
allergen form Brazil nuts (Ber e 1) is a water-soluble heterodimeric protein, 
consisting of 2 polypeptide chains of approximately 4 and 9 kDa that are held 
together by four intra-chain disulfide bonds in a distinctive right-handed fold 
(Alcocer, Murtagh et al., 2002).  
Ber e 1 is a very stable protein, highly resistant to temperature, 
digestion, guanidinium chloride and acidic pH. It was shown that this protein 
maintains its folding properties up to 75ºC and retains most of its secondary 
structure at 95ºC. Importantly, the original protein structure was largely regained 
upon cooling. Ber e 1 was shown to be the protein from Brazil nuts least 
susceptible to pepsin digestion, being highly resistant to acidic pH. The resistance 
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to unfolding was also displayed when Ber e 1 was exposed to the chemical 
denaturant guanidinium chloride (Murtagh, Archer et al., 2003).  
A model of tridimensional structure of Ber e 1 was constructed based 
on the conserved 2 S albumin disulphide connectivity of this protein, together 
with sequence and structural alignments with other 2 S albumin proteins 
(Alcocer, Murtagh et al., 2002). 
 
Figure 1.5.: Molecular modelling of Ber e 1 protein. Ribbon representation of the 
backbone of the model Ber e 1 structure. The disulphide bonds are represented as 
yellow broken lines (Alcocer, Murtagh et al., 2002).  
 
Although the allergenic potential of Ber e 1 is well established (Nordlee, 
Taylor et al., 1996; Pastorello, Farioli et al., 1998), it has been recently 
demonstrated that recombinant Ber e 1 is not able to induce anaphylactic 
antibodies production in mice when it is used alone, i.e., in the absence of the 
Brazil nuts natural lipids. In contrast, the production of anaphylactic antibodies 
was observed when the natural lipids from Brazil nuts were added to the protein 
(Dearman, Alcocer et al., 2007). These results corroborate with the fact that, not 
only intrinsic features, but also extrinsic factors such as the presence of lipids 
might be determinants for the initiation of an allergic process. 
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6.3. Nuts composition 
Throughout history, nuts have been part of the diet around the world. 
Records of eating pistachios date back to 7000 BC. Early descriptions of food 
intakes indicate that the Romans, Persians, and Arabs used nuts to cook and that 
this practice later extended to Europe (Brufau, Boatella et al., 2006; King, 
Blumberg et al., 2008). Nowadays, edible nuts are globally popular, and are valued 
for their sensory, nutritional, and health attributes (Venkatachalam e Sathe, 2006). 
The most popular and commercially important edible nuts are: almonds (Prunus 
dulcis), Brazil nuts (Bertholetia excelsa), cashew nuts (Anacardium occidentale), 
hazelnuts (Corylus avellana), macadamias (Macadamia integrifolia), pecans (Carya 
illinoinensis), pine nuts (Pinus pinea), pistachios (Pistachia Vera), and walnuts (Juglans 
regia) (Venkatachalam e Sathe, 2006).  
Nuts are rich in all major macronutrients: protein, carbohydrate, and 
lipid. The chemical composition of common edible nuts varies: water (1.47-
9.51%), protein (7.50-21.56%), lipid (42.88-66.71%), and ash (1.16-3.28%) 
(Venkatachalam e Sathe, 2006). Table 1.2. shows a summarized composition of 
common nuts (USDA, 2009). 
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 Energy 
(kcal) 
Water 
(g) 
Protein 
(g) 
Total lipid 
(g) 
Ash 
(g) 
Carbohydrate 
(g) 
Almond 575 4.7 21.22 49.42 2.99 21.67 
Brazil nut 656 3.48 14.32 66.43 3.51 12.27 
Hazelnut 628 5.31 14.95 60.75 2.29 16.7 
Macadamia 718 1.36 7.91 75.77 1.14 13.82 
Pecan 691 3.52 9.17 71.97 1.49 13.96 
Pine nut 673 2.28 13.69 68.37 2.59 13.08 
Pistachio 562 3.91 20.27 45.39 2.91 27.51 
Walnut 654 4.07 15.23 65.21 1.78 13.71 
Table 1.2: Chemical composition of raw nuts (USDA, 2009). 
 
The total protein content of nuts is relatively high, which makes nuts an 
important source of protein, especially for vegetarian diets. However, the 
biological protein value of nuts is not high since some essential amino acids are 
limiting (Brufau, Boatella et al., 2006). In general, threonine is the limiting amino 
acid for all nuts (25²40 mg/g of protein), being Brazil nuts the poorest (3.62 
mg/g) and cashews the richest in threonine (6.88 mg/g) (Brufau, Boatella et al., 
2006; Usda, 2009). Nuts are low in isoleucine, with a content ranging between 32 
and 40 mg/g of protein. Nuts are also deficient in the dibasic amino acid lysine. 
Methionine and cysteine (sulphur amino acids), are found in low amounts in 
most nut proteins with the exception of Brazil nut, which contains high amounts 
of sulphur amino acids (96 mg/g of protein) (Brufau, Boatella et al., 2006). Other 
amino acids such as phenylalanine, tyrosine, histidine and valine are present in 
significant amounts in the protein of all nuts (Brufau, Boatella et al., 2006). 
The total carbohydrate content in common edible nuts vary from 12.7 
to 27.5% (Usda, 2009). The lowest amounts are found in Brazil nuts, and 
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progressively increasing amounts occur in walnuts, Macadamia, hazelnuts, 
almonds, and pistachios (Table 1.2.). 
Nuts are also good sources of several other important nutrients, such as 
phytosterols and other phytochemicals such as phenolic compounds, flavonoids, 
luteolin and tocotrienols. A study showed that walnuts and pecans contained the 
highest phenolic content (1.5% of raw nut weight) followed by pistachios and 
Macadamia (0.5% of raw nut weight), cashews and hazelnuts (0.3% of raw nut 
weight), almonds and Brazil nuts (0.2% of raw nut weight). The flavonoid 
content was higher in walnuts and pecans (0.7% of raw nut weight) and lower in 
pistachios, macadamia, hazelnuts, Brazil nuts and almonds (approximately 0.1% 
of raw nut weight) (Yang, 2009). Other micronutrients present in notable 
quantities in most nuts include thiamine, niacin, riboflavin, selenium, potassium 
and iron (Brufau, Boatella et al., 2006).  
 
6.3.1. Nut lipids 
The main constituent of nuts is lipid, and as shown in Table 1.2., the 
total lipid content per 100 g ranges from 45.4% in pistachios to 75.8% in 
Macadamia nuts (USDA, 2009). The extraction of total lipids from nuts is usually 
SHUIRUPHGE\WUDGLWLRQDOPHWKRGVVXFKDV´)ROFKµH[WUDFWLRQ (Folch, Lees et al., 
1957) that is still used nowadays (Parcerisa, Codony et al., 1999; Moodley, 
Kindness et al., 2007); ´6R[KOHWµ (1879), a common  method for general 
triglyceride extraction, using petroleum ether (Amaral, Casal et al., 2003; 
Venkatachalam, Kshirsagar et al., 2007) or hexane (Chunhieng 2008); and also 
hexane extraction (Ryan, Galvin et al., 2006; Miraliakbari e Shahidi, 2008). 
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The lipid composition of nuts is low in saturated fatty acids (SFA) (4²
16%) and high in mono- and poly-unsaturated fatty acids (MUFA and PUFA, 
respectively). For instance, similar proportions of MUFA and PUFA are present 
in Brazil nuts, a predominance of PUFA over MUFA is observed in pine nuts, 
and in walnuts PUFA is mostly present (Ros e Mataix, 2006). Together, MUFA 
and PUFA contribute around 91% of the energy from fat in nuts (Kris-Etherton, 
Yu-Poth et al., 1999). These values may vary according to the method used to 
analyse fatty acids as well as to climate and soil conditions where the nuts are 
grown (Venkatachalam e Sathe, 2006; Chunhieng 2008).  
 Total lipids (g) TSFA (g) MUFA (g) PUFA (g) 
Almond 49.42 3.73 30.89 12.07 
Brazil nut 66.43 15.14 24.55 20.60 
Hazelnut 60.75 4.46 45.65 7.92 
Macadamia 75.77 12.06 58.88 1.5 
Pecan 71.97 6.18 40.80 21.61 
Pine nut 68.40 4.90 18.80 34.10 
Pistachio 45.39 5.56 23.8 13.74 
Walnut 65.21 6.13 8.93 47.17 
Table 1.3.: Lipid composition of several edible nuts. Data for raw nuts. TSFA, 
total saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, 
polyunsaturated fatty acids (USDA, 2009). 
 
Lipids can be divided into two broad classes, simple and complex 
lipids. This classification is based on the products yielded on hydrolysis 
processes; simple lipids yield at most two types of primary product per mole on 
hydrolysis and complex lipids yield three or more primary hydrolysis products per 
mole. Simple lipids include mono-, di-, and triacylglycerol (also called triglycerides 
- TG), which are made by fatty acids and glycerol; sterol; sterol ester; waxes; 
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tocopherol; and free fatty acids. The complex lipids include 
the glycerophospholipids (or phospholipids), which contain a glycerol backbone, 
one or more fatty acids, a polar phosphorus moiety and an alcohol; and 
the glycolipids (both glycoglycerolipids and glycosphingolipids), which contain a 
polar carbohydrate moiety. Amongst the glycerophospholipids are phosphatidic 
acid (PA), cardiolipin (diphosphatidylglycerol), phosphatidylcholine (PC), 
phosphatidylethanolamine (PE), phosphatidylglycerol (PG), phosphatidylserine 
(PS), and phosphatidylinositol (PI). The polar base is the major factor 
distinguishing different phospholipids. The glycerolipids include 
monogalactosyldiacylglycerol (MGDG), digalactosyldiacylglycerol (DGDG) and 
sulfoquinovosyldiacylglycerol or plant sulfolipid (SQDG) (Fahy, Subramaniam et 
al., 2009).  
Phospholipids isolation and analyses are usually performed by thin-layer 
chromatography (TLC) systems (Zlatanov M., Ivanov S. et al., 1999; Chunhieng 
2008) and high-performance liquid chromatography (HPLC) (Becard, Chevalier et 
al., 1999; Parcerisa, Codony et al., 1999). The total quantity of phospholipids can 
also be measured by the estimation of the phosphorous amount in the sample 
(Chunhieng 2008). 
Whilst data about the fatty acid composition of nuts is greatly available 
in the literature, information regarding their phospholipid content is scarce 
(Zlatanov M., Ivanov S. et al., 1999; Amaral, Casal et al., 2003; Ros e Mataix, 2006; 
Ryan, Galvin et al., 2006; Venkatachalam e Sathe, 2006; Usda, 2009).   
A study with Brazil nuts showed that the main phospholipids present in 
these seeds were PI, PC, PE, and PA. The fatty acids extracted from these 
phospholipids were also analysed and the main fatty acids found were 18:1, 16:0, 
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18:2 and 18:0 (Chunhieng 2008).  Similar results were found in hazelnuts, that 
were demonstrated to be composed mostly by PC, PE, and PI (Parcerisa, 
Codony et al., 1999).  
 
7. Lipids and immune system 
Lipids are common activators of the innate immune system (Podrez, 
Poliakov et al., 2002; Konger, Marathe et al., 2008). The interaction of lipids with 
immune cells leads to the formation and release of a large spectrum of 
inflammatory mediators which are essential for the early innate and subsequent 
adaptive immune reaction (Freudenberg, Tchaptchet et al., 2008; Galli e Calder, 
2009). In this vein, lipids have traditionally been thought of as adjuvants for Th1 
responses, not being usually associated with allergic processes. The Th-1 
stimulating activity is attributed to the activation of immune responses by the 
activation of naive T cells via the Toll-like receptor (TLR)4 pathway that 
traditionally activates APCs to produce the Th1 cytokines (Mazzoni e Segal, 
2004) or by natural killer (NK) T cells and CD1 presentation (Faveeuw, Angeli et 
al., 2002; Hansen, Siomos et al., 2003). However, there are now solid evidences 
for the involvement of lipids in Th2-type responses, either induced by TLR or 
CD1-NKT pathways (Eisenbarth, Piggott et al., 2002; Faveeuw, Angeli et al., 
2002; Delayre-Orthez, De Blay et al., 2004; Agea, Russano et al., 2005; Kim, Oh et 
al., 2007).  
 
7.1. Toll-like receptors (TLRs) 
TLRs are evolutionarily conserved innate receptors expressed in various 
immune and non-immune cells of the mammalian host, able to recognize 
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molecular patterns, that when associated with pathogens play an important role 
in the innate immune responses to microbial pathogens (Akira, Yamamoto et al., 
2003; Kawai e Akira, 2010); and that when associated with endogenous molecules 
play a role in inflammatory and autoimmune diseases (Kawai e Akira, 2010). 
TLRs are also related with humoral and cellular adaptive immune responses 
(Iwasaki e Medzhitov, 2004).  
Historically, the first evidence that TLRs were specific receptors 
participating in the development of immune responses was reported when a 
mutant Drosophila carrying loss-of-function mutations in the Toll receptor 
resulted in high susceptibility to fungi infection and the defective induction of an 
antifungal peptide (Lemaitre, Nicolas et al., 1996; Hoffmann, 2003). The human 
homolog of the Drosophila Toll protein was subsequently described (Medzhitov, 
Preston-Hurlburt et al., 1997).  
TLRs1-9 are conserved between humans and mice. TLR10 is expressed 
in humans but not in mice, whereas TLRs11-13 are present in mice but not in 
humans. It is known that TLRs 1, 2, 4 and 6 are primarily located on the cell 
surface and recognize bacterial membrane lipids. TLRs 3, 7, 8 and 9 are generally 
located in the intracellular endossomes and primarily recognize pathogen-derived 
nucleotides. Specifically, TLR4 recognizes lipopolysaccharide (LPS), TLR2 binds 
lipoproteins and peptidoglycans (Takeuchi, Hoshino et al., 1999), TLR1/2 and 
TLR1/6 heterodimers bind with lipopeptides and lipoproteins, TLR3 and TLR9 
recognize double strand RNA (dsRNA), and TLR7 and TLR8 recognize single 
strand RNA (ssRNA) (Akira e Takeda, 2004).  
TLRs contain extracellular leucine-rich repeats involved with pattern 
recognition, and the transmembrane and cytoplasmic Toll/interleukin-1 receptor 
(TIR) domains required for initiating intracellular signalling. The TLR-mediated 
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intracellular signalling is initiated by TIR-domain-dependent interactions with 
TIR-domain-containing cytosolic adapters such as myeloid differentiation 
primary response gene 88 (MyD88), TIR domain-containing adaptor protein 
(TIRAP)/MyD88-adaptor-like (MAL), TIR domain containing adaptor inducing 
IFN-Ƣ(TRIF)/TIR-domain containing adaptor molecule (TICAM)-1 and TRIF-
related adaptor molecule (TRAM), also known as TICAM2. A sequence of events 
will culminate in the activation of nuclear factor (NF)-kB and activating protein-1 
(AP-1) and in the production of pro-inflammatory cytokines (Akira e Takeda, 
2004). 
 
Figure 1.6. Representation of TLRs and their ligands (Kawai e Akira, 2006). 
 
 
7.2. TLR and lipids 
 The TLRs reported to bind lipids are TLR1, TLR2, TLR4 and TLR6; 
however, the underlying mechanisms by which lipids activate the immune system 
through TLR is not completely understood. Crystallographic data for the 
structure of a synthetic triacylated lipopetide (Pam3CSK4) bound to TLR2 and 
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TLR1 has been published (Jin, Kim et al., 2007); however, it is not clear how 
TLR2 and its co-receptors recognize the diverse set of physiological ligands with 
TLR2 agonist activity. For natural lipoproteins, it remains unknown how the 
peptide component or glycan component may influence signalling by TLR1, 
TLR2 and TLR6 (Jin, Kim et al., 2007). TLR2 agonist activity can modulate APC 
functions, including cytokine production and antigen presentation; therefore, its 
activation influences the direction of an immune response.  
TLR4 was the first described TLR (Lemaitre, Nicolas et al., 1996; 
Medzhitov, Preston-Hurlburt et al., 1997) and there is a plethora of studies 
available in this respect. TLR4 is essential for LPS recognition, which requires the 
formation of a protein complex containing accessory molecules. LPS is generally 
bound to LPS-binding protein (LBP) present in the serum and this complex is 
firstly recognized by CD14 receptor expressed in peripheral blood monocytes 
and macrophages. Once bound to CD14, LPS comes in close proximity with 
TLR4 and the secretion of myeloid differentiation (MD)-2 protein enhances the 
TLR4 signalling and triggers the inflammatory response (Hailman, Lichenstein et 
al., 1994). TLR4 also recognizes other molecules from different origins, including 
some agonists derived from plants such as taxol, a strong antitumor agent in 
humans derived from Taxus brevifolia (Kawasaki, Akashi et al., 2000) as well as 
synthetic glycolipids (Johnson, 2008).  
 LPS is well-known for generating Th1 responses. However, under 
appropriate conditions it can also support differentiation into other T-helper 
lineages, demonstrating its pleiotropic nature (Mcaleer e Vella, 2008). 
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7.3. TLR4 and allergy 
Evidence for the role of LPS in modulating Th2 immunity is robust, but 
the results obtained by different groups of investigators are still conflicting 
(Williams, Ownby et al., 2005). While some epidemiological studies claim that 
endotoxin exposure during childhood protects against the development of 
asthma later in life (Von Mutius, Braun-Fahrlander et al., 2000), other studies 
indicate that endotoxin exposure is a risk factor for asthma (Rizzo, Naspitz et al., 
1997; Thorne, Kulhankova et al., 2005). Experimental data are also controversial, 
exposure to LPS in different animal models could attenuate (Hollingsworth, 
Whitehead et al., 2006) or enhance allergic inflammation (Eisenbarth, Piggott et 
al., 2002). It is speculated that the ability of LPS to down- or up-regulate Th2-
mediated allergic responses depends on the route, concentration, timing and 
duration of LPS exposure (Tulic, Knight et al., 2001; Eisenbarth, Piggott et al., 
2002; Delayre-Orthez, De Blay et al., 2004; Hollingsworth, Whitehead et al., 
2006).  
An interesting relationship between TLR4 and allergy has been recently 
reported using the house-dust-mite allergen, Der p 2. It was demonstrated that 
Der p 2 has structural and functional homology with MD-2, the LPS-binding 
component of the TLR4 signalling complex, facilitating signalling through direct 
interactions with the TLR4 complex and reconstituting LPS-driven TLR4 
signalling in the absence of MD-2. Experimental allergic asthma was observed in 
MD-2-deficient, but not TLR4-deficient, mice sensitised to Der p 2 (Trompette, 
Divanovic et al., 2009). MD-2 belongs to the MD-like superfamily of lipid-
binding proteins and other members of this family are reported allergens 
(Ichikawa, Takai et al., 2009). Furthermore, the most defined major allergens are 
thought to be lipid-binding proteins. Thus, it can be speculated that the intrinsic 
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adjuvant activity expressed by lipid-binding proteins may have some generality as 
a mechanism underlying the phenomenon of allergenicity. 
In this vein, a phosporylcholine-containing glycoprotein secreted by 
filarial nematodes, called ES-62, is reported to directly interact with a number of 
cells of the immune system and this interaction appears to be dependent on 
complexing with TLR4 (Harnett e Harnett, 2009). It has been shown that ES-62 
can inhibit pro-inflammatory/Th1 immune responses and to actively support 
Th2 development (Harnett e Harnett, 2006). In mice, ES-62 induces the 
production of IgG1 rather than IgG2a antibodies, promotes the production of 
IL-10, and reduces levels of IL-12, IFN-ƣ DQG SUR-inflammatory cytokines 
(Houston, Wilson et al., 2000). The immunomodulatory activity of ES-62 appears 
to be largely due to the presence of phosphorylcholine moieties covalently 
attached to N-type glycans (Harnett e Harnett, 2009). Moreover, it was shown 
that in schistosome infections, schistosomal but not synthetic lyso-
phosphatidylserine activated TLR2, and induced IL-10-producing regulatory T 
cells (Van Der Kleij, Latz et al., 2002).  
Therefore, although the underlying mechanisms by which lipid 
molecules can interact with the innate and adaptive immune system are still 
unknown, it is clear they are important in the development of distinct immune 
responses.  
 
7.4. CD1 and allergy 
An additional pathway by which lipids can be recognized by the 
immune system is given by means of CD1. The CD1 proteins share sequence 
homology and overall domain structure with MHC class I molecules, being 
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comprised of a heavy chain with three extracellular domains that are non-
covalently associated with E2-microglobulin. Similar to MHC class I molecules, 
CD1 heavy chains consist of D1 and D2 domains that form the antigen-binding 
region, contained within two antiparallel D-helical structures that are situated on a 
E-folded sheet (Bauer, Huttinger et al., 1997; Zeng, Castano et al., 1997; Porcelli e 
Modlin, 1999). The D1 and D2 antigen-binding region is linked to an 
immunoglobulin-like D3 domain, which is attached to the membrane by a 
transmembrane segment, followed by a short cytoplasmic tail. However, 
differently from MHC class I molecules, CD1 proteins bind alkyl chains in 
hydrophobic channels that reside beneath the surface of CD1 molecules, whereas 
the hydrophilic head groups of lipid antigens protrude where the hydrophobic 
channels open to the membrane distal surface of the CD1 molecule. These head 
moieties are stabilized by hydrogen bonds, which also contribute to the correct 
positioning of the lipid antigens. CD1 proteins have deeper and more 
voluminous antigen-bind compartments than MHC class I molecules (Zeng, 
Castano et al., 1997; Porcelli e Modlin, 1999). 
Five isoforms of CD1 molecules have been described: CD1a, CD1b, 
CD1c, CD1d and CD1e. Humans express all CD1 isoforms whereas rodents 
express only CD1d. CD1a, CD1b and CD1c present lipid antigens to clonally 
diverse T cells while CD1d molecules present lipid antigens to natural killer (NK) 
T cells. NKT cells belong to a novel lymphoid lineage distinct from T cells, B 
cells or NK cells, and they are characterized by the expression of a single 
LQYDULDQW DQWLJHQ UHFHSWRU HQFRGHG E\ 9ơ DQG -ơ VHJPHQWV SDLUHG ZLWK D
GLYHUVH VHW RI 7&5 9Ƣ-FKDLQV PDLQO\ 9Ƣ (Godfrey, Macdonald et al., 2004; 
Kronenberg, 2005). Therefore, 9ơ 1.7 FHOOV DUH a distinct lineage of DE T 
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cells. The invariant chain in humans is VD24-JD18 and in mouse is VD14-JD18 
(Godfrey, Macdonald et al., 2004; Borg, Wun et al., 2007). The invariant 
9ơ9ƢUHFHSWRULVQRWH[SUHVVHGRQFRQYHQWLRQDO7FHOOVDQGLWVH[SUHVVLRQ
LVHVVHQWLDOIRUWKHGHYHORSPHQWRI9ơ1.7FHOOV,QIDFW the deletion of the 
-ơJHQHVHJPHQWUHVXOWVLQWKHVHOHFWLYHORVVRI1.7FHOOGHYHORSPHQW(NKT-
deficient mice) (Cui, Shin et al., 1997). 
Lipid stimulants of CD1-restricted T cells can be derived from 
mammalian cells (self lipids) or foreign sources, presenting considerable 
structural diversity. Examples of foreign lipids able to be recognized by NKT 
cells are diacylglycerols, sphingolipids, phospholipids and lipoproteins. Self lipids 
recognizable by NKT are gangliosides, phosphatidylinositols, 
phosphatidylethanolamines, phosphatidylcholine and others (Moody, 2006). $-
galactosylceramide (D-GalCer) is the most potent specific agent for activating 
9ơ+ CD1d-dependent NK T cells. A-GalCer is obtained from the marine 
sponge Agelas mauritanius and it was initially identified in a screen for agents that 
would prevent metastases of tumors to the livers of mice (Morita, Motoki et al., 
1995). The crystal structure of the TCR-D-GalCer-CD1d ternary complex was 
elucidated and the TCR of the NKT cells contact the protruding head group of 
D-GalCer and the CD1 D-helices. The footprint of the NKT-cell TCR on the 
surface of the D-GalCer-CD1d complex is parallel to the long axis of the Cd1 
binding groove and positioned in the extreme end of CD1d (Borg, Wun et al., 
2007). 
CD1d-restricted invariant (i) NKT cells represent about 1-3% of the 
normal splenic population and they comprise 10-20% more of the total T cell 
population in the liver (Matsuda, Gapin et al., 2002). Resting NKT cells have a 
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memory or partially activated phenotype and respond rapidly following TCR 
stimulation to produce cytokines, such as interferon-J (IFN-J) and IL-4. Once 
activated iNKT cells rapidly stimulate DCs, macrophages and NK cells, and 
recruit neutrophils to expand the immediate innate immune response and have 
an impact on the subsequent adaptive T-cell and B-cell responses (Barral e 
Brenner, 2007).   
VD14i NKT cells have been implicated in both the progression and the 
resolution of diverse animal models of disease. This depends on the cytokines 
produced by NKT cells and by other cell types stimulated downstream of NKT 
activation. Th2 cytokines, such as IL-4 and IL-13, have a palliative effect on 
several models of autoimmune diseases, but they are essential for the 
pathogenesis of allergic disease. Th1 cytokines, such as IFN-J aggravate 
autoimmunity and inflammatory disease models, but they are necessary for the 
clearance of infections and the prevention of tumour metastases. Possible 
mechanisms involved in the polarization of NKT cells in order to produce 
preferentially Th1 (IFN-J) or Th2 (IL-4) cytokines are still unknown. Signals such 
as antigen doses, IL-4, or IL12, involved in the polarization of Th cells did not 
affect the production of IL-4 or IFN-J by NK T cells stimulated with D-GalCer 
(Matsuda, Gapin et al., 2003).  
However, it has been reported that structural variants of D-GalCer can 
induce a systemic polarization of cytokine production initiated by NKT cells. 
OCH, an analogue of D-GalCer with a sphingosine base reduced from 18 to 9 
carbons and an acyl chain reduced by two carbons, was reported to be Th2 
polarizing (Miyamoto, Miyake et al., 2001). Contrastingly, the C-glycoside analog 
of D-GalCer has been reported to have a Th1 polarizing effect (Grajewski, 
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Hansen et al., 2008). There are indications that the cytokine polarization of NK T 
is related with the binding stability of the lipid with CD1d as well as with the 
TCR affinity. Induction of IFN-J secretion by NKT cells would require a longer 
period of stimulation and/or a higher antigen concentration while Th2-cytokines 
would be produced under decreased duration of glycolipid stimulation or 
decreased TCR affinity (Stanic, Shashidharamurthy et al., 2003; Oki, Chiba et al., 
2004). It has been suggested that the pharmacokinetic properties of glycolipids 
are a major determinant of cytokine skewing (Sullivan, Nagarajan et al., 2010). 
 The secretion of high concentrations of IL-4 by lipid-stimulated NKT 
cells has been implicated with the participation of these cells in the differentiation 
of Th2 cells (Yoshimoto, Bendelac et al., 1995; Leite-De-Moraes, Moreau et al., 
1998; Lisbonne, Diem et al., 2003). In an experimental model of allergic asthma 
using OVA as antigen, it has been demonstrated that the invariant VD14 NKT 
cell subset is required for airway eosinophilia, hyperresponsiveness, Th2 cytokine 
production, and elevated levels of IgE antibodies (Lisbonne, Diem et al., 2003). 
Other authors have reported that pollen allergic, but not normal subjects 
displayed circulating specific IgE and cutaneous reactions to phospholipids 
present in pollen (Agea, Russano et al., 2005). In addition, confocal microscopy 
revealed that the whole pollen is ingested within a few minutes, and outer 
membranes are progressively concentrated and digested within DCs cytoplasmic 
vesicles (Agea, Russano et al., 2005). These evidences support the participation of 
CD1 molecules in the presentation of lipid-antigens and its relation with allergic 
processes.  
CD1 is prominently expressed on cells involved in antigen presentation 
(APCs), binding distinct lipid-based antigens. The presentation of antigens by 
CD1 proteins usually requires uptake and intracellular processing by APCs. 
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Different mechanisms are described for the uptake of lipids, such as 
phagocytosis, C-type lectins that can bind mannose residues on glycolipids and 
internalization through scavenger receptors that can bind modified forms of low-
density lipoproteins (Barral e Brenner, 2007).  
The present work aimed to investigate the role that natural lipids from 
Brazil nuts play in the sensitisation to Ber e 1, the major allergen in Brazil nuts. 
Lipids were extracted, fractionated, and tested in an in vivo model of sensitisation 
to rBer e1. The mechanism(s) involved in the immune response induced by the 
lipid-protein complex was also investigated. The results of the experiments 
performed to address these objectives are presented and discussed in the 
following chapters. 
  
 57 
 
 
CHAPTER 2 
 
 
 
 
 
MATERIAL AND METHODS 
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1. Nuts/seeds 
Brazil nuts were purchased from a commercial supplier (Holland and 
Barrett, origin from Colombia). Sunflower seeds were purchased at local 
VXSHUPDUNHW6DLQVEXU\·V8.XQGHUWKHFRPPHUFLDOQDPHRI ¶&UD]\-DFN· 
 
2. Total lipid extraction  
,QRUGHUWRH[WUDFWOLSLGVIURPVHHGVQXWVD´)ROFKµVWDQGDUGSURWRFRO
for total lipid extraction was performed (Folch, Lees et al., 1957). Essentially, 
samples of seeds (70 g for Brazil nuts or 84 g for sunflower seeds) were 
macerated in 150 mL of chloroform : methanol (2:1) (Analytical grade, Fisher, 
UK). Seeds were ground in solvent solution using porcelain pestle and mortar. 
The paste obtained was filtered in filter paper (Whatman, UK) and dissolved in 
(100 mL) chloroform. This solution was again filtered and the dry paste obtained 
was discarded. The (250 mL) solution of chloroform and methanol (4:1) 
containing the total fraction of lipids present in the seeds was named fraction T 
and it was stored at -20ºC for further lipid fractionations and analyses.  
 
3. Lipid fractionation 
Once the total lipids were extracted, 4 procedures for fractionation were 
attempted:   
 
3.1. Fractionation by Thin-layer Chromatography (TLC)  
TLC was performed for preparative and analytical purposes following 
standard procedures (Christie, 2003). For the one dimensional preparative scale, 
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samples of total lipids (sample T above) were evaporated under vacuum in a 
rotator evaporator (Rotavapor R-3000, Buchi, UK) to eliminate the excess of 
solvent. The concentrated lipid samples were re-suspended in Chloroform : 
Methanol (2:1) and applied (2 cm from the border) to several silica gel TLC 
plates (150Å, 20cm x 20 cm glass plate and 250 µm thickness, Whatman, UK). 
The plates were firstly run all the way to the top in a saturated chamber 
containing chloroform only. The plates were then removed from the chloroform 
chamber, air dried, and placed in the same orientation in a second chamber 
containing chloroform, methanol, acetic acid and water in the proportion 50 : 
37.2 : 3.5 : 2 (v/v) (Christie, 2003) and run until the top. After air dried, the plates 
were exposed to iodine vapour for the general detection of fatty acid containing 
products (Christie, 2003). The yellowish bands were identified and individually 
removed from the plates by scraping the silica gel. The mixtures containing 
different bands of lipids and silica gel extracted from the plates were individually 
dissolved in chloroform and methanol (2:1) and the silica gel was removed by 
paper filtration (Whatman, UK). Final lipid fractions dissolved in chloroform and 
methanol solution were evaporated under vacuum in a rotator evaporator to 
eliminate the excess of solvent and they were stored in clean and glass tubes 
containing small volumes of methanol, at -20°C. 
 
3.2. Fractionation by Solid phase chromatography (SPC) 
The SPC column was packed using slurry of silica gel (35 g) (230-400 
mesh, Fluka, Germany) in chloroform onto a clean glass column (3 x 20 cm). 
Avoiding the introduction of air bubbles, the solid phase (silica gel) was 
successively washed with (150 mL) chloroform : methanol (2:1), (150 mL) 
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methanol and (300 mL) of chloroform under gravity. The washed column was 
ORDGHGZLWKWKHIUDFWLRQ7REWDLQHGE\´)ROFKµH[WUDFWLRQP/GLVVROYHGLQ
chloroform and methanol, 4:1, and the flow through fraction was named SPC 
fraction L. The subsequent fractions were: 
(1)     (150 mL) chloroform and methanol (2:1) (SPC fraction C);  
(2) (500 mL) methanol (SPC fraction M);  
(3) (800 mL) chloroform and acetic acid (9:1) (SPC fraction C:A);  
(4) (100 mL) water and acetic acid (9:1) (SPC fraction W:A);  
(5) (400 mL) methanol and acetic acid (9:1) (SPC fraction M:A).  
The samples were concentrated under vacuum conditions in a rota 
evaporator and in order to minimize oxidation, a solution containing 1 mL of 
chloroform:methanol (2:1) and 200 µL of anti-oxidant Butylated hydroxytoluene 
(BHT) 0.01% (m/v) were added to the lipids extracted. These samples were 
stored protected from light at -20°C.  
 
3.3. Fractionation by High-Performance Liquid 
Chromatography (HPLC)  
A Perklin Elmer Series HPLC was used with a Diode Array detector 
(UV-detector). The flow-rate nebulizer gas was 0.8 mL/min. A column of YMC-
Pack PVA-SIL-NP, S-5um, 12nm (100 x 4.9mm id) was obtained from TMC 
Europe GmbH. A ternary gradient elution scheme was required consisting of 
isohexane : methyltertbutyl ether (49 : 1, v/v; solvent A) and propan-2-ol : 
acetonitrile : butan-2-one (7 : 2 : 1, v/v/v; solvent B). The column temperature 
was maintained at 30°C (Christie Ww, 1998). The following gradient elution 
program was utilized (Table 2.1.): 
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Step Time (min) Flow (mL/min) Solvent A Solvent B 
0 5 0.8 100 0 
1 5 0.8 100 0 
2 10 0.8 80 20 
3 5 0.8 70 30 
4 10 0.8 0 100 
5 5 0.8 0 100 
6 5 0.8 100 0 
7 5 0.8 100 0 
Table 2.1.: Gradient elution used for HPLC.  
The SPC lipid fraction C described above extracted from Brazil nuts 
was run in the PE-HPLC system and samples were collected every 2 min for 45 
min; thus, 22 samples were obtained (HPLC fraction C 1 to HPLC fraction C 
22).Several runs of HPLC were performed in order to collect enough material of 
sub-fractions. The 22 sub-fractions were individually collected and the excess 
solvent was evaporated under vacuum conditions in a rota evaporator. The lipid 
samples were then stored in glass tubes containing (1 mL) chloroform and 
methanol (2:1) and (200 µL) of BHT (0.01%, m/v). The samples were stored 
protected from light at -20ºC. 
 
3.4. Fractionation by acetone precipitation  
Aliquots of (600 µL) of lipid samples were dissolved in (13 mL) acetone, 
mixed and centrifuged at 1,300 rpm (Mistral, UK) for 4 min at room temperature 
(Kates e Kushwaha, 1995). The supernatant, containing simple lipids (neutral and 
non-polar lipids), was evaporated under vacuum conditions in a rota-evaporator. 
The pellet, containing mainly complex lipids (polar lipids), and the concentrated 
supernatant, containing mainly simple lipids (neutral and non-polar lipids), were 
re-suspended in (900 µL) chloroform : methanol (2:1), and (200 µL), BHT 
(0.01%, m/v) and stored in glass tube protected from light at -20°C.  
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4. Lipid analysis  
4.1. TLC developing systems  
4.1.1.  One-dimension TLC: single run   
Samples of different lipid fractions were applied to TLC plates 
containing silica gel (aluminum 60 Å plates, thickness of 200 µm, Alumgram Sil 
G, Whatman, UK). The mobile phase was chloroform, methanol, acetic acid and 
water (50 : 37.2 : 3.5 : 2) (v/v) (Christie, 2003).  
 
4.1.2.  One-dimension TLC: multiple runs  
Four multiple run systems were employed using silica gel TLC plates 
(aluminum 60 Å plates, thickness of 200 µm, Alumgram Sil G, Whatman, UK). 
(a) Two runs in a chamber containing chloroform, methanol, acetic acid and 
water (50 : 37.2 : 3.5 : 2) (v/v). (b) One run in a chamber containing chloroform 
and a second run in chloroform, methanol, acetic acid and water (50 : 37.2 : 3.5 : 
2). (c) The plates run 6 times in chloroform, 1 time in chloroform, methanol, and 
water (75 : 25 : 25), and 2 times in chloroform, methanol, acetic acid and water 
(80 : 9 : 12 : 2) (Christie, 2003), (d) Two runs in the same direction, until the 
solvent reached the first half of the plate, in a chamber containing chloroform, 
methanol and water (60 : 30 : 5). And a third run in the complete plate in a 
chamber containing hexane, diethyl ether and acetic acid (80 : 20 : 1.5) (Kupke e 
Zeugner, 1978). 
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4.1.3.  Two-dimension TLC 
For identification and quantification purposes, a sample of the total 
lipids from Brazil nuts, fraction T was spotted in TLC plate (aluminum 60 Å 
plates, thickness of 200 µm, Whatman, UK). The plate was developed firstly with 
six runs in the same direction, in a chamber containing chloroform to remove 
nonpolar lipids. The next run was again in the same direction, but in a chamber 
containing chloroform, methanol and water (75 : 25 : 2.5). Once air dried, the 
plate was turned 90º to the right and two runs were performed in a chamber 
containing chloroform, methanol, acetic acid and water (80 : 9 : 12 : 2) (Christie, 
2003). 
4.1.4.  Detection of lipid bands 
In order to identify lipid samples separated by TLC systems, the plates 
were submitted to different treatments: a) exposure to iodine vapour (Iodine, 
Sigma, UK), which is a non-destructive technique that identify mainly 
unsaturated fatty acids; b) sprayed with Ninhydrin (Nynhidrin fixer spray reagent, 
Sigma, UK), kept at 100°C and 100% humidity; which stains lipids by binding to 
the amino groups; c) sprayed with Molybdenum (1.3% molybdenum blue and 
4.2M sulphuric acid ² Sigma, UK) for detection of phosphate groups, or d) 
charred in oven at 200°C, for 15 minutes in order to identify any organic 
compounds present in the plate, turning them brown.  
 
4.1.5.  Quantification of lipid classes identified by TLC 
Lipid classes detected by TLC were quantified by scanning the TLC 
plate in a densitometer (Bio-Rad, UK). The density, given by the optical density 
(OD)/mm2, and the area (mm2) occupied by each spot were quantified by a 
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dedicated software (Fluor S-Multimager). The results expressed the estimated 
percentage of different lipid classes in the sample used in the TLC plate.  
 
5. Phospholipids estimation 
The concentration of phospholipids present in different lipid fractions 
from Brazil nuts was estimated by determining the amount of phosphorus 
present in the fraction (Christie, 2003). Samples of the different fractions of lipids 
were dried under nitrogen gas (BOC, UK). Samples were placed in glass tubes 
and digested with concentrated perchloric acid (98% purity, Sigma-Aldrich, UK) 
by gentle refluxing in an air condenser for 2-3 hours on a heating block at 200-
300° C in a fume cupboard. When the solutions were clear and cooled, (400 µL) 
ammonium molybdate reagent (4.4 g/L of 1.4% sulphuric acid (v/v)), (200 µL) 
reducing reagent (sodium bisulphate (2.5 g), sodium sulphate (0.5 g) and amino-
naphtol sulphonic acid (0.042 g) dissolved in 250 mL of water); and water (4 mL) 
were added. The samples were read in spectrophotometer at 700 nm every 30 
minutes for 2 hours. The amount of phosphorus in the samples was read from a 
calibration curve, prepared at the same time by performing the reaction on 
known amounts (4 to 0.015 mM) of a standard solution of NaH2PO4. 
 
6. Animals 
6.1. Animals at the University of Nottingham 
Animals kept in our facilities were used for sensitisation protocols 
(Chapters 4 and 5) and PCA technique (Chapters 4, 5 and 6). Young adult (8²12 
weeks old) female BALB/c strain mice used throughout these studies were 
obtained from Harlan Seralab, Oxfordshire, UK or bred in our animal facilities. 
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Food and water were available ad libitum. Rodent maintenance diet was used 
(2018 Tecklad Global, 18% protein rodent diet, Harlan, UK). The diet 
composition includes wheat, corn, soybean, corn gluten, soybean oil, brewer 
yeast, vitamins and minerals. Importantly, the diet does not contain any traces of 
Brazil nuts or sunflower seeds. The ambient temperature was maintained at 
21±2°C and relative humidity was 55 ± 10% with a 12 h light/dark cycle. All 
experiments were carried out under a Home Office Licence, following the 
guidelines of the UK Animals (Scientific Procedures) Act, 1986. 
 
6.2. Animals at the Hospital Necker, Paris 
 The experiments with animals to study NKT activation were 
performed in the Centre National de la Recherche Scientifique (CNRS), Unite´ 
Mixte de Recherche 8147, Hospital Necker, Paris, France, under supervision of 
Prof. Maria Leite-de-Moraes. 
6.2.1.  BALB/c wild type mice 
Young adult (8²12 weeks old) male BALB/c mice were bred in the 
facilities of Centre National de la Recherche Scientifique (CNRS), Unite´ Mixte 
de Recherche 8147, Hospital Necker, Paris, France. Animals were kept in well-
controlled animal housing facilities and had free access to tap water and pellet 
food throughout the experimental period. The animal diet did not contain Brazil 
nuts. 
 
6.2.2.  C57BL/6 wild type and JD18 knockout mice 
Young adult (8²12 weeks old) male C57BL/6 wild-type (WT) and JD18 
-/- were bred in the facilities of Centre National de la Recherche Scientifique 
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(CNRS), Unite´ Mixte de Recherche 8147, Hospital Necker, Paris, France. 
Animals were kept in well-controlled animal housing facilities and had free access 
to tap water and pellet food throughout the experimental period. The animal diet 
did not contain Brazil nuts. 
 
7. Sensitisation protocols 
 
Sensitizing protocols consisted in two subsequent intra-peritoneal (i.p.) 
injections of protein solutions on days 0 and 7. Protein solutions· details are 
exposed in the following sections (Items 7.1. and 7.2). Animals were bled 
fourteen days after the first sensitisation injection (day 14). The exsanguinations 
were performed by intra-cardiac route under lethal doses of pentobarbital 
VRGLXP DSSUR[LPDWHO\  Ƭ/ SHU DQLPDO 'ROHWKDO LQMHFWLRQ  PJP/
9HWRTXLQRO8.$QDYHUDJHYROXPHRIƬ/RIEORRGZDVFROOHFWHGLQP/
plastic vials (Standard Micro Test Tube, Eppendorf, UK), stored at 4°C 
overnight and centrifuged at 8000 rpm for 4 min (Sanyo/MSE Hawk 15/05, 
8.$QDYHUDJHRIƬ/RIVHUXPZDVUHFRYHUHGIURPHDFKEORRGVDPSOHDQG
 Ƭ/ DOLTXRWV ZHUH VWRUHG LQ  P/ SODVWLF YLDOV 6WDQGDUG 0LFUR 7HVt Tube, 
Eppendorf, UK) at -80°C.   
 
7.1. OVA sensitisation  
BALB/c mice received two subsequent intra-peritoneal (i.p.) injections 
of solutions containing 2.5 mg of Grade V chicken egg OVA (Sigma, UK) in 200 
µL of phosphate buffered saline (PBS; composed by 8 g of NaCl, 0.2 g of KCl, 
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1.44 g of Na2HPO4, 0.24 g of KH2PO4 in 1 L of distilled water)  on days 0 and 7. 
Animals were bled fourteen days after the first sensitisation injection (day 14). 
Serum collection and storage were performed as described above (Item 7).  
 
7.2. BER-lipid -sensitisation 
BALB/c mice received two subsequent intra-peritoneal (i.p.) injections 
RIVROXWLRQVFRQWDLQLQJPJRIU%HUHDQGƬJRIGLIIHUHQWOLSLGfractions 
in 200 µL of PBS, on days 0 and 7. Details of BER-lipid solution preparation are 
given below (Item 7.2.1). Animals were bled fourteen days after the first 
sensitisation injection (day 14). Serum collection and storage were performed as 
described above (Item 7). 
  
7.2.1.  Preparation of BER-lipid sensitisation solution 
Ber experimental groups were sensitised with solutions containing 2.5 
PJ RI SURWHLQ DQG  ƬJ OLSLG IUDFWLRQ & 3URWHLQ VROXWLRQ ZDV SUHSDUHG
dissolving lyophilised rBer e 1 in deionized water to a concentration of 16 
mg/mL. The appropriate amount of lipids stored in chloroform and methanol 
(2:1) solution was evaporated under nitrogen gas (Nitrogen compressed gas, 
BOC, UK) and ressuspended in methanol. The volume of methanol used to 
dissolve the lipids was equivalent to 20% of the protein solution used. Lipid 
solution was dropwise added to the protein solution and mixed thoroughly in 
order to avoid protein precipitation. All procedures were performed in cleaned 
and defatted glass tubes to avoid lipid contamination and lipid losses. The final 
lipid-protein solution was freeze-dried and ressuspended in PBS adjusted to a 
ILQDOYROXPHRIƬ/DQLPDO)RUFRQWUROJURXSVWKHVROXWLRQZDVSUHSDUHGDV
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described before, but no lipids were used, methanol alone was added to the 
protein solution.  
 
7.3. Ber-LPS sensitisation  
Lipopolysaccharide (LPS) from Escherichia coli (0111:B4; Sigma, UK) 
diluted in PBS was added to Ber e 1. The dose of protein used was 2.5 mg and 
the doses of LPS ranged from 0.06 to 150 µg per animal, per sensitisation. The 
doses used are specified in each experiment, Results and Discussion section, 
Chapter 5.  
 
7.4. Sensitisation using Alum 
Two different sensitisation protocols were performed using alum 
(AlOH3) (Imject alum, Thermo Scientific Pierce, UK) as adjuvant.  
 
7.4.1. Alum protocol 1 
BALB/c mice received two i.p. injections containing 2.5 mg of protein 
(rBer e 1 or OVA) and 2 mg of alum, diluted in 200 µL of PBS on days 0 and 7. 
Animals were bled on day 14. Serum collection and storage were performed as 
described above (Item 7). 
 
7.4.2. Alum protocol 2  
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BALB/c mice received two i.p. injections containing 2.5 mg of protein 
(rBer e 1 or OVA) and 2 mg of Alum in 200 µL of PBS on days 0 and 7. Then, 
animals received two additional i.p. injections containing of 2.5 mg of protein 
(Ber e 1 or OVA) on days 14 and 21. Animals were bled on day 28. Serum 
collection and storage were performed as described above (Item 7). 
 
7.5. SFA-sensitisation 
BALB/c mice received two subsequent intra-peritoneal (i.p.) injections 
of solutions containing 2.5 mg of SFA-DQGƬJRIGLIIHUHQWOLSLGIUDFWLRQVLQ
200 µL of PBS, on days 0 and 7. Animals were bled fourteen days after the first 
sensitisation injection (day 14). Serum collection and storage were performed as 
described above (Item 7).  
 
8. PCA 
Individual and/or pooled serum samples (25 µL) were injected into the 
dermis of the ears of naïve recipient mice using 30 gauge needles (Microlance 
needles, BD, UK) and 50 PL glass syringes (Microlitre glass syringe, Luer tip, 
Hamilton, UK). To facilitate the intra-dermal injection and avoid any animal 
suffering, animals were anesthetised with a mixture containing Ketamine (100 
mg/kg, Ketaset® Injection, Fort Dodge, UK) and Acepromazine (2.5 mg/kg) 
intra-peritoneally. The anesthetic solution was prepared mixing 1 mL of 
ketamine, 1.25 mL of acepromazine and 3.875 mL of distilled water. The final 
volume injected was 0.1 mL/20 g of animal. The intra-dermal injection was 
performed as soon as the animal showed signs of adequate sedation. Animals 
were kept in warm environment (around 30°C) until the total recover from the 
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anesthesia). Two days later a protein solution containing dye was injected 
intravenously by tail veins. The protein solution was composed by 0.25 mg of 
relevant protein (OVA or BER) + Evans blue dye (1.25 mg) diluted in 0.25 mL 
of physiological saline solution (0.9% m/v, NaCl). The intravenous injection was 
also conducted under anesthesia using a mixture containing Ketamine (100 
mg/kg) and Medetomidine (1 mg/kg, Dormitor®, Pfizer, UK). The anesthetic 
solution was prepared mixing 0.75 mL of ketamine, 1 mL of medetomidine and 
3.825 mL of distilled water. The final volume injected was 0.1 mL/20 g of 
animal. The intravenous challenge injection was performed when the animal 
presented signs of deep anesthesia, i.e. absence of reflexes, absence of motor 
response to noxious stimuli, increase in depth and decrease in respiration rate. 
Animals were kept in a heating box at 39°C for thirty minutes following the 
challenge and then culled. The diameter of cutaneous reactions present on the ear 
lobe was measured in millimeters with a Vernier caliper (Absolute Digimatic 
caliper, Mitutoyo, USA). Diameters higher than 3 mm were considered as 
positive reactions. 
 
8.1. Heating treatment    
 Specific anti-OVA IgE (Serotec, UK) was added to serum from naïve 
animals at 25,600 ng/mL and serially diluted in serum from naïve animals until 
reaching the concentration of 10 ng/mL. Pooled sera from OVA-sensitised 
animals were serially diluted in serum from naïve animals ranging from neat to 
 $OLTXRWV RI  Ƭ/ RI DOO VHUXP VDPSOHV ZHUH LQFXEDWHG LQ  P/ 3&5
tubes (PCR tubes, Eppendorf, UK) and heated at 56ºC in a PCR machine 
(GeneAmp 2400 Applied Biosystem, UK) for 1 hour; following the protocol 
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previously described (Faquim-Mauro, Coffman et al., 1999). Control serum 
samples were kept at 4ºC. These samples were tested in mice for PCA reactions 
(described in Item 8).  
 
8.2. Protein G adsorption  
For removal of IgG, equal volumes of protein G-agarose 
(Calbiochem®, Merck Biosciences, UK) and mouse serum were employed. This 
procedure was adapted from the literature (Lehrer, Reish et al., 2004) and 
performed with pooled serum from OVA-sensitised mice and with serum from 
naive mice containing 6,400 ng/mL of commercial anti-OVA IgE (Serotec, UK).  
For this, 300 µL of neat OVA-sensitised mice serum was mixed with 300 µL of 
protein G in 1.5 mL vial (Standard Micro Test Tube, Eppendorf, UK). In 
another vial, 300 µL of serum containing commercial anti-OVA IgE (6.4 µg/mL) 
was mixed with 300 µL of protein G. The sample vials were incubated for 30 min 
at room temperature, centrifuged at 3000 g (Sanyo/MSE Hawk 15/05, UK) for 2 
min and the supernatants were collected. The supernatant from OVA-sensitised 
mice serum sample was further diluted 8 times in serum from naive animals (1/8 
diluted serum). The supernatant from serum containing commercial anti-OVA 
IgE was diluted in serum from naive mice to reach the concentrations of 1,600 
and 400 ng/mL. These samples were tested in mice for PCA reactions (described 
in Item 8).  
 
8.3. PCA time course 
PCA procedure described above (Item 8) was performed in a group of 
10 naïve recipient mice with serum from OVA-sensitised animals and a different 
 72 
group of 10 animals with serum containing only commercial anti-OVA IgE (3.2 
ƬJP/7KHFKDOOHQJHLHWKHLQWUDYHQRXVLQMHFWLRQRI29$DQG(YDQV·EOXH
was performed 2, 3, 5, 7 or 12 days after the i.d. serum injection, using 2 animals 
for each challenge.  
 
9. NKT activation protocols 
9.1. NKT activation protocol 1 
9.1.1. Animal procedure 
 
At T=0h, BALB/c mice received (i.p.) 2.5 mg of rBer e 1 and 600 Pg of 
SPC fraction C (n=3) or SPC fraction M (n=3) extracted from Brazil nuts lipids. 
A positive control group received 2 Pg of D-GalCer (Kirin Brewery Co., Japan) 
(n=2) and two naive mice were used as negative control. Two hours later (T=2h) 
animals were euthanized and the spleens were removed for flow cytometry 
analyses (FACs). 
 
9.1.2. Splenocytes preparation  
Spleens promptly removed from mice were kept in individual tubes (50 
mL Falcon Test Tubes, BD, France) containing 15 mL of 2% of foetal calf serum 
(FCS) (Sterile FCS, BD) in PBS. Spleens were smashed in cell strainers (Cell 
strainer, 70 Pm, BD). And the cell suspensions obtained after straining were 
centrifuged at 1,200 rpm, at 4ºC for 5 min. The supernatant was discarded and 
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500 PL of FCS was added to each sample and mixed thoroughly. 2 mL of red 
blood cells lysing solution (Pharm Lyse lysing buffer, BD, France) was added to 
the samples, 2 min later 15 mL of PBS containing  2% of FCS was added to the 
tubes and they were centrifuged at 1,200 rpm, at 4ºC for 5 min. The supernatant 
was discarded and the cells resuspended with 2 mL of PBS, 2% FCS. Samples of 
cells suspensions were diluted 1/10 and 1/100 in Trypan Blue solution (Trypan 
Blue solution, 0.4%, Sigma, France) and the viable cells (not blue) were counted 
in a haemocytometer glass chamber. Two aliquots of 4 x 106 cells from each 
animal were prepared for the extracellular staining and two aliquots of 6 x 106 
cells from each animal were prepared for intracellular staining. Individual cell 
aliquots were stored in 1.5 mL plastic vials (Standard Micro Test Tube, 
Eppendorf, France) at 4ºC. 
 
9.1.3. Cell staining 
9.1.3.1. Surface staining  
TCR, CD8, CD4, CD69 labelling  
One aliquot of 4 x 106 cells from each animal was centrifuged at 1,200 
rpm, at 4ºC for 5 min and the supernatant was discarded. Cells suspensions were 
incubated for 30 min at 4ºC with tetrameter CD1d-D-GalCer-biotinylated (NHI 
Tetramer facilities, France) and anti-biotin-APC (Allophycocyanin) antibodies 
(BD, Pharmingen, France). Cells suspensions were washed in cold staining buffer 
(2% FCS, 0.1% Sodium Azide in PBS), centrifuged at 1,200 rpm, at 4ºC for 5 
min and the supernatant was discarded. Cells suspensions were then incubated 
for 30 min at 4ºC with a mixture containing anti-TCR-FITC (Fluorescein 
isothiocyanate) antibodies (BD, Pharmingen, France), anti-CD8-PB (Pacific Blue) 
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antibodies (BD, Pharmingen), anti-CD4-APC H7 antibodies (eBiosciences, 
France) and anti-CD69-PE (Phycoerythrin) antibodies (BD, Pharmingen, France) 
diluted in staining buffer. The cells were washed with cold staining buffer, 
centrifuged, and the supernatant was discarded. Cells were then fixed with 600 
µL of 4% paraformaldehyde PBS solution. Cells were again washed with staining 
buffer, centrifuged, and the supernatant was discarded. Cells were re-suspended 
in 800 µL of FACSCanto II flow cytometry buffer (BD, Pharmingen, France). 
TCR, Dx5, and CD24 labelling   
Another aliquot of 4 x 106 cells from each animal was centrifuged at 
1,200 rpm, at 4ºC for 5 min and the supernatant was discarded. Cells suspensions 
were incubated for 30 min at 4ºC with a mixture containing anti-Dx5-FITC 
antibodies (BD, Pharmingen, France), anti-CD24-PB (BD, Pharmingen, France) 
and anti-TCR-APC (Pharmingen, France). Cells suspensions were washed with 
cold staining buffer and again centrifuged. The supernatant was discarded and 
the cells were fixed with 600 µL of 4% paraformaldeid PBS solution. Cells were 
washed with cold staining buffer, centrifuged and the supernatant was discarded. 
Cells were re-suspended in 800 PL of FACSCanto II flow cytometry buffer (BD, 
Pharmingen, France). 
 
9.1.3.2. Intracellular staining 
Two aliquots of 6 x 106 cells from each animal were centrifuged at 1,200 
rpm, at 4ºC for 5 min and the supernatant was discarded. Cells suspensions were 
first incubated for 30 min at 4ºC with surface tetrameter CD1d-D-GalCer-
biotinylated (NHI Tetramer facilities, France) and anti-biotin-APC antibody (BD, 
Pharmingen, France). Cells were washed in cold staining buffer, centrifuged and 
the supernatant was discarded. Cells suspensions were then incubated for 30 min 
 75 
at 4ºC with a mixture containing anti-TCR-FITC (BD, Pharmingen, France) and 
anti-CD4-PB (eBiosciences, France).  
IL-4 and IFN-J labelling 
To intracellular staining, one aliquot of cells suspension was washed 
with cold staining buffer and again centrifuged. The supernatant was discarded 
and cells were permeabilized and fixed with 900 µL of 4% paraformaldehyde + 
0.5% saponin PBS solution (Sigma-Aldrich, France) for 30 min at room 
temperature. Cells suspensions were centrifuged, the supernatant was discarded 
and the cells were washed. The cells were then incubated for 45 min at 4ºC with a 
mixture of anti-IL-4-PECy7 antibodies (eBiosciences, France) and anti-IFNJ-PE 
antibodies (BD, Pharmingen, France) in PBS 0.5% saponin buffer (Sigma-
Aldrich, France). Cells suspensions were washed with PBS 0.5% saponin buffer 
(Sigma-Aldrich, France) and again centrifuged. The supernatant was discarded 
and cells were fixed with 900 µL of 4% paraformaldeid PBS solution. Cells were 
washed with cold staining buffer, centrifuged, and the supernatant was discarded. 
Cells were re-suspended in 1,200 PL of FACSCanto II flow cytometry buffer 
(BD, Pharmingen, France). 
 Control antibodies (Ig) labelling  
To cellular staining, another aliquot of cells suspension was washed with 
cold staining buffer and again centrifuged. The supernatant was discarded and 
cells were permeabilized and fixed with 900 µL of 4% paraformaldehyde + 0.5% 
saponin PBS solution. Cells suspensions were centrifuged, the supernatant was 
discarded and the cells were washed. The cells were then incubated for 45 min at 
4ºC with isotype control antibodies: anti-Ig-PECy7 (BD, Pharmingen, France) 
and anti-Ig-PE (BD, Pharmingen, France) in PBS 0.5% saponin buffer (Sigma-
Aldrich, France). Cells suspensions were washed with PBS 0.5% saponin buffer 
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(Sigma-Aldrich, France) and again centrifuged. The supernatant was discarded 
and cells were fixed with 900 µL of 4% paraformaldeid PBS solution. Cells were 
washed with cold staining buffer, centrifuged, and the supernatant was discarded. 
Cells were re-suspended in 1,200 PL of FACSCanto II flow cytometry buffer 
(BD, Pharmingen, France). 
 
9.1.4. Flow cytometry analyses 
Stained cells were acquired in a flow cytometric FACSCanto II (Becton 
Dickinson, BD, Pharmingen, France) and data analyzed using FlowJo software 
(Flow Cytometry Analysis Software, USA).  
 
9.2. NKT activation protocol 2 
9.2.1. Animal procedure 
 
C57BL/6 WT (n=5) and JD18 -/- (n=5) received two subsequent i.p. 
LQMHFWLRQV RI VROXWLRQV FRQWDLQLQJ  PJ RI U%HU H  DQG  ƬJ RI 63& OLSLG
fraction C in 200 µL of PBS, on days 0 and 7 (Protein-lipid solution preparation 
described in the Item 7.2.1. Animals were bled fourteen days after the first 
sensitisation injection (day 14). The exsanguination was performed by intra-
cardiac route under lethal doses of pentobarbital sodium (Dolethal® injection, 
 PJP/ 9HWRTXLQRO 8. $Q DYHUDJH YROXPH RI  Ƭ/ RI EORRG ZDV
stored at 4°C in 1.5 mL vials (Standard Micro Test Tube, Eppendorf, UK) 
overnight, centrifuged at 8000 g for 4 min (Sanyo/MSE Hawk 15/05, UK). An 
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DYHUDJHRIƬ/RIVHUXPZDVUHFRYHUHGIURPHDFKEORRGVDPSOHDQGƬ/
aliquots were stored in 0.5 mL vials (Standard Micro Test Tube, Eppendorf, UK) 
at -80°C. The spleen was collected for further analyses. 
 
9.2.2. Splenocytes preparation 
The same as described above (Item 9.1.2.).  
9.2.3. Cell staining 
9.2.3.1. Surface staining 
One aliquot of 4 x 106 cells from each animal was centrifuged at 1,200 
rpm, at 4ºC for 5 min and the supernatant was discarded. Cells suspensions were 
incubated for 30 min at 4ºC with tetrameter CD1d-D-GalCer-biotinylated (NHI 
Tetramer facilities, France) and anti-biotin-APC antibody (BD, Pharmingen, 
France) diluted in staining buffer (2% FCS, 0.1% Sodium Azide in PBS). Cells 
suspensions were washed in cold staining buffer, centrifuged at 1,200 rpm, at 4ºC 
for 5 min and the supernatant was discarded. Cells suspensions were then 
incubated for 30 min at 4ºC with a mixture containing anti-TCR-FITC antibodies 
(BD, Pharmigen, France), anti-CD8-PB antibodies (BD, Pharmingen), anti-CD4-
APC H7 antibodies (eBiosciences, France) and anti-CD69-PE antibodies (BD, 
Pharmingen, France) diluted in staining buffer. Cells were washed with cold 
staining buffer, centrifuged, and the supernatant was discarded. Cells were then 
fixed with 600 µL of 4% paraformaldehyde PBS solution. Cells were again 
washed with staining buffer, centrifuged, and the supernatant was discarded. 
Cells were re-suspended in 800 µL of FACSCanto II flow cytometry buffer (BD, 
Pharmingen, France). 
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9.2.4. Flow cytometry   
Cells were analyzed in a FACSCanto II (Becton Dickinson) by using 
FlowJo software (Flow Cytometry Analysis Software, USA).  
 
10. ELISA (Enzyme-linked immuno sorbent assay) 
10.1. Total Immunoglobulins 
Total mouse IgG1/IgG2a and IgE content were determined by ELISA 
using commercial kits (Bethyl Laboratories®, USA) following the manufactXUHU·V
instructions and adapted to a 384 well-plate scale. In brief, 384 well-Maxisorp 
plates (Nunc, Copenhagen, Denmark) were coated with purified goat anti-mouse 
IgG1/IgG2a or IgE in carbonate buffer (0.05 M carbonate-bicarbonate pH 9.6) 
at room temperature (RT) for one hour (25 µL/well). After three consecutive 
washes with washing buffer - 50 mM Tris, 0.14 M NaCl and 0.05% (w/v) Tween-
20 at pH 8 - plates were blocked with 50 mM Tris, 0.14 M NaCl and 1% bovine 
serum albumin (BSA) at pH 8.0 for 30 minutes at RT (50 µL /well). Then 
incubated with either animal sera or standard antibody at appropriate dilutions 
with sample dilution buffer (50 mM Tris, 0.14 M NaCl, 0.05% (w/v), 1% BSA, 
pH 8.0), for one hour at RT. Detection was carried out using a goat anti-mouse 
IgG1/G2a/E ² horseradish peroxidase antibody diluted in sample dilution 
buffer, for one hour at RT (25 µL /well). For visualization, a ready-to-use 
substrate containing 3,3´,5,5´- tetramethylbenzidine (Tebu-Bio laboraties) was 
added to each well and incubated for 30 minutes at RT in the dark (25 µL/well).  
The reaction was stopped with the addition of 2M H2SO4 (25 µL /well) and the 
absorbance measured at 450 nm using FLUOstar Galaxy microplate reader 
(BMG Labtech, Germany). Standard curves (optical density, OD, versus 
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concentration) detecting minimum and maximum saturation points presented a 
sigmoidal shape and were analyzed using Weibull Distribution Model 
(CurveExpert 1.4 Software). The equation generated was equivalent to: 
. The concentration (ng/mL) correspondent to the OD 
values obtained from each sample dilution was calculated using the equation 
above. The results represent the average of the concentrations from all dilutions 
referent to the same sample.  
 
10.2. Specific Immunoglobulins 
Specific IgG1/IgG2a content was determined by ELISA using 
FRPPHUFLDO NLWV %HWK\O /DERUDWRULHV 86$ IROORZLQJ WKH PDQXIDFWXUHU·V
instructions and adapted to a 384 well-plate scale. Basically, 384 well-Maxisorp 
plates (Nunc, Copenhagen, Denmark) were coated with protein solution at 400 
µg/mL (rBer e 1) in carbonate buffer (0.05 M carbonate-bicarbonate pH 9.6) at 
room temperature for one hour (25 µL/well). After three consecutive washes 
with washing buffer - 50 mM Tris, 0.14 M NaCl and 0.05% (w/v) Tween-20 at 
pH 8 - plates were blocked with 50 mM Tris, 0.14 M NaCl and 1% bovine serum 
albumin (BSA) at pH 8.0 for 30 minutes at RT (50 µL/well). Then incubated 
with either animal sera or standard antibody at appropriate dilutions with sample 
dilution buffer (50 mM Tris, 0.14 M NaCl, 0.05% (w/v), 1% BSA, pH 8.0), for 
one hour at RT. Detection was carried out using a goat anti-mouse IgG1/G2a ² 
horseradish peroxidase antibody diluted in sample dilution buffer, for one hour at 
RT (25 µL/well). For visualization, a ready-to-use substrate containing 3,3´,5,5´- 
tetramethylbenzidine (Tebu-Bio laboraties), was added to each well and 
incubated for 30 minutes at RT in the dark (25 µL/well).  The reaction was 
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stopped with the addition of 2M H2SO4 (25 µL/well) and the absorbance 
measured at 450nm using FLUOstar Galaxy microplate reader (BMG Labtech, 
Germany). Standard curves were performed as described in the previous item 
(10.1.)  
 
11. TLR activation  
Samples of SPC fraction C were sent to a commercial laboratory 
(Invivogen, Toulouse, France) for an in vitro cell screening of human (h)TLR 
activation. The samples were tested on recombinant HEK-293 cell line that 
functionally expresses a given TLR protein as well as a reporter gene driven by 
NFkB promoter. The TLR activation results were given as optical density values 
(OD). Each 293-TLR cell line was induced with a known specific ligand as a 
positive control. Samples were tested in parallel. The positive control ligands 
used were: PAM2 (100 ng/mL) for the 293-hTLR2 cell line; Poly I:C (100 
ng/mL) for the 293-K7/5FHOOOLQH/36.ƬJP/IRUWKH-hTLR4 cell 
OLQH)ODJHOOLQƬJP/IRUWKH-K7/5FHOO OLQHV5ƬJP/IRUWKH
293-hTLR7 and  293-K7/5DQG2'1ƬJP/IRUWKH-hTLR9. A 
recombinant HEK-293 cell line for the reporter gene driven by NFkB promoter 
only was used as a negative control for the TLR cell lines. The negative control 
value for each clone was the background signal of these non induced clones. 20 
Ƭ/RIHDFKVDPSOHWREHWHVWHG63&OLSLGIUDFWLRQ&IURP%UD]il nuts) was used 
WRVWLPXODWHDOOWKHFHOOOLQHVLQDƬ/RIUHDFWLRQYROXPH 
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12. Endotoxin detection 
Freeze-dried samples of SPC lipid fraction L (Loading) and SPC lipid 
fraction C (C:M) were sent to a commercial laboratory (Profos AG, Regensburg, 
Germany) for detection of endotoxins by limulus amebocyte lysate (LAL) assay 
(Lonza, BioSciences, Lot GL017U). Detailed information is available in 
Appendix 2.   
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CHAPTER 3 
 
 
 
 
LIPIDS FROM BRAZIL NUTS: 
EXTRACTION AND FRACTIONATION. 
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INTRODUCTION 
This chapter describes a series of experiments undertaken to address 
objective 1 of the present project:  to extract and fractionate lipids from Brazil 
nuts.  This chapter therefore provides a description of the lipid content of Brazil 
nuts, an overview of the methodology used in its fractionation and the main lipid 
analytical tools utilised in this project; thus, focusing on the isolation, putative 
identification and characterization of Brazil nuts lipid fractions that would be 
tested in in vivo and in vitro systems. 
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RESULTS and DISCUSSION 
 
1. Total lipid fraction of Brazil nuts 
In order to characterize the total lipid fraction from Brazil nuts, total 
lipids were extracted E\´)ROFKµSURFHGXUH (as described in Chapter 2, Item 2) 
and analysed by two-dimension TLC.  
 
Figure 3.1.: A sample of total lipid fraction (fraction T) developed in a two-
dimension TLC system, as described in Chapter 2 (Item 4.1.3.). The plate was 
sprayed with molybdenum and then burned at 200°C for 1 hour.  
 
 
 
As shown in Figure 3.1., the total lipid fraction from Brazil nuts was 
fractionated into several sub-fractions, represented by dark spots in the TLC 
plate. The lipid classes present in these sub-fractions were putatively identified 
based on standard two-dimension TLC results in the literature, shown in Figure 
3.2.. (Kupke e Zeugner, 1978). The most abundant spot was observed in the 
upper-right side of the figure and it is composed by simple lipids The spots 
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identified by numbers (1 to 7) represent different classes of complex lipids and 
the identification is shown in Table 3.1. 
  
Figure 3.2.  Schematic representation of two-dimensional TLC separation of 
complex lipids from A. thaliana. TLC system (Kupke e Zeugner, 1978). Lipid 
classes identified:  monogalactosyldiacylglycerols (MGDG); 
digalactosyldiacylglycerol (DGDG); sulfoquinovosyldiacylglycerol (SQDG); 
diphosphatidylglycerol (DPG); phosphatidylglycerol (PG); 
phosphatidylethanolamine (PE); phosphatidylinositol (PI); 
phosphatidylserine(PS); and phosphatidylcholine (PC).  
 
In order to estimate the contribution of different lipid classes present in 
the total lipid fraction, four replicates of the two-dimensional TLC plate 
described above (Figure 3.1.) were scanned and, based on the density, the 
estimated percentage of the lipid classes were measured (Table 3.1.). Since the 
quantification was based on the optical density (OD) divided by the occupied 
area, the fraction of simple lipids could not be quantified by this method. Due to 
its high concentration, the optical density of this fraction was probably over the 
 86 
limit of detection and the values would be mistakenly underestimated. Therefore, 
only identified classes of complex lipids were quantified by this method.  
The total amount of phosphorus present in the fraction T of Brazil nuts 
was calculated as 100.6 mM (Method described in Chapter 2, Item 5). Assuming a 
mean molecular weight (MW) of phospholipids in the range of 800, the 
concentration of phospholipids in the fraction T can be estimated as 
approximately 301.7 mg/L. Based on this value, the concentrations of the 
different classes of phospholipids were estimated and are also shown in Table 
3.1. This result was comparable to the total phospholipid content of Brazil nuts 
found in the literature, in which the phosphorus concentration of Brazil nut oil 
was 377 mg/L (Chunhieng 2008). 
 
Spot Lipid  Area (mm2) Density 
(OD/mm2) 
Estimated 
percentage  
Estimated 
concentration 
1 SQDG 17.2 + 10.7 135.5 + 20.9 19 % 57.2 mg/L 
2 PI 20.1 + 14.1 95.9 + 3.6 14  % 42.2 mg/L 
3 PC 27.3 + 19.5 113.8 + 14 16 % 48.3 mg/L 
4 PG 12.1 + 5.9 72.9 + 10.3 10 % 30.2 mg/L 
5 PE 13.3 + 9.1  107.7 + 18.8 15 % 45.3 mg/L 
6 MGDG 11.5 + 10.5 115 + 10.9 16 % 48.3 mg/L 
7 PA 5.4 + 3.2 70.7 + 8.5 10 % 30.2 mg/L 
 
Table 3.1.: Seven lipid classes present in the total lipid fraction from Brazil nuts, 
observed in a two-dimension TLC (Figure 3.1.). Results are in means of 
quadruplicate. Legend: Sulfoquinovosyldiacylglycerol (SQDG); 
phosphatidylinositol (PI); phosphatidylcholine (PC), phosphatidylglycerol (PG); 
phosphatidylethanolamine (PE); monogalactosyldiacylglycerols (MGDG) and 
phosphatidic acid (PA). OD: optical density. 
 
The estimated percentage of lipid classes identified in the complex lipid 
fraction of Brazil nuts varied from 10% to 19% (Table 3.1.). Unexpectedly, the 
putative sulfoquinovosyldiacylglycerol (SQDG) was more abundant than the 
other classes, and the least abundant fractions were PG and PA. However, the 
phospholipid profile of Brazil nuts demonstrated here was similar to the data 
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found in the literature, in which the main phospholipids found in Brazil nuts 
were PI (30%), PC (24%), PE (21%), and PA (24%) (Chunhieng 2008). Similar 
results were also found in a study with hazelnut, in which the main phospholipids 
found in hazelnuts were PC, PE, and PI (Parcerisa, Codony et al., 1999).  
In order to estimate and compare the global contribution of total 
phospholipids, the total phospholipid content in oils from different nuts was 
shown to be at levels of 0.8% in almond oil, 2.8% in hazelnut oil, and 0.9% in 
walnut oil. The major components, identified by TLC systems, were PC (18²
50%), PI (18²45%), and PE (8²16%). Small amounts of phosphatidylserine (PS), 
phosphatidic acids (PA), phosphatidylglycerols (PG), lysophosphatidylcholine, 
and lysophosphatidylethanolamine were also detected (Zlatanov M., Ivanov S. et 
al., 1999).  
 
2. Fractionation of lipids from Brazil nuts 
In order to identify potential biologically active lipids present in Brazil 
nuts, several lipid fractions were produced by four independent fractionation 
procedures: thin-layer chromatography (TLC), solid phase chromatography 
(SPC), and high-performance liquid chromatography (HPLC), and acetone 
preciptation. The fractions obtained by these different methods were analysed 
and then tested in an animal model of sensitisation to rBer e 1. The in vivo results 
are discussed in Chapter 5.  
 
2.1. Lipid fractionation by acetone precipitation and TLC 
Acetone precipitation is a simple and efficient procedure for separating 
complex lipids from neutral lipids (Kates e Kushwaha, 1995). The total lipid 
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fraction was extracted from Brazil nuts and then fractionated by acetone 
precipitation (as described in Chapter 2, Item 3.4.). Two fractions were obtained: 
pellet (rich in complex lipids) and supernatant (rich in simple lipids). The 
complex lipids-rich fraction was further fractionated by preparative TLC system.  
 
Figure 3.3.: One-dimension TLC plate developing system (as described in 
Chapter 2, item 4.1.2.a) was performed with a sample of complex lipids extracted 
from the total fraction of Brazil nuts. The plate was exposed to iodine vapour 
and ten yellow bands (Bands 1 - 10) were observed. Legend: triglycerides (TG); 
phosphatidylethanolamine (PE); Sulfoquinovosyldiacylglycerol (SQDG); 
phosphatidylcholine (PC).  
 
 
Figure 3.3. shows the ten bands (yellow) observed after iodine vapour 
exposure, which is a non-destructive method of detection. In order to identify 
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the lipid classes detected, samples of these 10 lipid fractions (Bands 1 to 10) were 
extracted from the TLC plate and individually analysed by one-dimensional TLC-
developing system (data not shown). The putatively identified lipid classes are 
showed in the Figure 3.3.: PC (Band 3), SQDG (Band 4), PE (Band 7), and TG 
(Band 10). These lipid classes had already been identified in the total lipid 
fraction from Brazil nuts (shown in Figure 3.1. and Table 3.1.). 
Fractions of complex lipids containing PC, SQDG, and PE (extracted 
by TLC) as well as the simple lipid-rich fraction (supernatant extracted by 
acetone precipitation) were tested in the animal model of sensitisation carried out 
in the present work and the in vivo results are discussed in Chapter 5 (Figure 5.2.).  
The extraction of lipids using the TLC system involved several steps: 
WRWDO OLSLG H[WUDFWLRQ E\ ´)ROFKµ PHWKRG FRPSOH[ OLSLGV H[WUDFWLRQ E\ DFHWRne 
precipitation, and several preparative TLC systems to obtain enough amounts of 
lipids to be tested in animals. This multi-step protocol facilitates the lipid 
oxidation as well as the production of undesirable artefacts. Therefore, in order 
to circumvent these limitations, a different method was performed to obtain lipid 
fractions from Brazil nuts, solid phase chromatography (SPC). 
 
2.2. Lipid fractionation by SPC 
SPC lipid extraction presents some advantages when compared to 
preparative TLC systems. Firstly, one single run of SPC can produce sufficient 
amounts of lipids to be used in lipid analyses and to be tested in animal protocols 
of sensitisation. Moreover, the extraction of lipids by SPC was not time-
consuming, minimising the probability of lipid oxidation and the production of 
artefacts. Although the resolution in the fractionations is inferior to the one with 
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TLC or even HPLC, SPC extracted lipid fractions contain consistent groups of 
lipids and can be reliably reproduced (Christie, 1992).  
Therefore, the total lipid fraction from Brazil nuts was fractionated by 
SPC (as described in Chapter 2, Item 3.2.). Two of the collected fractions, named 
as SPC fraction C and SPC fraction M, were analyzed by one-dimensional TLC 
along with known standard classes of commercial lipids. 
  
 91 
 
Figure 3.4.: One-dimensional TLC-developing system (as described in Chapter 
2, Item 4.1.2.d). The plate was sprayed with molybdenum and then burned at 
200°C for 1 hour. The samples used were: 1. Total lipid fraction of Brazil nut 
(fraction T); 2. Brazil nut SPC fraction C; 3. Brazil nut SPC fraction M; 4-21, 
Commercial samples of: 4. lyso-phosphatidylinositol (LPI); 5. Phosphatidic 
acid (PA); 6. Phosphatidylserine (PS); 7. Lyso-phosphtidylserine (Lps); 8. 
Phosphatidylinositol (PI-laboratory standard); 9. Phosphatidylinositol (PI-Fluka); 
10. Lyso-phosphatidylethanolamine (LPE); 11. Esterified steryl-glucoside (ESG); 
12. Steryl glucoside (SG); 13. E-Sinositol; 14. Digalactosyldiglyceride (DGDG); 
15. Lipopolissacharide from E. coli (LPS); 16. Phospatidyletanolamine (PE); 17. 
Stearic acid (SA); 18, 19, 20: Soy lecithin; 21. LPS from E. coli. Legend: LPC 
(Lyso-phosphatidylcholine), SL (sulfolipids), PC (Phosphatidylcholine), PI 
(Phosphatidylinositol), PA (Phosphatidic acid), PE (Phospatidyletanolamine), SG 
(Steryl glucoside), ESG (Esterified steryl-glucoside). 
 
Figure 3.4. shows the bands detected in the fractions SPC C and SPC M 
from Brazil nuts and in the standard commercial lipids. The putative 
 
 
1    2    3        4    5    6    7    8   9   10   11  12  13 14  15  16  17  18  19  20  21 
 
LPC + SL 
PC + PI 
PA 
ESG 
SG 
PE 
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identification of the lipid classes were carried out by comparison with the 
detected bands of standard lipids, as well as based on data from the literature 
(Figure 3.5.). The detected lipid bands in the SPC fraction C were mainly TG and 
traces of SG. The SPC fraction M presented simple lipids (TG, SG and ESG), 
but complex lipids were also identified: sulfolipids (SL), PC, and PE. Since the 
same amount of fractions were used for the TLC, it can be concluded that the 
concentration of complex lipids is higher in the fraction M that in the fraction C. 
 
Figure 3.5.: Schematic separation of simple lipids and phospholipids of plasma 
by TLC (as described in Chapter 2, Item 4.1.2.d). Abbreviations: CE, cholesterol 
esters; TG, triacylglycerols; FFA, free fatty acids; C, cholesterol; PE, 
phosphatidylethanolamine; PC, phosphatidylcholine; SPH, sphingomyelin; LPC, 
lysophosphatidylcholine (Kupke e Zeugner, 1978). 
 
SPC fractions C and M were tested in the animal model of sensitisation 
to rBer e 1 carried out in the present work, and, as discussed in Chapter 5 (Figure 
5.3.), SPC fraction C was the only fraction able to induce the production of Ber-
specific anaphylactic antibodies. Since SPC fraction C is composed by different 
classes of lipids, this fraction was further fractionated by HPLC in order to 
identify possible specific lipid classes involved in the immune activation observed 
in animals.  
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2.3. Fractionation of SPC lipid fraction C by HPLC 
HPLC is widely used to analyse phospholipids (Jungalwala, 1976; Samet, 
Friedman et al., 1989; Christie, 1998). This technique provides a higher resolution 
system for lipid fractionation than SPC and TLC systems. Moreover, HPLC has 
the advantage of delivering clean fractions, i.e. without trace contaminants such 
as silica and dyes. For this experiment, SPC lipid fraction C was applied in a 
HPLC column (as described in Chapter 2, Item 3.3.), resulting in several lipid 
sub-fractions.  
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Figure 3.6.: Separation of Brazil nut SPC lipid fraction C by high performance 
liquid chromatography (HLPC), as described in Chapter 2 (Item 3.3.). Legend: 
triacylglycerols (TG); sterols; acylsterylglycosides (ASG); sterylglycosides (SG); 
sulpholipids (SL); digalactosyldiacylglycerol (DGDG) and 
phosphatidylethanolamine (PE). Samples were collected every 2 min, therefore 
22 samples were obtained by HPLC.  
 
Figure 3.6. shows the HPLC profile obtained with SPC lipid fraction C. 
The large base line drift and lack of detection for more complex lipids was due 
mainly to the type of detector used in this work. The specific light-scattering 
detector (ACS 750/14 Mass Detector, Applied Chromatography Systems Ltd., 
Luton, Beds., UK) (Christie, 1998) able to detect phospholipids was not available 
for this equipment. Therefore, the fractions were collected and separated by 
retention time only. The putative identification of lipid classes present in the SPC 
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lipid fraction C were performed by comparing the HPLC results (Figure 3.6.) 
with data in the literature (Figure 3.7). The main lipid fractions identified were: 
triacylglycerols (TG); sterols; acylsterylglycosides (ASG); sterylglycosides (SG); 
sulfolipids (SL); and digalactosyldiacylglycerol (DGDG) or PE.  
 
Figure 3.7.: Separation by high performance liquid chromatography on a YMC-
PVA-SIL (Hichrom) column of A) Lipid classes from leaves of a single plant of 
Arapidopsis thaliana; and B) Lipids from a uncharacterised Arapdopsis mutant 
deficient in acylsterylglycosides. Key to peak identities: wax esters (WE); sterol 
esters (SE); triacylglycerols (TG); sterols (S); acylsterylglycosides (ASG); 
sterylglycosides (SG); monogalactosyldiacylglycerol (MGDG); 
digalactosyldiacylglycerol (DGDG); cereboside (CER); phosphatidylglycerol 
(PG); sulphoquinovosyldiacylglycerol (SQDG); phosphatidylethanolamine (PE); 
phosphatidylinositol (PI); phosphatidylserine (PS), and phosphatidylcholine (PC). 
Graphs extracted from (Christie, 1998). 
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Samples of each lipid sub-fraction were grouped accordingly to their 
classification, representing the main classes of identified lipids: HPLC sub-
fractions C 1-5 (TG), 6-8 (ASG), 9-11 (SG), 12-14 (not identified), 15-17 (SL), 
and 18-22 (DGDG or PE). These grouped lipid sub-fractions were tested in the 
animal model of sensitisation used in the present work (Chapter 5, Figure 5.5.) in 
order to identify the biologically active lipid fractions present in the SPC fraction 
C. However, as discussed in Chapter 5, none of the grouped sub-fractions was 
able to induce the in vivo immune activation observed when the whole SPC 
fraction C was tested.  
As previously mentioned, HPLC provides more accurately fractionated 
and cleaner lipid fractions than SPC or TLC obtained fractions (Christie, 1998). 
However, only small fractions are obtained and several runs are necessary to 
produce minute quantities for an in vivo work. Thus, possible explanations for the 
negative results observed in animals related to the technique could be the 
occurrence of undesired contaminations during the HPLC process, selective 
binding to the HPLC column or lipid oxidation during the process. Other 
possibilities, related to the animal response, are discussed in Chapter 5 (Figure 
5.5). Based on the in vivo results, a different method (acetone precipitation) was 
used to fractionate the SPC fraction C into two sub-fractions: complex lipids-rich 
fraction and simple-lipids-rich fraction.  
  
2.4. Fractionation of SPC lipid fraction C by acetone 
precipitation 
The present experiment used acetone precipitation to fractionate SPC 
fraction C into two sub-fractions: pellet and supernatant, as described in Chapter 
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2 (Item 3.4.). SPC fraction C consisted in 99.9% of neutral lipids (supernatant) 
and 0.1% of complex lipids (pellet). A TLC system was performed in order to 
analyse the sub-fractions of SPC fraction C. 
 
Figure 3.8.: One-dimensional TLC-developing system (as described in Chapter 
2, Item 4.1.2.d) of sub-fractions from SPC fraction C. The plate was sprayed with 
molybdenum and then burned at 200°C for 1 hour. The samples used were: 
Spots 1 and 2. SPC fraction C; 3 and 4. Pellet from SPC fraction C; 5 and 6. 
Supernatant from SPC fraction C; 7. Soy lecithin.  
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Figure 3.8. shows the detected bands from SPC fraction C and from its 
sub-fractions, pellet and supernatant. The classes of lipids present in these 
fractions were putatively identified by comparison with standard soy lecithin 
(spot 7) as well as with literature data, showed in Figure 3.5. (Kupke e Zeugner, 
1978).  
The lipid band equivalent to simple lipids (TG) was more evident in the 
supernatant sub-fraction and less evident in the pellet sub-fraction. The lipid 
bands representing complex lipids (LPC, PC, PI, SL, PA and PE) were more 
concentrated in the pellet sub-fraction. These results confirm the separation of 
simple and complex lipids by acetone precipitation. The reason why the complex 
lipids observed in the pellet fraction have not been identified in the original SPC 
fraction C (Figures 3.4. and 3.8.) is probably due to the concentration, which was 
much higher in the pellet fraction.  
 The concentration of phosphorus was measured in these three samples 
(SPC fraction C, pellet and supernatant), and the results obtained are shown on 
Table 3.2..  
 Phosphorus 
(mM) 
Molecular 
weight 
Phosphorus 
(mg/L) 
SPC fraction C 0.23 ~800 184.00 
Pellet from SPC fraction C 1.79 ~800 1,432.00 
Supernatant from SPC fraction C 0.15 ~800 120.00 
Table 3.2.: Estimation of phosphorus content in different lipid fractions from 
Brazil nuts. 
 
As expected (Table 3.2), the concentration of phosphorus was 
approximately 10 times higher in the complex lipids-rich fraction (pellet), 
comparing to the neutral lipids-rich fraction (supernatant) and to the original SPC 
fraction C. These data confirm the results obtained by TLC (Figure 3.8.), in 
which the phospholipids bands were more evident in the pellet fraction.  
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The pellet and supernatant sub-fractions were individually tested in the 
animal model of sensitisation and the results are discussed in Chapter 5 (Figure 
5.6.).  
In summary, the total fraction of lipids from Brazil nuts, which 
represents approximately  RI WKH VHHG·V GU\ ZHLJKW (Usda, 2009), was 
H[WUDFWHG E\ ´)ROFKµ H[WUDFWLRQ (Folch, Lees et al., 1957) and fractionated by 
various methods, such as TLC, SPC, HPLC and acetone precipitation. The 
obtained lipid sub-fractions were analysed mainly by TLC and the identification 
of lipid classes present in each of the sub-fractions was performed in comparison 
with standard lipids and literature data. The total lipid fraction was found to 
contain mostly simple lipids, but also SQDG, MGDG, PC, PE, PI, PG, and PA, 
in agreement with recent literature in Brazil nuts (Chunhieng 2008). The sub-
fraction C, extracted by SPC, contained mainly simple lipids (99.9%), such as TG 
sterols, SG, and ASG; and the identified lipid classes present in the complex 
lipids-rich fraction (0.01%) were LPC, PC, PI, SL, PA, and PE. The sub-fraction 
M, extracted by SPC, was composed mainly by simple lipids, such as TG, SG, 
ESG, and the other classes of lipids identified were, SL, PC, and PE.  
Therefore, the methodologies used to extract, fractionate and identify 
Brazil nut lipids were here described. Considering the advantages and 
disadvantages associated with each techinique used, the results obtained in the 
present chapter aimed to base the investigations on the role that Brazil nut 
natural lipids play in in vivo and in vitro immune reactions, which is discussed in 
the next chapters.  
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CHAPTER 4 
 
 
 
 
PCA: 
OPTIMIZATION AND 
CHARACTERIZATION 
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INTRODUCTION 
As discussed in Chapter 1, passive cutaneous anaphylaxis (PCA) is a 
reliable and simple technique, widely used to identify anaphylactic antibodies 
(Ovary, 1950; Inagaki, Nagai et al., 1988; Wakayama, Hasegawa et al., 1998; 
Faquim-Mauro, Coffman et al., 1999). Several techniques can be performed to 
quantify antibodies, such as RAST, ELISA, and microarrays (Eriksson e Ahlstedt, 
1977; Wiese, Belosludtsev et al., 2001; Lebrun, Petchpud et al., 2005; Harwanegg e 
Hiller, 2006); however,  PCA is able to assess the biological function of 
antibodies by partially mimicking an immediate allergic process (Miyajima, 
Dombrowicz et al. 1997; Woo, Kim et al. 2006; Nonaka, Izumo et al. 2008).  
Immunoglobulin isotypes are described to have anaphylactic activity, 
IgE and IgG1 (Mota, Wong et al., 1968; Becker, 1971; Lehrer e Vaughan, 1976; 
Dombrowicz, Flamand et al., 1997; Blaikie e Basketter, 1999; Ryan, Kashyap et al., 
2007). Different protocols of PCA are performed in order to identify 
anaphylactic responses (Nishikawa e Hong, 1987; Dearman, Alcocer et al., 2007) 
as well as to differentiate the immunoglobulin isotypes involved in the reaction 
(Inagaki, Nagai et al., 1988; Silva, Casabuono et al., 2008). However, PCA is an in 
vivo procedure and it involves a sequence of events, being evaluated only the final 
blood extravasation, which is consequence of the increased vascular permeability 
caused by mediators secreted by activated mast cells. Therefore, a definite 
differentiation of immunoglobulins isotypes using PCA might not be 
straightforward.    
Therefore, since the anaphylactic activity of antibodies was the main 
indication of allergy in animals sensitised to rBer e 1 in the present work, this 
chapter describes and discusses the results from a series of experiments aimed at 
 102 
optimizing and characterizing PCA reactions, focusing mainly on sensitivity, and 
immunoglobulin isotype specificity of this technique. 
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RESULTS AND DISCUSSION 
 
1. PCA sensitivity to immunoglobulin class E (IgE) 
In order to evaluate the sensitivity of the PCA technique to detect 
immunoglobulin class E, increasing concentrations of commercial anti-OVA IgE 
were tested in naïve recipient BALB/c mice (Figure 4.1).  
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 Figure 4.1. showed that the optimized PCA procedure run in our facilities 
was able to detect commercial  anti-OVA IgE. The dose response curve was of 
sigmoidal shape, with the lowest significant dose detectable at 200 ng/mL and 
the highest quantified concentration around 800 ng/mL.  
  Although 100 and 50 ng/mL doses resulted in positive reactions, 
smaller diameters than the 3 mm published cut off (Dearman, Alcocer et al., 
2007) were observed. At 400 ng/mL, the diameters of reactions were variable 
(from 1 to 9 mm). From 800 ng/mL onwards, the dose response reached a 
saturation plateau and all reactions were strongly positive, the diameters varied 
between 8 and 10 mm. Therefore, PCA technique was able to detect 
concentration as low as 200 ng/mL of IgE and there was no difference in the 
results of doses higher than 800 ng/mL. The latter could be explained since, due 
to size limitation of mice ears, the maximum measurable diameter of cutaneous 
reactions was 8-10 mm.  
Assuming that commercial anti-OVA IgE presented the same avidity 
and affinity as IgE produced in vivo sensitisation in our facilities, the lowest 
concentration of IgE able to be measured by cutaneous anaphylaxis using our 
protocol of PCA was 200 ng/mL (i.e., 5 ng of IgE in 25 PL of serum dermally 
injected). This result is in agreement with the literature, in which 15 ng was the 
amount of IgE required to elicit PCA reactions (Dearman, Skinner et al., 2005). 
In order to expand the dynamic range of detected concentrations by PCA 
(measuring higher concentrations than 800 ng/mL), a sample dilution would be 
needed. The same procedure is commonly performed in ELISA assays, in which 
diluted samples are used in order to detect accurate antibody concentrations 
(Birmingham, Payankaulam et al., 2003). However, the main aim here was to 
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evaluate the PCA sensitivity, evaluating the minimum concentrations of IgE that 
could be detected by PCA.  
 
2. Discriminating between IgE and IgG1 activity in PCA 
reactions 
 PCA positive reactions in mice can be elicited by IgE and/or IgG1 
anaphylactic antibodies (Ovary, 1982; Hazenbos, Gessner et al., 1996; Miyajima, 
Dombrowicz et al., 1997). In an attempt to identify the classes of 
immunoglobulins involved in the PCA reactions performed in the present work, 
a series of experiments were carried out exploring the heat stability of IgE and 
their adsorption to affinity supports. IgE antibodies are described as heat-labile 
immunoglobulins whereas IgG1s are heat-stable, maintaining their anaphylactic 
property after being heated at 56°C for one hour (Lehrer e Vaughan, 1976; 
Faquim-Mauro e Macedo, 2000; Bortolatto, Borducchi et al., 2008). Additionally, 
IgG1 can be adsorbed by protein G while IgE anaphylactic activity is not affected 
by protein G adsorption (Peng, Becker et al., 1994).  
 
2.1. Characterizing commercial anti-OVA IgE anaphylactic 
activity  
In order to verify the reliability of the protocols used to differentiate 
IgE and IgG1 involved in PCA (heating and protein G), they were performed 
using serum containing only anti-OVA IgE.  
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Figure 4.2. shows that sera containing 400 to 25,600 ng/mL of anti-
OVA IgE not submitted to high temperature presented positive PCA reactions. 
By heating up these sera, the anaphylactic property of IgE was totally lost in sera 
containing 400 to 12,800 ng/mL of IgE (p<0.001). Thus, these results 
corroborate the literature, high temperature treatment was able to inactivate the 
anaphylactic property of IgE (Ishizaka, Ishizaka et al., 1967; Kulczycki, Isersky et 
al., 1974; Lehrer e Vaughan, 1976; Faquim-Mauro e Macedo, 2000; Bortolatto, 
Borducchi et al., 2008). However, this effect was concentration dependent; heated 
serum containing high concentrations of IgE (25,600 ng/mL) had the 
anaphylactic property significantly diminished, but not lost. It could be 
speculated that the heat efficiency of the system used here was not uniform or 
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that 1 hour at high temperature is not enough to denaturate IgE. In some 
protocols, the serum is heated up for 4 hours in order to reach a complete loss of 
IgE anaphylactic activity (Kulczycki, Isersky et al., 1974). One other possibility is 
that the thermal denaturation is a reversible process that can be only detected at 
high concentration. Therefore, in our protocol, the anaphylactic property of IgE 
was totally abolished by heating treatment only when IgE concentration in the 
sample was lower than 12,800 ng/mL.  
The following experiment (Figure 4.3.) was carried out in order to verify 
whether mouse IgE is able to be adsorbed with protein G.  
 
 
Figure 4.3. shows that the anaphylactic property of commercial anti-
OVA IgE in the concentrations tested (400, 1,600 and 6,400 ng/mL) was not 
affected by adsorption with protein G. PCA reactions performed with IgE serum 
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treated with protein G were not statistically different from PCA reactions 
performed with non-treated IgE. The variability observed at the concentration 
400 ng/mL was probably due to individual animal differences. The two ears of 
the same mouse were used to test treated and non-treated samples and the values 
obtained for each animal were consistently similar.    
Protein G was shown to bind to the Fc portion of IgG, but not to IgE 
in serum from human patients (Peng, Becker et al., 1994). This property is also 
reported for mouse immunoglobulins, with protein G being used to isolate IgG 
antibodies as well as to remove this class of immunoglobulin from serum samples 
(Kadooka, Idota et al., 2000; Lehrer, Reish et al., 2004). Unfortunately, certified 
IgG1 specific for OVA was not commercially available. The protein G used in 
our protocol binds very well to mouse IgG1 and IgG2a and less efficiently to 
IgG2b and IgG3 (technical information informally given by the manufacturer, 
Dave Walker, Merck Biosciences, UK). Therefore, the results obtained in this 
experiments confirm the data from the literature, assuring that IgE activity is 
maintained after been adsorbed with protein G (Peng, Becker et al., 1994; 
Kadooka, Idota et al., 2000; Lehrer, Reish et al., 2004).  
 
2.2. Anaphylactic antibodies in serum of OVA-sensitised animals 
in our facilities 
In order to investigate the participation of OVA-specific IgE and OVA-
specific IgG1 in the passive cutaneous anaphylaxis protocol performed in the 
present work, pooled sera obtained from 5 OVA-sensitised mice were 
investigated. Animals were sensitised according to described in Chapter 2 (Item 
7.1). The presence of OVA-specific IgE as well as OVA-specific IgG1 in the 
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serum sample was first confirmed by ELISA. The sample of pooled OVA-sera 
were tested in triplicates in an ELISA plate and the results exposed in the 
following table (Table 4.1.) represent the average (AV) and standard deviation 
(SD) of the three replicates tested. 
Immunoglobulin AV + SD (ng/mL) 
Anti-OVA IgE 585.8  +  89.08 
Anti-OVA IgG1 147,386.5  + 8,151 
Table 4.1.: Concentration of anti-OVA IgE and anti-OVA IgG1 present in 
pooled serum from OVA-sensitised mice. Antibodies measurements performed 
by ELISA according to the described in Chapter 2 (Item 10.2).   
    
These pooled sera were then tested in PCA reactions. In order to 
investigate the participation of IgE in the anaphylaxis induced by OVA-serum, 
the serum were submitted to heating treatment, since IgE but not IgG1 is 
reported to heat-labile (Faquim-Mauro e Macedo, 2000).   
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Figure 4.4. shows that the heating procedure influenced the PCA 
activity in a concentration dependent way. PCA reaction was totally abolished in 
heated serum diluted 64 times (1/64), while PCA reactions performed with non-
heated 1/64 serum showed diameters of 5, 5, 7.5 and 7.5 mm (p<0.001). In 1/32 
diluted sera, heated samples showed two negative and two positive reactions (0, 
0, 4 and 5 mm), significantly different from non-heated serum (7.5, 8, 8 and 8.5 
mm; p<0.001). At 1/16, the heating treatment did not abolish the anaphylactic 
property, but the difference between heated and non-heated serum was 
statistically different (p<0.05). At 1/8 dilution, the PCA reactions were slightly 
weaker in the heated than non-heated serum samples, but no statistical difference 
was found. More concentrated samples (1/4 and neat serum) were not affected 
by the heating procedure.  
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Considering that the concentration of anti-OVA IgE in neat serum 
samples was 18,627 ng/mL, positive PCA was totally abolished by heating in 
serum containing approximately 300 ng/mL (1/64 dilution), it was diminished in 
serum containing 600 or 1200 ng/mL (1/32 and 1/16 dilutions, respectively) and 
PCA was not affected by heating in serum containing around 2,400; 4,800 and 
18,627 ng/mL (1/8, 1/4 and neat serum, respectively). Bearing in mind the 
results within Figure 4.2., in which PCA activity was completely abolished in 
serum samples containing up to 12,800 ng/mL of anti-OVA IgE; it is possible to 
speculate that besides IgE, other class(es) of immunoglobulin is(are) influencing 
PCA reactions performed with serum from OVA-sensitised animals.  
In addition to IgE, the class of immunoglobulin reported to have 
anaphylactic activity in mice is IgG1. Considering that two types of mouse IgG1 
are described in the literature, anaphylactic and non-anaphylactic IgG1 (Mota e 
Perini, 1982; Faquim-Mauro, Coffman et al., 1999), the class of immunoglobulin 
that was also being detected by PCA technique in our facilities is likely to be 
anaphylactic IgG1. ELISA results showed that OVA-sensitised animals indeed 
present anti-OVA IgG1; however, this in vitro technique is not able to discern the 
two biologically distinct IgG1 fractions. 
In order to further investigate the presence of anaphylactic IgG1 in 
serum of OVA-sensitised animals in our facilities, sera from these animals were 
treated with protein G and PCA was performed (Figure 4.5). 
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Figure 4.5. shows that at 1/8 dilution the absorption with protein G 
totally abolished passive anaphylactic reactions (p<0.001). In neat serum, 
absorption with protein G significantly diminished (p<0.001) but did not abolish 
PCA reactions.  
Protein G does not bind to polyclonal or monoclonal IgE (Peng, Becker 
et al., 1994). This fact was confirmed in our previous experiment (Figure 4.3.), in 
which IgE anaphylactic activity was not affected by protein G adsorption. 
Therefore, the diminished PCA activity observed in OVA-serum adsorbed with 
protein G (Figure 4.5) corroborates previous findings (Figure 4.4.), indicating that 
IgG1 might be involved in the OVA-anaphylaxis model used.  
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The following experiment was performed in order to verify the duration 
of contact between different classes of anaphylactic immunoglobulins and their 
respective receptors on mast cells. For this, a modification was made on the PCA 
technique, allowing longer periods between sensitisation (serum injection on day 
0) and challenge (antigen injection). Serum from OVA-sensitised animals and 
serum containing commercial anti-OVA IgE were tested.  
 
Figure 4.6. shows that commercial anti-OVA IgE maintained its 
anaphylactic activity up to 12 days after been injected on mice ears (day 0). PCA 
carried out with sera from OVA-sensitised mice were positive only up to 3 days 
following the serum injection, being all PCA reactions negative after that. These 
results indicate that the binding of IgE and its high affinity FcHRI lasts for at least 
12 days, the longest period tested in the present experiment. This data is in 
agreement with other studies that showed that the half life of IgE bound to mast 
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cells was equivalent to 2 weeks (Ishizaka e Ishizaka, 1971). It has also been 
reported that sensitised skin can remain active for PCA for several weeks 
(Kulczycki e Metzger, 1974). However, a quantitative study of Fc-IgE showed 
that the half life of FcR and IgE dissociation is 12 hours. Considering that IgE 
binds to FcHRI  in a reversible manner (Segal, Taurog et al., 1977), it is possible 
that dissociation and rebinding of IgE to their receptors on mast cells take place 
during an extensive period of time.  
Although anti-OVA IgE antibodies were present in the serum of OVA-
allergic animals, the concentration of this class of antibody (585.8 ng/mL, Table 
4.1.) was just above the limit of PCA detection (200 ng/mL, Figure 4.1.). 
Moreover, since OVA-sensitised mice presented other classes of 
immunoglobulins specific to OVA, this fact could interfere in the anaphylaxis 
induced by IgE. Evidence that allergen-specific IgG can block IgE-mediated 
anaphylaxis in vivo corroborates with this hypothesis (Strait, Morris et al., 2006). It 
was shown that cross-OLQNDJHRILQKLELWRU\)Fƣ5,,EZLWKDn activation receptors 
such as the FcH5, )Fƣ5, RU )Fƣ5,,, FDQ LQKLELW SUR-inflammatory signalling 
(Daeron, Latour et al., 1995) )Fƣ5,,E DQG )Fƣ5,,, SUHVHQW LGHQWLFDO OLJDQG
binding properties and co-expression on mast cells (Daeron, 1997; Ravetch e 
Bolland, 2001; Chong, Andrew Bouton et al., 2003); corroborating the idea that 
other immunoglobulins present in the serum of OVA-allergic mice interfere in 
the anaphylactic responses.  
Altogether, the findings obtained so far provided a better understanding 
about classes of immunoglobulins involved in the PCA reactions performed in 
our facilities. It was clearly shown that passive anaphylaxis can be elicited by IgE 
as well as by IgG1 antibodies. This information is important to understand the 
mechanisms involved in the sensitisation protocols performed in our facilities 
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(discussed in Chapter 5). The differentiation between the two fractions of IgG1, 
anaphylactic and non-anaphylactic, is important because these immunoglobulins 
are modulated by different cytokines. Anaphylactic IgG1 is positively regulated 
by IL-4 and negatively regulated by IL-12 and/or IFN-g, indicating it is involved 
in a Th2-pattern response. In contrast, the synthesis of IgG1 antibodies that lack 
anaphylactic activity is IL-4-independent and it is enhanced in the presence of IL-
12 or IFN-J(Faquim-Mauro e Macedo, 2000). The synthesis of the two fractions 
of IgG1 is regulated by adjuvants. In a model of allergy using OVA, it was shown 
that animals sensitised with Alum (AlOH3), a Th2 adjuvant, produced mostly the 
DQDSK\ODFWLF W\SH :KHQ 29$ ZDV LQMHFWHG LQ FRPSOHWH )UHXQG·V DGMXYDQW
(CFA), it induced mainly the non-anaphylactic type production (Faquim-Mauro, 
Jacysyn et al., 2003).  
It is important to emphasize that anaphylaxis resultant of mast cells 
activated by IgG1 bound to its FcJreceptors or activated by IgE bound to FcHR 
are of similar magnitude. It was shown that FcHRI D chain knock-out mice 
expressed active systemic anaphylactic responses, associated with extensive mast 
cell degranulation and a high mortality rate (Miyajima, Dombrowicz et al., 1997). 
An asthma model using mutant mice that produce all Ig isotypes except IgE, 
showed that these animals became anaphylactic on antigen challenge and 
displayed tachycardia and pulmonary function changes similarly to the wild type 
animals (Oettgen, Martin et al., 1994). Therefore; as the final parameters used to 
analyse PCA results are mast cell degranulation and the consequent increased 
blood vessels permeability; it is not possible to separately evaluate the 
participation of IgG1 or IgE in the passive anaphylaxis model used in the present 
work. Nevertheless, the most important advantage of passive cutaneous 
anaphylaxis is that, by evaluating the biological activity of antibodies, it 
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determinates exclusively anaphylactic immunoglobulins, a very important 
information in allergy investigations.     
 
2.3. Investigating anaphylactic antibodies in serum of BER-
sensitised animals 
Previous investigation showed that serum from mice sensitised with 
rBer e 1 alone does not induce positive PCA reactions and does not contain titers 
of Ber-specific IgG or IgG1. Conversely, animals sensitised with rBer e 1 in the 
presence of natural lipids presented positive PCA reactions and increased titers of 
Ber-specific IgG and IgG1 (Dearman, Alcocer et al., 2007).  
The present work aimed to further investigate the role of Brazil nut 
lipids in a similar protocol of sensitisation to rBer e 1. The main indication of a 
Th2-driven response was given by the type of humoral response developed 
(results discussed in Chapter 5), considering mainly the titers of IgE and IgG1, 
typical Th2 classes of antibodies. If present in detectable levels in the serum, 
these immunoglobulins can be measured by ELISA; however, as previously 
mentioned, this techinique does not distinguish between anaphylactic and non-
anaphylactic IgG1.  
In order to investigate the classes of immunoglobulins associated with 
positive PCA reactions observed in serum from Ber-sensitised animals, animals 
were sensitised with Ber e 1 and an immune active fraction of natural lipids 
(named SPC fraction C, described in Chapters 3 and 6). For the following 
experiments, these animals were named BER-allergic animals. Sera from these 
animals were collected, pooled and investigated. The quantity of Ber-specific IgE 
as well as of Ber-specific IgG1 was first measured by ELISA. The sample of 
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pooled BER-sera was tested in triplicates in an ELISA plate and the results 
exposed in the following table (Table 4.2.) represent the average (AV) and 
standard deviation (SD) of the three replicates tested. 
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Immunoglobulin AV + SD (ng/mL) 
Anti-Ber IgE Not detected  
Anti-Ber IgG1 21,050 + 10,990  
Table 4.2.: Concentration of anti-Ber IgE and anti-Ber IgG1 present in pooled 
serum from 5 BER-allergic mice. Antibodies measurements performed by ELISA 
according to the described in Chapter 2 (Item 10.2).   
 
 
Surprinsingly, only titers of Ber-specific IgG1 could be detected in the 
serum of BER-allergic animals. ELISA was repeated several times, with the same 
sample of sera as well as with sera from different batches of BER-allergic 
animals, but no Ber-specific IgE could be detected. ELISA is the most used 
technique for antibody determination and can detect very low concentrations of 
antibodies, in the order of nanograms/mL. The sensitivity (nanograms/mL) of 
our tests is comparable to mouse IgE ELISAs described in the literature. 
(Morafo, Srivastava et al., 2003; Boehme, Chen et al., 2009). To detect specific 
titers of IgE, for instance, the antibody capture is usually made by the specific 
antigen pre-attached to the ELISA plate, followed by the enzyme-linked anti-IgE 
antibody and substrate (Yamaguchi, Sugita et al., 2006; Wang, Mei et al., 2007; 
Hashizume, Togawa et al., 2008; Van Ginkel, Iwamoto et al., 2008). Thus, 
different classes of immunoglobulins that are specific for the same antigen can be 
also captured, and this competition interferes with detection of allergen-specific 
IgE, reducing test sensitivity. It was shown that the removal of murine serum 
IgG antibodies, which may be in more than 100-fold excess to IgE antibodies, 
enhanced the IgE detection by ELISA (Kadooka, Idota et al., 2000; Lehrer, Reish 
et al., 2004). Therefore, one possibility for the negative anti-Ber IgE results 
obtained by ELISA could be the interference of high concentration of anti-Ber 
IgG1 in the serum. The serum was then tested in a sandwich-type ELISA, in 
which the plate was coated with anti-IgE antibodies to avoid cross-ligation with 
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other classes of immunoglobulins. Biotinylated-Ber, enzyme-labeled streptavidin 
and substrate were used to finalize the reaction, but no IgE detection was 
obtained. Attempts to measure anti-Ber IgE were also made by microarray 
technique using high power lasers but the results were unsuccessful. 
Moreover, serum from OVA-sensitised animals presented 
approximately 150,000 ng/mL of OVA-specific IgG1 and 600 ng/mL of OVA-
specific IgE (Table 4.1.), detected by ELISA. Therefore, the high concentration 
of antigen-specific IgG1 (around 8 times higher than in BER-allergic animals) did 
not impair the detection of antigen-specific IgE. This corroborates the 
hypothesis that the cutaneous anaphylaxis induced by serum from BER-allergic 
animals was elicited mainly by anaphylactic IgG1 and not necessarily IgE. 
Serum from BER-allergic animals, i.e. animals sensitised with rBer e 1 
and lipids from Brazil nuts, was then tested for PCA reactions (Figure 4.7.) 
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Figure 4.7. shows that serum from BER-allergic animals elicited strong 
positive PCA reactions when it was tested neat. However, after being diluted 8 or 
64 times no anaphylaxis was observed. Therefore, serum from animals sensitised 
with rBer e 1 and SPC lipid fraction C did produce anaphylactic antibodies; 
however, the concentrations detected in the sera of these animals are not as high 
as in animals sensitised with OVA (Figure 4.4.). This is in agreement with the 
levels of antigen-specific IgG1 and IgE obtained by ELISA (Tables 4.1. and 4.2.) 
and with previous published results (Dearman, Alcocer et al., 2007). However, in 
order to further check the presence of anaphylactic IgG1 and IgE in the serum of 
BER-allergic animals, a PCA investigation with heated or protein G-adsorpted 
serum would have to be attempted; however, these procedures required amounts 
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of BER-allergic serum unavailable at the time, and, for this reason, these 
experiments were not carried out. 
Altogether, the results obtained in this chapter indicated that IgE as well 
as IgG1 can elicit positive PCA reactions performed in our facilities. These 
findings are in agreement with literature data, in which a sub-class of IgG1 is 
reported to have anaphylactic activities (Inagaki, Nagai et al., 1988; Faquim-
Mauro, Jacysyn et al., 2003).  Since the present PhD project aimed to evaluate the 
role of lipids in the development of a Th2 response towards rBer e 1 based 
mainly on the humoral response presented by sensitised animals, the information 
obtained in the present Chapter are of great importance. Furthermore, 
considering that Ber-specific IgE was not detectable by ELISA, a widely used 
technique to measure antibodies, the PCA results provide the major indication of 
a Th2-skewed response. In general, as no validated animal model is available to 
study food allergy, PCA results reveal important information regarding the 
immune profile presented by sensitised animals.  
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CHAPTER 5 
 
 
 
 
HUMORAL RESPONSE INDUCED BY  
rBER e 1 AND LIPIDS 
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INTRODUCTION 
 
The present chapter describes and discusses the results of a series of 
experiments, aiming to investigate the humoral response induced by rBer e 1 
alone or in the presence of lipids. Different fractions and doses of lipids from 
Brazil nuts were tested as well as synthetic lipids or lipids extracted from 
sunflower seeds. rBer e 1 was also tested in the presence of two well established 
adjuvants: alum (AlOH3), a Th2 adjuvant (Brewer, Conacher et al., 1999; 
Bortolatto, Borducchi et al., 2008), and LPS, a lipid compound known to interfere 
in the development of adaptive immune responses (Delayre-Orthez, De Blay et 
al., 2004; Piggott, Eisenbarth et al., 2005; Tan, Chen et al., 2010). 
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RESULTS AND DISCUSSION 
 
1. $FRPSDULVRQRI¶ZLOGW\SH·%HUHDQGUHFRPELQDQW Ber e 1 
activity in an in vivo model of allergy  
As previously reported, ¶ZLOG W\SH· %HU H , which is a mixture of 
proteins and natural lipids from Brazil nuts, elicited anaphylactic antibody 
responses in mice; whereas no passive anaphylactic reactions were observed 
when animals were sensitised with the delipidated wild type or recombinant Ber e 
1 (rBer e 1), which is free of lipids. The capacity of inducing anaphylaxis was 
shown to be related with the presence of natural lipids from Brazil nuts, since the 
anaphylaxis was re-established when rBer e 1 was used in the presence of Brazil 
nut lipids (Dearman, Alcocer et al., 2007)7KH¶ZLOGW\SH·%HUH was composed 
of 50% protein (Ber e 1) and 50% lipids. The procedure used to isolate and 
purify ¶ZLOG W\SH· %HU H  IURP %UD]LO QXV ZDV SUHYLRXVO\ GHVFULEHG (Sun, 
Altenbach et al., 1987). Recombinant Ber e 1 was produced in Pichia pastoris and 
prepared as previously published (Alcocer, Murtagh et al., 2002). This preparation 
contained no lipids and it was shown to be biophysically equivalent to the native 
form of this protein (Alcocer, Murtagh et al., 2002). 
For the following experiment, the same extracts as those used by 
Dearman et al ¶ZLOGW\SHµDQGUHFRPELQDQW%HUHZHUHused in the mouse 
model selected for this PhD in order to assess both sensitisation protocol and in 
vivo model of anaphylaxis (PCA). Animals were sensitised with 2.5 mg of protein 
¶ZLOGW\SHµ%HUHRUU%HUHRQGD\VDQGDVGHVFULEHGLQChapter  2 (Item 
7.2.). 
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The groups used are specified below: 
Groups Sensitisation 
wild Ber ¶ZLOGW\SH·%HUHPJ 
rBer  rBer e 1 (2.5 mg) 
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The results expressed on Figures 5.1. (a-f) indicated that animals 
sensitised with rBer e 1 alone did no present increase in titers of antibodies and 
negative PCA reactions were observed. An immune activation was observed in 
the group sensitised ZLWK¶ZLOGW\SH·%HUHThese animals presented significant 
higher levels of Ber-specific and total IgG1 (Figure 5.1.a and b), and total IgE 
(Figure 5.1.e) compared to animals sensitised with rBer e 1. Low titers of Ber-
specific IgG2a (Figure 5.1.c) were observed in both groups. Positive cutaneous 
DQDSK\OD[LVZDVREVHUYHGRQO\LQWKH¶ZLOGW\SH·%HUHJURXS (Figure 5.1.f).  
The first conclusion to be taken is that the protocols used are working 
accordingly, since the sensitisation protocol was able to induce anaphylactic 
antibodies production and these antibodies could be detected by PCA. Secondly, 
no response was detected in the absence of lipids. These results confirm the 
findings previously published (Dearman, Alcocer et al., 2007), in which serum 
from BALB/c mice sensitised with rBer e 1 failed to induce PCA reactions and 
did not present detectable titers of BER-specific IgG and IgG1; while animals 
sensitised ZLWK ¶ZLOG W\SH· %HU H  SUHVHQWHG SRVLWLYH 3&$ UHDFWLRQV DQG
significant increased titers of BER-specific IgG and IgG1 (Dearman, Alcocer et 
al., 2007).  
Allergic processes are chacterized as Th2-type responses, involving 
increased production of IgE, IgG1, low IgG2a, and the secretion of cytokines, 
such as IL-4, IL-5, and IL-13 (Del Prete, 1992; Raz e Spiegelberg, 1999; 
Maezawa, Nakajima et al., 2003; Lee e Flavell, 2004; Mishra, Rir-Sima-Ah et al., 
2008). Therefore, the results presented here indicated that, besides Ber e 1, lipid 
compounds present in the food matrix of Brazil nuts are necessary for the 
development of a Th2-type response, characterized by increased levels of IgG1 
and IgE, low IgG2a, and positive PCA reactions. Since the lipid fraction present 
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LQWKH¶ZLOGW\SH·%HUHZDVFRPSRVHGE\DPL[WXUHRIGLIIHUHQWFODVVHVRIOLSLGV
the following experiments aimed to investigate the role of specific classes of 
lipids in the sensitisation to rBer e 1.  
 
2. Activities of different fractions of natural lipids extracted by 
TLC compared to synthetic lipids 
As discussed in Chapter 3, several lipid classes are present in the the 
total lipid fraction of Brazil nuts. This experiment aimed to investigate the role of 
different lipid classes in the development of a Th2-type immune response. For 
this, the total lipid fraction was fractionated by acetone precipitation and two 
sub-fractions were obtained. The first sub-fraction, rich in tryglicerides, was 
attached to rBer e 1 and tested in animals. The second sub-fraction, rich in 
complex lipids, was re-fractionated by TLC and the new sub-fractions were 
individually attached to rBer e 1 and tested in animals.  
The identified lipid classes present in the TLC sub-fractions tested in 
this experiment were PC, PE and SL. The activities of equivalent synthetic PC 
and PE lipid fractions were also tested in order to compare the activity of natural 
and synthetic lipids.  
As the lipid extraction and the protein-lipid attachment were performed 
in our facilities, this experiment also aimed to evaluate whether the manipulation 
of lipids and proteins would interfere in the ability of the lipid-protein complexes 
to induce an immune response. 
For the sensitisation, the different fractions of natural and synthetic 
lipids (600 µg) were individually added to rBer e 1 (2.5 mg), as described in 
Chapter 2 (Item 7.2.1.). A PCA positive control group was performed, sensitizing 
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mice with 2.5 mg of rBer e 1 and 150 µg of LPS. The dose of LPS used was 
lower dose than the dose of lipids due to its endotoxic properties. It is reported 
as lethal dose of LPS 35 mg/kg body weight, approximately 700 µg per mouse 
(Jones, Mansell et al., 2007).  
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The groups used are specified below: 
Groups Sensitisation 
rBer rBer e 1 (2.5 mg) 
rBer + nat TG rBer e 1 (2.5 mg) + 600 µg of natural TG 
rBer + nat PC rBer e 1 (2.5 mg) + 600 µg of natural PC 
rBer + synt PC rBer e 1 (2.5 mg) + 600 µg of  synthetic PC 
rBer + nat PE rBer e 1 (2.5 mg) + 600 µg of natural PE 
rBer + synt PE rBer e 1 (2.5 mg) + 600 µg of synthetic PE 
rBer + nat SL rBer e 1 (2.5 mg) + 600 µg of natural SL 
Ber + LPS rBer e 1 (2.5 mg) + 150 µg of LPS 
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As shown in Figure 5.2. (a-f), animals sensitised with rBer e 1 alone did 
not show increase in antibodies titers or positive PCA reactions, confirming, 
once again, previous findings (Dearman, Alcocer et al., 2007). 
The fraction rich in TG did not induce immune activation, since animals 
sensitised with rBer e 1 and TG presented a humoral response similar to animals 
sensitised with the protein alone.  
The other lipid fractions tested, natural or synthetic, produced different 
patterns of immune activation. The group sensitised with rBer e 1 and natural PC 
presented significantly increased titers of total IgG2a (Figure 5.2.d) and slight, but 
not significant, increased titers of Ber-specific IgG1 (Figure 5.2.a) when 
compared to the control group, treated with rBer e 1 alone. Animals sensitised 
with rBer e 1 and the synthetic PC did not present these differences. No 
differences were found in the titers of other antibodies tested (Figure 5.2.b, c and 
e), and no positive PCA reactions were observed in both natural and synthetic 
PC groups (Figure 5.2.f).  
The groups sensitised with natural or synthetic PE presented 
significantly increased titers of total IgG1 (Figure 5.2.a and b) and slight, but not 
significant, increased titers of IgE (Figure 5.2.e). No differences were found in 
the titers of other antibodies tested (Figure 5.2.a, c, d and e), and no positive 
PCA reactions were observed (Figure 5.2.f) for both natural and synthetic PE 
groups. 
The group sensitised with rBer e 1 and natural SL presented significantly 
increased titers of total IgE (Figure 5.2.e), and increased, but not significant, titers 
of specific IgG1 (Figure 5.2.a). This group presented positive PCA reactions, 
indicating the presence of anaphylactic antibodies in the serum of these animals 
 132 
(Figure 5.2.f). No differences were found in the titers of others antibodies tested 
(Figure 5.2.b, c and d).  
In the positive control group, rBer+LPS, it was observed a strong 
immune activation, with significant increase in titers of all classes of antibodies 
tested, except total IgG1 (Figure 5.2. a-e). Although the total IgE titer was not 
increased in this group, PCA reactions were strongly positive (Figure 5.2.f). As 
discussed in Chapter 4, these results are in agreement with the literature, in which 
not only IgE, but also anaphylactic IgG1 are able to induce anaphylactic reactions 
(Inagaki, Nagai et al., 1988; Hazenbos, Gessner et al., 1996; Faquim-Mauro, 
Coffman et al., 1999; Faquim-Mauro e Macedo, 2000; Silva, Casabuono et al., 
2008). Several studies report the role of LPS in the development of allergy 
(Eisenbarth, Piggott et al., 2002; Hollingsworth, Whitehead et al., 2006; Bortolatto, 
Borducchi et al., 2008; Dong, Li et al., 2009); however, the role of LPS in the 
sensitisation to rBer e 1 will be discussed in more details in the following 
sections. 
Comparing natural and synthetic lipids, their activities appeared to be 
different for PC but no differences were found between natural and synthetic 
PE. As the immune activation induced by these classes of lipids was not clearly 
evident, no important conclusions can be taken in this respect so far. In the 
literature, there is indication that natural and synthetic lipids play different roles 
in the immune system. In schistosome infections, schistosomal but not synthetic 
lyso-PS induced the development of IL-10-producing regulatory T cells (Van Der 
Kleij, Latz et al., 2002). Differently, other study showed that synthetic PC-
containing molecules had in vitro immunomodulatory effects similar to those 
induced by the native molecule, extracted from the parasite Ascaris suum (Kean, 
Ohtsuka et al., 2006).  
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Of the TLC prepared Brazil nut fractions, the SL-rich fraction was the 
only natural lipid that induced positive PCA reactions. Thus, amongst the tested 
fractions, SL appears to be the only involved with the development of allergic 
responses. Results previously published in Brazil nuts showed that a natural lipid 
fraction containing SL, PC, PE and PI  induced anaphylactic antibodies 
productions (Dearman, Alcocer et al., 2007), corroborating the immune activity 
of SL. However, since other classes of lipids were present in this fraction, more 
investigations would be necessary to conclude that the anaphylactic activity was 
definitely induced by SL. Here, no evident immune activation was observed when 
natural fractions containing PC or PE were tested. However, these results could 
suggest that natural PC and PE lack immune activity or that the TLC extraction 
altered lipid properties. Considering that TLC is a multi-step technique, it can 
result in lipid oxidation as well as in the production of undesirable artefacts. Since 
different lipid classes present distinct physical and chemical properties, the 
procedures such as lipid extraction and lipid-protein binding can work differently 
for particular classes of lipids. 
Another disadvantage of using TLC for lipid extraction is that only very 
small quantities of lipids could be prepared. In order to circumvent these 
limitations, a different procedure was identified to more efficiently obtain 
separated classes of lipids and therefore, for the following experiments, lipid 
fractions were obtained by solid phase chromatography (SPC).  
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3. Activities of different fractions of Brazil nut natural lipids 
extracted by SPC 
SPC is more efficient than TLC because higher quantities of lipids are 
obtained in a shorter period of time, avoiding lipid oxidation and the production 
of artefacts (Christie, 1992). As considerable amounts of lipids were necessary to 
perform animal experiments and lipid analyses, this technique was used to obtain 
lipid fractions from Brazil nuts for the following experiments. 
The total fraction of Brazil nuts (fraction T) was fractionated by SPC, 
and from the several sub-fractions obtained; three were chosen to be tested in 
this experiment. The three SPC fractions used were: SPC fractions L, C and M.  
Therefore, animals were sensitised with rBer e 1 (2.5 mg) and 600 µg of 
different lipid fractions (Fraction T, SPC fractions L, C and M), following the 
sensitisation protocol described in Material and Methods (Chapter 2, Item 7.2.). 
For this experiment a group of naive, i.e. not manipulated animals, was included.  
The groups used are specified below: 
Groups Sensitisation 
Naive None 
rBer rBer e 1 (2.5 mg) 
rBer + T rBer e 1 (2.5 mg) + 600 µg of fraction T 
rBer + L rBer e 1 (2.5 mg) + 600 µg of SPC fraction L 
rBer + C rBer e 1 (2.5 mg) + 600 µg of SPC fraction C 
rBer + M rBer e 1 (2.5 mg) + 600 µg of SPC fraction M 
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The results presented in Figure 5.3. (a-f) showed that animals sensitised 
with the protein alone (rBer e 1) had the same pattern of responses to those 
observed in naïve animals, i.e., there were no significant changes in levels of 
antibodies produced. Once again, these data confirmed the previous observations 
that natural lipids are necessary for the development of an immune reaction to 
rBer e 1 (Dearman, Alcocer et al., 2007).  
Lipid fraction T, which represented the total lipid fraction of Brazil 
nuts, induced significantly increased titers only of total IgG2a (Figure 5.3.d). No 
differences were found in titers of the other antibodies tested and no positive 
PCA was observed (Figure 5.3.f). This fraction was shown to contain mainly 
simple lipids, such as tryglicerides, but other classes of lipids were also identified, 
such as PA, PC, PI, PG, PE, SQDG, and MGDG (Chapter 3, Figure 3.1. and 
Table 3.1). These results differ from previous findings, in which the total lipid 
fraction of Brazil nuts was able to induce the production of anaphylactic 
antibodies in 7 out of 9 sensitised animals (Dearman, Alcocer et al., 2007). 
However, the total lipid fraction used by those investigators presented reduced 
levels of triglycerides, altering, therefore, the final concentration of other lipid 
classes present in the fraction. This difference could be the explanation for the 
different results observed here.  
SPC lipid fraction L presented increased titers of total IgG1, total IgG2a 
and total IgE (Figure 5.3. b, d and e), but no differences were found in the titers 
of Ber-specific IgG1 or IgG2a (Figure 5.3.a and c) when compared to rBer e 1 
group. Despite the increased titers of IgE, negative PCA reactions were observed 
(Figure 5.3.f), indicating that these immunoglobulins were not Ber-specific. 
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Therefore, this fraction induced a non-specific immune activation, with increased 
titers of total antibodies but no differences in Ber-specific antibodies. 
SPC fraction M induced the production of Ber-specific and total IgG1, 
presenting significant high titers of these immunoglobulins (Figure 5.3.c and d). 
Total IgG2a was also significantly increased (Figure 5.3.d), but no other 
differences were observed.  
SPC lipid fraction C induced significantly higher titers of Ber-specific 
and total IgG1 than other lipid fractions (Figure 4.3.a and b). Animals did not 
present increased Ber-specific IgG2a, although the titers of total IgG2a were 
significantly augmented (Figure 5.3.c and d). SPC fraction C also induced a 
significant increase in the titers of IgE (Figure 5.3.e), and most importantly, this 
was the only fraction able to induce positive PCA reactions (Figure 5.3.f)   
Altogether, these results indicate that different fractions of lipids 
induced distinct patterns of immune activation. Although nearly all lipid fractions 
induced increased levels of total immunoglobulins, such as IgG1 or IgG2a; only 
fractions C and M induced a more specific immune activation. Fraction C 
favoured a Th2-type immune response, with high titers of specific IgG1 and total 
IgE, low titers of specific IgG2a and the presence of anaphylactic antibodies 
confirmed by the positive PCA reactions. This pattern of humoral response is 
observed in murine models of allergy, in which animals present high levels of IgE 
and IgG1, and low levels of IgG2a (Keller, Mucida et al., 2006; Barbas, Downing 
et al., 2008). In contrast, lipid fraction M induced low titers of IgG1 and IgE, high 
titers of IgG2a and absence of anaphylactic antibodies (negative PCA), a Th1-
skewed response (Hochreiter, Ferreira et al., 2003; Takeno, Yoshikawa et al., 
2004). Therefore, the lipid fraction most likely to be involved in the sensitisation 
to rBer e 1 was the SPC fraction C.  
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The contents of SPC lipid fractions C and M were analysed by TLC (as 
described in Chapter 3) and, although triglycerides (TG) was the most abundant 
lipid class present in both fractions, they differed in other components. The lipid 
classes SL, LPC, PC, PI, PA, and SG were putatively identified in the fraction C, 
whereas SL, PC, PE, SG, and ESG were the putative fractions present in SPC 
fraction M. Therefore, we could speculate that the active lipid(s) were the ones 
present exclusively in the SPC fraction C. In the literature, different lipid classes 
of complex lipids are shown to interact with adaptive immune responses. Lyso-
PS from schistosome, for instance, was shown to affect immune polarization 
through TLR-2 (Van Der Kleij, Latz et al., 2002); and a phosphorylcholine-
containing molecule (ES-62) present in nematodes was reported tosupport Th2 
immunological phenotype though TLR-4 (Harnett e Harnett, 2009). LPC was 
shown to promote mature dendritic cell generation (Coutant, Perrin-Cocon et al., 
2002) and act as adjuvant triggering cellular and specific humoral immunity 
(Perrin-Cocon, Agaugue et al., 2006; Bach, Perrin-Cocon et al., 2010). However, 
SPC fraction C was extracted from the total fraction of Brazil nuts lipids (fraction 
T) and the pattern of immune response induced by these fractions was different. 
Suggesting, therefore, that not only the class, but also the concentration of lipids 
may be important in determining the course of the immune response generated. 
 
4. Activity of SPC lipid fraction C in different concentrations 
As the results from the previous experiment indicated that the doses of 
lipids used to sensitize animals in the presence of rBer e 1 might interfere in the 
type of immune response developed, the present experiment aimed to evaluate 
the immune response induced by different doses of SPC lipid fraction C. 
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For this, animals were sensitised with rBer e 1 (2.5 mg) and different 
doses of the SPC lipid fraction C, according to the protocol described in Chapter 
2 (Item 7.2.). The doses of lipids used were: 15 µg, 150 µg, 600 µg, 1,500 µg or 
3,750 µg.  
The groups used are specified below: 
Groups Sensitisation 
rBer rBer e 1 (2.5 mg) 
rBer + 15C rBer e 1 (2.5 mg) + 15 µg of SPC fraction C 
rBer + 150C rBer e 1 (2.5 mg) + 150 µg of SPC fraction C 
rBer + 600C rBer e 1 (2.5 mg) + 600 µg of SPC fraction C 
rBer + 1500C rBer e 1 (2.5 mg) + 1,500 µg of SPC fraction C 
rBer + 3750C rBer e 1 (2.5 mg) + 3,750 µg of SPC fraction C 
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Figure 5.4. (a-f) showed that the lipid doses varying from 15 µg to 1,500 
µg induced similar immune activation. The concentration of Ber-specific IgG1 in 
these groups was slightly higher than the control group (rBer e 1 alone), but this 
difference was not significant (Figure 5.4.a). No significant differences were 
observed in the titers of total IgG1, Ber-specific and total IgG2a compared to the 
control group. The total IgE was slightly, but not significantly, augmented 
compared to the control group. However, different concentrations of lipids 
induced different PCA results (Figure 5.4.f). While lower doses of SPC fraction C 
(15 and 600 µg) induced clear positive passive anaphylactic reactions, this was not 
observed when higher dose of lipids were used (1,500 µg).  
The group immunized with rBer e 1 and high dose of SPC fraction C 
(3,750 µg) presented an evident immune activation. Significant increases in the 
levels of Ber-specific IgG1 and IgG2a, and slight increase in the total IgE were 
observed in these animals (Figure 5.7.a and c). However, this group presented 
weak PCA results (Figure 5.7.f): two negative reactions (0 mm) and two weakly 
positive reactions (3 mm). Considering PCA is an in vivo techinique, the animal 
variation has always to be considered. However, as discussed in Chapter 4, IgG2a 
can directly inhibit mast cell and basophil degranulation by triggering inhibitory 
signal transduction by means of inhibitory FcJRII receptors (Daeron, Latour et 
al., 1995; Takai, Ono et al., 1996), suggesting why these animals presented weak 
PCA reactions. Furthermore, since PCA reactions can be triggered by antigen-
specific IgE as well as by antigen-specific IgG1 (Inagaki, Nagai et al., 1988), 
positive PCA could be expected in this group. However, the weakly positive PCA 
could be explained if the IgE antibodies detected were not Ber-specific and the 
Ber-specific IgG1antibodies were non-anaphylactic (Faquim-Mauro, Jacysyn et al., 
2003). Thus, the weak PCA reactions observed in mice sensitised with high dose 
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of lipids (3,750 µg) could be interpreted as the presence of low concentration of 
specific anaphylactic antibodies, or as the competition with the high 
concentration of Ber-specific IgG2a.  
Altogether, these results indicate that the concentration of lipids was 
important for the development of the immune reaction. While doses varying 
from 15 to 600 µg of SPC fraction C induced similar humoral response, 
characterized by increased levels of Ber-specific IgG1, low levels of Ber-specific 
IgG2a and presence of anaphylactic antibodies; higher lipid concentrations 
induced strong immune activation, with increased titers of Ber-specific IgG1 and 
IgG2a, but negative PCA. However, based on these data, it is not possible to 
conclude whether the different patterns of immune response were consequence 
of different concentrations of one particular lipid (the putative immune active 
lipid fraction) or due to the increasing amounts of lipids to which animals were 
exposed to.  
In order to investigate possible classes of lipids present in the SPC 
fraction C involved immune activation observed, this fraction was further 
fractionated by HPLC and the obtained sub-fractions were tested in the animal 
protocol of sensitisation used in the present work.  
 
5. Activities of sub-fractions of lipids extracted from SPC 
fraction C by HPLC 
Of the three SPC fractions tested, fraction C was shown to be the only 
fraction able to induce the production of anaphylactic antibodies (Figure 5.3.). It 
was shown that the lipid concentration was important to direct the immue 
response (Figure 5.4.). This experiment aimed to identify whether specific lipid 
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classes present in the SPC fraction C were responsible for the Th2-type response 
observed.  
For this, the SPC fraction C was fractionated into 22 sub-fractions by 
HPLC (HPLC sub-fractions C). The putative identification of the lipid classes 
present in the 22 sub-fractions was performed by comparison with literature data 
and the sub-fractions were grouped according to it (as described in Chapter 3, 
Item 2.3.). HPLC sub-fractions C 1-5 contained mainly TG, 6-8 contained ASG, 
9-11 contained SG, 12-14 could not be identified, 15-17 contained SL, and 18-22 
contained DGDG and/or PE. Therefore, six groups of lipids were tested: HPLC 
sub-fractions C 1-5, 6-8, 9-11, 12-14, 15-17 and 18-22.  
Animals were sensitised with rBer e 1 (2.5 mg) and 600 µg of pooled 
HPLC sub-fractions C, following the sensitisation protocol described in Chapter 
2 (Item 7.2.).  
The groups used are specified below: 
 
Groups Sensitisation: 
rBer rBer e 1 (2.5 mg) 
rBer + C(1-5) rBer e 1 (2.5 mg) + 600 µg of pooled HPLC sub-fractions C 
1-5 
rBer + C(6-8) rBer e 1 (2.5 mg) + 600 µg of pooled HPLC sub-fractions C 
6-8 
rBer + C(9-11) rBer e 1 (2.5 mg) + 600 µg of pooled HPLC sub-fractions C 
9-11 
rBer + C(12-14) rBer e 1 (2.5 mg) + 600 µg of pooled HPLC sub-fractions C 
12-14 
rBer + C(15-17) rBer e 1 (2.5 mg) + 600 µg of pooled HPLC sub-fractions C 
15-17 
rBer + C(18-22) rBer e 1 (2.5 mg) + 600 µg of pooled HPLC sub-fractions C 
18-22 
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The results presented in Figure 5.5. (a-f) showed that animals sensitised 
with rBer e 1 alone did not present detectable titers of Ber-specific antibodies 
and no positive PCA reactions were observed, confirming previous results 
(Figures 5.1. to 5.4.) and literature data (Dearman, Alcocer et al., 2007).  
The titers of antibodies induced by HPLC sub-fractions C 1-5 (TG) 
were similar to the observed in the rBer e 1 group. Therefore, no detected 
immune activation was induced by these sub-fractions. The HPLC sub-fractions 
C 6-8 (ASG) induced significantly increased titers of total IgE (Figure 5.5.e), but 
no differences were observed in the titers of other immunoglobulins. HPLC sub-
fractions C 9-11 (SG) did not induce increase in the titers of antibodies, except a 
slight increase observed in the titers of total IgE (Figure 5.5.e). HPLC sub-
fractions C 12-14 did not induce any relevant increase in antibodies titers. HPLC 
sub-fractions C 15-17 (SL) induced increased titers of Ber-specific IgG1 and Ber-
specific IgG2a (Figure 5.5.a and c) but the difference was significant only for 
IgG2a. No differences were found in the titers of other antibodies. Finally, the 
HPLC sub-fractions C 18-22 (DGDG and/or PE) did not induce increase in the 
titers of antibodies, except a slight increase observed in the titers of Ber-specific 
IgG1 (Figure 5.5.a). None of the groups presented anaphylactic antibodies, since 
the PCA reactions were all negative. 
Therefore, only two fractions induced significantly high levels of 
antibodies. The fraction containing ASG (6-8) induced increased IgE and the 
fraction containing SL (15-17) induced increased Ber-specific IgG1 and IgG2a. 
There are no previous results on the activity of ASG classs of lipid; however, a 
TLC-extracted lipid fraction containing SL induced increased titers of IgG1, IgE 
and positive PCA reactions (Figure 5.2.). Therefore, although the HPLC sub-
fractions 15-17 (SL) did not induce positive PCA, the increased concentration of 
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antibodies observed could indicate that this class of lipid might be involved with 
immune activation.  
Altogether, these results showed that although some sub-fractions were 
able to induce high levels of particular classes of antibodies, no clear pattern of 
immune activation could be identified. Furthermore, despite the fact SPC 
fraction C was able to induce the production of anaphylactic antibodies, causing 
positive PCA reactions (Figure 5.3.f); none of its sub-fractions was able to 
produce a similar effect. The frst possibility to be considered is that the lipids 
were affected by the HPLC procedure, as discussed in Chapter3 (Figure 3.7.). 
Since several HPLC runs had to be performed in order to obtain enough 
amounts of lipids for this experiment, this could have facilitated the occurrence 
of undesired contaminations, selective binding to the HPLC column, or lipid 
oxidation. In order to eliminate this possibility, a group receiveing all HPLC-sub-
fractions in the same proportion as present in the original SPC fraction C would 
be necessary; however, due to the limited amount of lipids extracted by HPLC, 
this group could not be performed. Other explanation for these results could be a 
possible synergistic effect between two or more sub-fractions of lipids. Finally, as 
previously mentioned, the concentration of specific lipid classes might play a role 
in the development of immune reactions. This possibility is in agreement with the 
results obtained from animals sensitised with rBer e 1 and the total lipid fraction 
from Brazil nuts (fraction T, Figure 5.3.), in which all lipid classes were present 
and no anaphylactic antibodies were produced. And also in agreement with the 
previous experiment, in which animals receiving different concentrations of SPC 
fractio C presented different humoral response towards rBer e 1. 
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In order to further investigate the presence of potential biologically 
active lipid classes in the SPC fraction C, a different method was used to its 
fractionation, named acetone precipitation. 
6. Activities of sub-fractions of lipids extracted from SPC lipid 
fraction C by acetone precipitation   
Since none of the HPLC sub-fractions extracted from SPC fraction C 
induced the production of anaphylactic antibodies, SPC fraction C was 
fractionated by acetone precipitation, resulting in two sub-fractions: pellet 
(phospholipid-rich fraction) and supernatant (triglycerides-rich fraction). It is 
important to mention that SPC fraction C consisted of 0.1% of pellet and 99.9% 
of supernatant.  
Using these two sub-fractions (pellet and supernatant), animals were 
sensitised with rBer e 1 (2.5 mg) and 600 µg of lipids. Two control groups were 
added for this experiment. One group was sensitised with the rBer e 1 and the 
whole lipid fraction C, working as a positive control group. The other group was 
included as a control for the acetone precipitation technique, with both fractions 
extracted from fraction C (pellet and supernatant) being reconstituted together in 
a similar proportion as present in the original fraction C. Animals were sensitised 
as described in Chapter 2 (item 7.2.). 
The groups used are specified below: 
Groups Sensitisation 
rBer rBer e 1 (2.5 mg) 
rBer + C rBer e 1 (2.5 mg) + 600 µg of SPC fraction C 
rBer + Cpell rBer e 1 (2.5 mg) + 600 µg of pellet from SPC fraction C 
rBer + Csup rBer e 1 (2.5 mg) + 600 µg of supernatant from SPC 
fraction C 
rBer + Cpell + 
Csup 
rBer e 1 (2.5 mg) + 0.6 µg of pellet + 599.4 µg of 
supernatant from SPC fraction C 
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The first observation in Figure 5.6. was that, once again, the presence of 
natural lipids was essential for an immune activation. Animals sensitised with 
rBer e 1 alone did not present increased titers of antibodies and negative PCA 
reactions were observed.  
Secondly, it was observed that the positive control group (rBer + C) 
worked well. Animals sensitised with rBer e 1 and SPC lipid fraction C induced 
similar immune activation as found in the previous experiment (Figure 5.3.). This 
fraction induced a slight but not significant increase in the levels of Ber-specific 
IgG1 (Figure 5.6.a), reaching values similar to the observed in the previous 
experiment, an average of 18.9 + 16.9 µg/mL. Low titers of Ber-specific IgG2a 
(Figure 5.6.c) and significantly increased titers of total IgE (Figure 5.6.e) were 
observed. SPC fraction C also induced positive PCA reactions (Figure 5.6.f).  
The group used to control the process of lipid fractionation 
(rBer+Cpell+Csup) showed similar immune activation to the positive control 
(group rBer+C). This group presented significant increased titers of total IgE 
(Figure 5.6.e), low titers of Ber-specific IgG2a (Figure 5.6.c), and positive PCA 
reactions (Figure 5.6.f). Therefore, indicating that the procedure used to extract 
the two sub-fractions from SPC fraction C did not alter the main features of the 
lipids.  
The pellet fraction extracted from SPC fraction C induced an evident 
immune activation. Animals from this group (rBer+Cpell) presented significantly 
increased titers of Ber-specific IgG1 and Ber-specific IgG2a (Figure 5.6.a and c). 
The total titers of IgE were also increased when compared to rBer e 1 group 
(Figure 5.6.e), but no statistical difference was found. Yet despite the high titers 
of Ber-specific IgG1 and total IgE present in this group, no positive anaphylactic 
response was observed (Figure 5.6.f). As mentioned before, this could be due the 
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inhibitory function that IgG2a antibodies play in the mast cell degranulation 
(Daeron, Latour et al., 1995; Takai, Ono et al., 1996), or due to the lack of 
anaphylactic IgG1 (Faquim-Mauro, Coffman et al., 1999)and Ber-specific IgE.  
In the animals sensitised with rBer e 1 and the supernatant extracted 
from SPC fraction C (rBer+Csup), the only class of antibody significantly 
increased was total IgE (Figure 5.6.e). However, PCA reactions were negative 
(Figure 5.6.f), indicating that the detected total IgE antibodies were not Ber-
specific. Therefore, triglycerides, the main component of the SPC fraction C 
(99.9%), were not able to induce a detectable immune activation. This confirms 
previous results, in which triglycerides extracted from the total lipid fraction from 
Brazil nuts did not induce immune activation (Figure 5.2.). 
The main conclusions from this experiment were that the SPC fraction 
C was confirmed to be able to induce anaphylactic antibodies and that the two 
sub-fractions from SPC fraction C (pellet and supernatant) used separately did 
not present this property. However, when these two sub-fractions were 
reconstituted and added to rBer e 1, the PCA reactions were strongly positive, 
showing that the fractionation process did not affect the immune potential of the 
lipids tested.  Two hypotheses could explain this phenomenon: (i) there might be 
a synergistic effect and certain classes of lipids present in the SPC fraction C need 
to interact to be able to stimulate the immune system; or (ii) there is a dose 
response effect. Since SPC fraction C is composed by 99.9% of supernatant and 
0.1% of pellet, animals sensitised with 600 µg of fraction C receive 599.4 µg of 
supernatant and 0.6 µg of pellet. When performing this experiment, the 
rBer+Cpell group received 600 µg of pellet, a thousand times more than the 
quantity in the SPC fraction C. The second hypothesis would also explain the 
pronounced immune activation observed in the rBer+Cpell group, since these 
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animals received very high concentrations of the phospholipid-rich fraction. In 
addition, if the second hypothesis is true, the lipids responsible for the immune 
activation observed in the SPC fraction C are likely to be present in the pellet 
fraction, which is rich in phospholipids. This is because the dose of supernatant 
used for the rBer+Csup group was similar to the concentration present in the 
original SPC fraction C and no anaphylactic antibodies were observed in this 
group.  
 
7. rBer e 1 in the presence of LPS, Alum or sunflower lipids  
The following experiments were performed in order to investigate the 
humoral response induced by rBer e 1 in the presence of different compounds 
and then compare with the effects induced by natural lipids from Brazil nuts. The 
compounds chosen to be tested were LPS, which has been reported to be 
involved with Th1 as well as Th2 responses (Eisenbarth, Piggott et al., 2002; 
Williams, Ownby et al., 2005; Hollingsworth, Whitehead et al., 2006), alum, which 
is a Th2-adjuvant (Brewer, Conacher et al., 1999; Bortolatto, Borducchi et al., 
2008), and lipids from sunflower seeds, edible seeds whose overall incidence of 
allergy is very low  (Alcocer, Murtagh et al., 2002).  
 
7.1. Activity of different concentrations of LPS in the 
sensitisation to rBer e 1  
Evidences of the role of LPS in modulating Th2 immunity is robust, 
although the data in this area is still controversial (Williams, Ownby et al., 2005). 
It has been reported that the pattern of immune response in the presence of LPS 
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is dose-dependent (Eisenbarth, Piggott et al., 2002; Delayre-Orthez, De Blay et al., 
2004; Dong, Li et al., 2009).  
This experiment was performed in order to observe the effect of 
different doses of LPS in the antibody production of rBer sensitised animals. For 
this, animals were sensitised with rBer e 1 in the presence of different doses of 
LPS (0.06 µg, 0.6 µg, 6 µg, 60 µg or 150 µg), according to the protocol described 
in Chapter 2 (Item 7.3.) 
The groups used are specified below: 
Groups Sensitisation 
rBer rBer e 1 (2.5 mg) 
rBer + LPS 0.06 rBer e 1 (2.5 mg) + 0.06 µg of LPS 
rBer + LPS 0.6 rBer e 1 (2.5 mg) + 0.6 µg of LPS 
rBer + LPS 6 rBer e 1 (2.5 mg) + 6 µg of LPS 
rBer + LPS 60 rBer e 1 (2.5 mg) + 60 µg of LPS 
rBer + LPS 150 rBer e 1 (2.5 mg) + 150 µg of LPS 
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Figure 5.7. (a-f) shows that the groups sensitised with rBer e 1 and low 
doses of LPS (0.06 Pg and 0.6 Pg) did not present significant differences in 
antibody production compared to the control group (rBer e 1 alone). No 
anaphylactic antibodies were detected by PCA.  
The group rBer+LPS6 (6 Pg of LPS) presented significant increase in 
the titers of Ber-specific and total IgG1 (Figure 5.7.a), but no significant 
differences were found in the titers of IgG2a or IgE. Positive PCA reactions 
were observed (Figure 5.7.f).  
The groups sensitised with rBer e 1 and higher doses of LPS (60 Pg or 
150 Pg) presented increased titers of Ber-specific IgG1 (Figure 5.7.a) but this 
increase was not significantly different from the control group (rBer). The titers 
of Ber-specific IgG2a were also increased in both groups (60 Pg or 150 Pg), but 
the difference was significant only for the rBer+LPS60 (Figure 5.7.c). The total 
levels of IgG2a were significantly increased in the group rBer+ LPS150 (Figure 
5.7.d). Both groups presented positive PCA reactions (Figure 5.7.f).  
The first conclusion to be taken is that LPS had an adjuvant effect in 
the sensitisation model used in the present work. The antibody response 
observed in animals sensitised with rBer e 1 and different doses of LPS was 
different from the response observed in animals immunized with rBer e 1 alone. 
The dose of LPS also had an impact in the development of the immune response 
to rBer e 1, since only higher doses of LPS were able to induce the production of 
anaphylactic antibodies.  
Although it is known that signalling through TLRs is required for 
adaptive T helper cell type 1 (Th1) responses, the mechanisms by which TLRs 
may participate in the Th2 priming are still unclear (Williams, Ownby et al., 2005). 
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A report showing the effect of different doses of LPS in a model of allergic 
asthma showed that low doses of LPS (0.01 Pg) induced Th2-type responses, 
with increased titers of antigen-specific IgE and IgG1, low titers of antigen-
specific IgG2a, type-2 cytokines and eosinophils; whereas high levels of LPS (100 
Pg) induced a Th1-patterned response, with increased titers of antigen-specific 
IgG1 and IgG2a, low titers of antigen-specific IgE, increased number of 
neutrophils, and increased production of IFN-J (Eisenbarth, Piggott et al., 2002). 
Another study in mouse model of asthma has also demonstrated that low doses 
of LPS favour a Th2-type response while higher doses favour a Th1-type 
response (Dong, Li et al., 2009). In contrast, a study using a C57BL/6 murine 
model of AHR (Airway hyper-reactivity) showed that LPS-free antigens were 
more efficient to induce an allergic reaction than antigens contaminated with low 
doses of LPS (Watanabe, Miyazaki et al., 2003). In our model, only doses of LPS 
higher than 6 Pg were able to induce increased titers of IgG1 and IgG2a as well 
as the production of anaphylactic antibodies. Therefore, the role played by 
different doses of LPS in murine models of allergy is indeed controversial. 
However, it is relevant to emphasize that different animal models are used, with 
different sensitisation routes, exposure time, and LPS doses. 
Comparing the effects induced by increasing concentrations of LPS 
(Figure 5.7.) with the effects induced by increasing concentrations of the natural 
SPC lipid fraction C (Figure 5.5.), it is observed that they were contrasting. While 
high doses of LPS were necessary to induce the production of anaphylactic 
antibodies, only low doses of SPC lipid fraction C were able to induce positive 
PCA reactions. However, it is important to emphasize that the doses of LPS and 
natural lipids used were of different magnitude. LPS doses varied from 0.06 to 
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150 Pg and the doses SPC lipid fraction C varied from 15 to 3,750 Pg. Higher 
doses of LPS could not be tested due to its endotoxic properties, being the lethal 
dose of LPS in mice 750 Pg (Jones, Mansell et al., 2007). The lowest dose of SPC 
fraction C able to induce anaphylactic antibodies was not evaluated. 
Lipids can be recognized by the immune system by different 
mechanisms. LPS, for instance, is recognized TLR4 and the mechanisms 
underlying its recognition and the consequent intracellular signalling events are 
well described (Lu, Yeh et al., 2008; Kawai e Akira, 2010). Although TLRs are 
usually related with innate responses, it is now well established that LPS 
participates in Th1 as well as in Th2 responses. Other mechanisms by which 
lipids can be recognized by the immune system, not involving TLRs, will be 
discussed later in the present study.   
Hence, the different pattern of humoral response induced by rBer e 1 in 
the presence of LPS or natural lipids are probably related not only to different 
doses used, but also to the different mechanisms by which lipids are being 
recognized by the immune system. The possible mechanism(s) by which lipids 
from Brazil nuts may activate the immune system will be discussed in Chapter 6. 
 
7.2. Activity of Alum in the sensitisation to rBer e 1 and OVA 
rBer e 1 was able to induce the production of anaphylactic antibodies in 
the presence of SPC fraction C from Brazil nuts and in the presence of different 
doses of LPS, which is reported to participate of allergic processes (Eisenbarth, 
Piggott et al., 2002; Kim, Oh et al., 2007; Dong, Li et al., 2009). However, rBer e 1 
sensitisation has not been tested in the presence of alum (AlOH3), a robust Th2 
adjuvant (Brewer, Conacher et al., 1999). 
 157 
Ber e 1 is the major allergen in Brazil nuts and no studies have 
investigated its activity in the presence of a well-established Th2-adjuvant. The 
following experiment was performed in order to evaluate the activity of rBer e 1 
in the presence of alum and to compare the results with the same protocol 
performed using OVA as allergen. 
Two different sensitisation protocols were used, as described in Chapter 
2 (Item 7.4.). In order to facilitate the visualization, the groups used are specified 
below: 
Groups Sensitisation 
 Day 0 Day 7 Day 14 Day 21  
 Protein+
Alum 
Protein+
Alum 
Protein Protein Exsanguination 
rBer ¥ ¥   Day 14 
rBer+Al (14d) ¥ ¥   Day 14 
rBer+Al (28d) ¥ ¥ ¥ ¥ Day 28 
OVA ¥ ¥   Day 14 
OVA+Al (14d) ¥ ¥   Day 14 
OVA+Al (28d) ¥ ¥ ¥ ¥ Day 28 
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The results (Figure 5.8. a-f) indicated that rBer e 1 and alum did not 
induce immune activation in both sensitisation protocols tested. No statistical 
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differences were found comparing levels of antibodies in the presence or absence 
of alum.  
In contrast, animals sensitised with OVA and alum presented a clear 
Th-2 pattern of antibody production, with significantly increased titers of anti-
OVA IgG1 (Figure 5.8.a) and total IgE (Figure 5.8.e), and low titers of anti-OVA 
IgG2a (Figure 5.8.c). These animals also presented positive PCA reactions 
(Figure 5.8.f), indicating that the adjuvant used was able to induce Th2-type 
responses.   
Mice sensitised with OVA alone (with no adjuvant) presented low levels 
of antibodies but positive PCA reactions were observed, indicating that OVA 
alone is able to induce the production of anaphylactic antibodies. 
Comparing the two sensitisation protocols used, the longer protocol 
(with challenges on days 14 and 21) induced a more pronounced Th2 antibody 
response in OVA-sensitised mice, inducing higher levels of IgG1 and IgE than 
mice sensitised on days 0 and 7 with no further challenges. It is important to note 
that the longer the titers of OVA-specific IgG1 and total IgE were much higher 
compared with previous results on rBer e 1-sensitised animals. Contrastingly, 
when rBer e 1 was used in the presence of alum, not even the longer protocol 
induced detectable levels of antibodies. 
Therefore, alum did show potent Th2-adjuvant properties when used in 
the presence of OVA, but this was not observed when in the presence of rBer e 
1. Alum is a Th2 adjuvant widely used in animal models of allergy, inducing the 
secretion of Th2-type  immunoglobulins cytokines and (Bortolatto, Borducchi et 
al., 2008; Darcan-Nicolaisen, Meinicke et al., 2009; Fujita, Teng et al., 2009; 
Raymond, Rubio et al., 2009; Suzuki, Zheng et al., 2009). Animal models of 
asthma using OVA and alum show increased levels of IgE and IgG1 in the 
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serum, IL-4, IL-5 and IL-13 in the broncho-alveolar lavage (BAL), increased 
airway hyper-activity (AHR) and eosinophil infiltration (Keller, Mucida et al., 
2006; Nakajima e Takatsu, 2007). Animal models of food allergy also use alum as 
adjuvant in the presence of several antigens, such as OVA, peanut and cow milk, 
and a Th2-pattern response is observed, with high levels of IgE, IgG1, IL-4 and 
IL-5 (Brandt, Strait et al., 2003; Adel-Patient, Bernard et al., 2005).  
The major allergen from Brazil nuts induces Th2-type responses in the 
presence of a particular fraction of natural lipids (SPC fraction C) and in the 
presence of LPS; however, no immune activation was observed when rBer e 1 
was administrated with alum. Although SPC fraction C and LPS have distinct 
compositions, both products contain lipids while this is not present in Al(OH)3. 
Therefore, it is possible to speculate that the mechanisms by which the immune 
system builds a Th2-type response towards rBer e 1 involve lipid recognition. As 
mentioned before, LPS acts through TLR4 and lipids can be recognized by the 
immune system in the context of TLR or CD1 molecules (Miyamoto, Miyake et 
al., 2001; Moody, 2006). These mechanisms will be investigated and discussed in 
Chapter 6. Here, the main conclusion is that alum does not induce a Th2-
response in the presence of rBer e 1, whereas this response is achieved when rBer 
e 1 is attached to natural lipid fractions (SPC fraction C) or to LPS.  
It is also relevant to consider that the capacity of rBer e 1 to bind lipids 
could interfere in the course of the immune response. It is been reported that the 
allergenic 2S albumin Sin a 1 from mustard seeds is able to interact with 
phospholipid vesicles and this could be involved with its allergenicity (Onaderra, 
Monsalve et al., 1994). A different study showed that melittin, an allergen from 
bee venom, binds to cell membranes and it is correlated with an enhancement of 
its immunogenicity (Fehlner, Kochoumian et al., 1991). Therefore, it is possible 
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that the immune system recognizes the whole complex, protein-lipid, in order to 
develop an immune response towards rBer e 1.  
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7.3. Activity of lipids from sun flower seeds in the sensitisation 
to rBer e 1.  
rBer e 1 was demonstrated to induce Th2-skewed responses in the 
presence of natural lipids from Brazil nuts and in the presence of LPS. However, 
it was not observed in the presence of alum, a Th2-adjuvant. In order to 
investigate whether lipids from other seeds could also induce an allergic response 
to rBer e 1, lipid fractions were extracted from sunflower seeds by SPC and 
tested in the presence of rBer e 1. The fractions obtained from sunflower were: 
SPC fraction C(SF) and SPC fraction M(SF). 
Therefore, animals were sensitised with rBer e 1 in the presence of 600 
µg of sunflower lipids (SPC fraction C(SF) or SPC fraction M(SF)), according to 
the protocol described in Chapter 2 (Item 7.2.) 
 The groups used are specified below: 
Groups Sensitisation 
rBer rBer e 1 (2.5 mg) 
rBer + C(SF) rBer e 1 (2.5 mg) + 600 µg of SPC lipid fraction C from 
sunflower 
rBer + M(SF) rBer e 1 (2.5 mg) + 600 µg of SPC lipid fraction M from 
sunflower 
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Figure 5.9. (a-f) shows that lipid fractions from sunflower seeds induced 
a slight immune activation in animals sensitised with rBer e 1. SPC fraction C(SF) 
induced significant increased titers of Ber-specific IgG1 and total IgE (Figure 
5.10.a and e), and SPC fraction M(SF) induced significantly increased titers of 
Ber-specific IgG2a (Figure 5.10.c). However, none of the lipid fractions from 
sunflower were able to induce the production of anaphylactic antibodies (Figure 
5.10.f).  
It is important to note that the levels of Ber-specific antibodies 
presented by animals sensitised with rBer e 1 and SPC C and M from sunflower 
lipids (Figure 5.9.) were similar to the levels observed in animals sensitised with 
SPC fractions C and M from Brazil nuts (Figure 5.3. and 5.6.). However, the 
levels of total IgG1 and total IgE were lower in animals sensitised with lipids 
from sunflower (Figure 5.9.) than in animals sensitised with lipids from Brazil 
nuts (Figure 5.3.and  5.6).  
Therefore, lipids from sunflower seemed to have an immunogenic 
effect but no indications of a Th2-patterned response was observed. It is 
important to highlight that, although extracted by the same technique, lipid 
fractions extracted from different sources differ in composition, and some special 
classes of lipids may be present in one seed and absent in the other. This 
experiment was one more indication that SPC fraction C from Brazil nuts has a 
distinct adjuvant property in the model of allergy used in the present work. 
 
8. Activity of natural lipid fraction C attached to SFA-8 protein 
The results obtained so far indicated that SPC fraction C from Brazil 
nus are involved with the Th2-patterned responsed observed in Ber-sensitised 
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animals. This phenomenon was not observed when alum or lipids from 
sunflower seeds were used.  
In order to further investigate the role of Brazil nut SPC fraction C and 
check whether its Th2-immune activity was also present when attached to 
different proteins, similarly to Th2 adjuvants like alum, it was tested in the 
presence of SFA-8, a protein from sunflower.  
Therefore, for this experiment, Brazil nut SPC fraction C was added to 
SFA-8 and tested in our protocol of sensitisation. SPC fraction L, which did not 
induce anaphylactic antibodies in Ber-sensitisation protocol, was used as a 
negative control; and LPS, which induced anaphylactic antibodies in the presence 
of rBer e 1, was used as a positive control.  
Animals were sensitised according to the protocol described in Chapter 
2 (Item 7.2.). The groups used are specified below: 
Groups Sensitisation 
Naive None 
SFA SFA-8 (2.5 mg) 
SFA + L SFA-8 (2.5 mg) + 600 µg of SPC fraction L 
SFA + C SFA-8 (2.5 mg) + 600 µg of SPC fraction C 
SFA + LPS SFA-8 (2.5 mg) + 150 µg of LPS 
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Figure 5.10. (a-f) shows that SFA-8 alone was not able to induce a 
specific immune activation. Mice sensitised with SFA-8 (group SFA) presented 
levels of Ber-specific IgG1 and Ber-specific IgG2a similar to naive animals. The 
titers of total IgE were significantly increased (Figure 5.10.e), but no positive 
PCA reactions were observed (Figure 5.10.f). PCA reactions can be elicited by 
anaphylactic IgG1 or IgE, since these animals did not present detectable titers of 
Ber-specific IgG1, it can be speculated that the high levels of total IgE levels 
presented by animals sensitised with the protein alone were composed mainly by 
non-specific immunoglobulins.  
Mice sensitised with SFA-8 and SPC fraction L did not present 
important immune activation, all antibody titers tested were low. A slight increase 
was observed in the titers of SFA-specific IgG1 (Figure 5.10.a) but it was not 
significantly different from the controls (naive and SFA groups). 
The group sensitised with SFA-8 and SPC lipid fraction C presented 
increased SFA-specific IgG1 (Figure 5.10.a), but not statistically different from 
the control. Low IgG2a and IgE were observed (Figure 5.10.c-e). However, 
strongly positive PCA reactions were observed (Figure 5.10.f), indicating that 
these animals presented anaphylactic antibodies. 
Finally, the group SFA+LPS presented significantly increased levels of 
SFA-specific IgG1 (Figure 5.10.a), slight increase in the titers of SFA-specific 
IgG2a (Figure 5.10.c) and low titers of IgE (Figure 5.10.e). The PCA reactions 
were strongly positive (Figure 5.10.f). 
These results indicated that the Th2-adjuvant property of SPC fraction 
C from Brazil nuts was not Ber e 1 specific. The humoral response induced in 
SFA-8 sensitised animals was similar to the response observed in Ber-sensitised 
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animals, characterized by increased titers of antigen-specific IgG1, low titers of 
IgG2a and positive PCA reactions.  
SFA-8 and Ber e 1 are proteins of the same 2 S albumin seed storage 
family that share structural and biological similarities (Murtagh, Archer et al., 
2003). However, whereas the allergenicity of Ber e 1 is well established (Nordlee, 
Taylor et al., 1996; Pastorello, Farioli et al., 1998), SFA-8 appears to be a weaker 
allergen. The incidence of sunflower allergy is very low even in countries where 
this seed is highly consumed, such as Spain, Germany and Greece (Alcocer, 
Murtagh et al., 2002; Kean, Goodridge et al., 2006). Confirming epidemiological 
data, an in vitro work showed that Ber e 1 but not SFA-8 was able to polarize 
dendritic cells in a Th2 direction (Kean, Goodridge et al., 2006). Considering Ber 
e 1 and SFA-8 originate from different seeds and differ on their allergenic 
potential, the fact that the fraction SPC C from Brazil nuts was able to induce 
Th2-skewed humoral responses in the presence of Ber e 1 as well as in the 
presence of SFA-8 could indicate that these lipids present a Th2-adjuvant like 
effect, being able to play a non-specific role. However, considering the structural 
similarities between these two proteins, the possible lipid-protein binding prior to 
the immune recognition cannot be discarded.  
In summary, the results presented in this Chapter confirmed previous 
findings (Dearman, Alcocer et al., 2007) evidencing the essential role that natural 
lipids play in the sensitisation to rBer e 1, since this protein alone did not induce 
the production of anaphylactic antibodies. Several fractions of lipids from Brazil 
nuts were tested in the in vivo model of sensitisation to rBer e 1 and only one 
fraction (SPC C) was able to induce a Th2-skewed humoral response. The 
pattern of immune activation induced by this fraction was shown to be dose-
dependent, since lower doses induced anaphylactic antibodies and higher doses 
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did not. Several lipid classes were putatively identified in the SPC fraction C, but 
when further fractionated into sub-fractions containing identified classes of 
lipids, SPC lipid fraction C lost its ability to induce the production of 
anaphylactic antibodies, indicating then, that the doses and/or the presence of 
particular classes of lipids (possibly synergistically) are important for determining 
the course of the Th2 immune reaction observed. The immune effect of rBer e 1 
was also tested in the presence of different compounds, such as LPS, alum and 
natural lipids from sunflower. Amongst them, LPS was the only molecule that, 
similarly to SPC fraction C, induced the production of anaphylactic antibodies in 
Ber-sensitised animals also in a dose-dependent way. However, the pattern of 
humoral response induced by LPS and SPC fraction C was different in the sense 
that LPS induced significant increase in titers of antigen-specific IgG1 and IgG2a 
and SPC fraction C induced only increase titers if IgG1. Similar humoral pattern 
was observed when a LPS or SPC fraction C were tested in animals sensitised to 
a different protein, SFA-8, from sunflower.  
Therefore, the in vivo findings described so far evidenced an immune 
phenomenon in which natural lipids play an essential role. The mechanisms by 
which these lipids might be interacting with the immune system and directing the 
course of the response will be investigated in the next Chapter.  
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CHAPTER 6 
 
 
 
MECHANISMS OF IMMUNE 
ACTIVATION BY LIPIDS FROM BRAZIL 
NUTS 
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INTRODUCTION 
As discussed in depth in Chapter 1, the role of plant and animal lipids 
has been investigated in different aspects of the immune system and two main 
ways of lipid immune activation have been reported, involving TLR or CD1 
molecules. This chapter describes and discusses the results of experiments carried 
out to investigate the potential mechanism(s) by which natural lipids interact with 
the immune system, particularly focusing upon TLR and CD1-NKT sytems.  
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RESULTS AND DISCUSSION 
1. The ability of the SPC lipid fraction C to bind and activate 
TLRs 
 In the present work, we have shown that animals sensitised with rBer e 
1 and different doses of LPS produced anti-Ber anaphylactic antibodies. The 
same results were observed in animals sensitised with rBer e 1 and SPC lipid 
fraction C from Brazil nuts. Animals sensitised with rBer e 1 alone did not 
produce anaphylactic antibodies (Results in Chapter 5).  
In order to investigate whether the immune activation induced by SPC 
lipid fraction C from Brazil nuts involved TLRs, samples of this fraction of lipids 
were sent to a commercial company and tested in an in vitro model of TLRs 
activation (assay details are provided in Chapter 2, Item11).  
Within the context of immune regulation involving TLRs, it is relevant 
to mention that SPC lipid fraction C was also tested for endotoxin testing in a 
LAL system and no LPS or measured endotoxin contamination was found. This 
information is shown in the Appendix 2 (fraction C:M refers to SPC fraction C).  
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Figure 6.1.: Activation of different human (h) TLRs (2, 3, 4, 5, 7, 8 and 9) by 
positive controls (T+) and by SPC lipid fraction C (sample). Results are given in 
OD.  
 
 
Figure 6.1. shows that the SPC lipid fraction C (sample) was not able to 
activate any of the human TLRs tested. This result and the endotoxin analysis 
strongly suggest that the immune activation induced by SPC lipid fraction C is 
not through TLRs.  
Therefore, although lipid molecules are reported to direct the adaptive 
response via TLRs, such as LPS via TLR4 (Mcaleer e Vella, 2008), ES-62 from 
nematodes via TLR4 (Harnett e Harnett, 2009), and lyso-PS from schistosome 
via TLR2 (Van Der Kleij, Latz et al., 2002); this does not seem to be the case for 
lipids from Brazil nuts. 
Nevertheless, the possible interaction between SPC fraction C and 
TLRs cannot be completely excluded. The first consideration in this respect is 
that the in vitro system used might not have reproduced properly the events 
happening in vivo. The presence of lipids was shown to be essential for the 
development of an in vivo Th2-biased response (Dearman, Alcocer et al., 2007) 
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and these results were confirmed in the present work (Chapter 5). Conversely, 
when the same rBer e 1 proteins were tested in an in vitro model using bone 
marrow DCs (Kean, Goodridge et al., 2006), the presence of natural lipids did not 
change the profile of cytokines expressed by DCs. In the absence of other 
regulatory mechanisms, rBer e 1 alone was able to induce a Th2 polarization of 
DCs (Kean, Goodridge et al., 2006). This observation corroborates the absence 
of in vitro TLR activation observed in the present experiment. It is known that 
DCs express TLR and these cells are also able to efficiently present antigens to T 
cells (antigen presenting cells, APC). DCs bridge the native and adaptive immune 
system playing a key role in driving the development of an immune response, and 
therefore, in vitro systems lack other regulatory factors present in vivo experiments. 
It is also important to highlight that the role of the natural lipids from 
Brazil nuts in the development of an allergic response was observed in mice 
(Dearman, Alcocer et al., 2007). No evidence of this activity is reported in 
humans. The TLRs present in the cell lines tested in vitro were human TLRs and 
this fact could interfere in the results, not reproducing the events observed in vivo. 
Therefore, although the results indicate that the activation of TLRs is not the 
main mechanism of activation of SPC lipid fraction C, this can not be 
categorically proved due to limitations on the in vitro system. 
 In order to circumvent the limitations of in vitro systems, the activity of 
SPC lipid fraction C could be tested in animal models using different lineages of 
mice, which can be knocked-out for one or more TLRs (Calcaterra, Sfondrini et 
al., 2008; Chandran, Verhoeven et al., 2009; Hammad, Chieppa et al., 2009; 
Stowell, Seideman et al., 2009) as well as for molecules involved in TLRs 
signalling pathways (Cai, Batra et al., 2009), such as MyD88 (Chen, Lei et al., 
2010), TRIF and TIRAP (Horng, Barton et al., 2002). Therefore, further studies 
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using knockout mice would be necessary to confirm that the activity of SPC 
fraction C is not TLR-dependent. 
 
2. Activity of SPC fraction C via NKT-CD1 
The following experiments were performed in order to investigate 
whether the role of natural lipids from Brazil nuts in developing a Th2 response 
could involve the activation of NKT cells, and therefore, CD1 molecules.  
 
2.1. NKT activation by SPC lipid fractions in BALB/c mice 
As previously shown (Chapter 5, Figure 5.3.), SPC lipid fractions C and 
M extracted from Brazil nuts by SPC differed in the ability to induce the 
production of anaphylactic antibodies in the sensitisation protocol performed in 
the present work. Animals sensitised with rBer e 1 and SPC fraction C presented 
anaphylactic antibodies whereas it was not observed in animals sensitised with 
rBer e 1 and SPC fraction M (Chapter 5, Figure 5.3.).   
It has been demonstrated that the injection of D-GalCer, a potent 
inducer of NKT cells, leads to the production of both IFN-J and IL-4 by nearly 
all NK T cells in the liver and in the spleen within 2 h. These cells mostly 
disappear by 5 h, and they do not reappear after 1 week (Matsuda, Naidenko et 
al., 2000). Therefore, in experiments carried out in Paris with the supervision of 
Dr. Leite-de-Moraes, the SPC lipid fraction C and SPC lipid fraction M were 
tested in a 2h-long protocol of NKT activation and compared to the activity of 
D-GalCer, used as a positive control (as described in Chapter 2, Item 9.1.).  
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The groups used are specified below: 
Groups I.p. injection: 
Naive - 
SPC fraction C rBer e 1 (2.5 mg) + 600 µg of SPC fraction C 
SPC fraction M rBer e 1 (2.5 mg) + 600 µg of SPC fraction C 
D-GalCer 2 µg of D-GalCer 
 
 
Figure 6.2. shows that all animals present NKT cells, which are TCR+ 
and TT+, and are represented in the gate underlined in pink (Figure 6.2.a, e, i and 
m). The other plots represent the IL-4 and/or IFN-J production by NKT cells. It 
was observed that animals that received rBer e 1 with SPC fraction C or with 
SPC fraction M did not show NKT cells producing detectable levels of IL-4 or 
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IFN-J The upper-right quadrants (Figure 6.2.f-h and j-l) presented similar 
amount of marked cells compared to not-manipulated animals (Naive group, 
Figure 6.2.b-d). Differently, 24.5% of NKT cells from animals that received D-
GalCer produced IL-4 (Figure 6.2.n), 33% of NKT cells produced IFN-J, and 
23.6% of NKT cells produced both IL-4 and IFN-J.   
$-GalCer is the most potent ligand fRUWKHLQYDULDQW9ơ1.7DQWLJHQ
receptor, which is exclusively presented by CD1d. When activated by D-GalCer, 
NKT cells promptly produce large amounts of IFN-J and IL-4 (Kawano, Cui et 
al., 1997). The activation of NKT cells by different lipids might differ in timing 
or other mechanisms involving their presentation by DCs, altering the results 
observed. Therefore, the fact that the NKT cells from animals injected with 
natural lipids from Brazil nuts did not show as evident production of IL-4 and 
IFN-J as observed with D-GalCer does not necessarily mean that these lipids 
were not recognizable by NKT.  
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The expression of CD69 indicates the activation of lymphocytes. Figure 
6.3. shows the activated NKT cells in plots (second column of graphs) and 
histograms (third column of graphs). No significant differences in NKT 
activation were observed amongst all groups of animals studied. However, by 
overlaying the histograms of individual groups it was possible to observe that the 
D-GalCer group presented higher activation than the naive group (Figure 6.4.). 
No differences were observed overlaying the graphs from other groups.  
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Figure 6.5. showed the expression of CD69 by CD4 and CD8 T cells. 
Second and third columns of plots were gated in T cells (TT- and TCR+), 
showed in first column of plots (Figure 6.5.a, d, g and j). No statistically 
significant differences were observed amongst the groups, indicating that under 
the conditions of the present protocol the lipids did not activate T cells. 
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Figure 6.6. shows the expression of CD69 by B cells (CD24high+) and 
NK cells (Dx5+). No statistic differences (p>0.05) were found in the activation 
of B cells comparing all groups (Figure 6.6.b, e, h and k). However, there was an 
indication that both lipid fractions SPC C (Figure 6.6.f) and SPC M (Figure 6.6.i) 
presented more activated NK cells compared to naive animals (Figure 6.6.c). This 
difference was not statistically different (p>0.05) from the control (naive), 
probably due to the low number of animals tested (n=2 or n=3). A similar 
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increase was observed in the cells from animals that received D-GalCer (Figure 
6.6.l), but it was not statistically different from the control either (p>0.05). 
Altogether, the results showed that D-GalCer clearly activated NKT 
cells and that this activation was not observed when SPC fraction C or SPC 
fraction M was used. Therefore, using the present protocol, natural lipids from 
Brazil nuts did not induce evident NKT cell activation. There was an indication 
however, that the SPC fractions C and M of lipids from Brazil nuts induced an 
activation of NK cells, similarly to the observed with D-GalCer, indicating that 
the conjugates lipid+rBer e 1 injected in the animals are activating the innate 
immune system. It is important to consider; however, that different classes of 
lipids present different levels of affinity to bind CD1 molecules (Stanic, 
Shashidharamurthy et al., 2003; Oki, Chiba et al., 2004). This fact as well as the 
dose of antigen and the affinity to NKT TCR determinate the duration of TCR 
signalling (Sullivan, Nagarajan et al., 2010); therefore, in order to further 
investigate the role of natural lipids in the activation of NKT cells using the 
present model of NKT activation, different protocols testing different doses of 
lipids and time duration would need to be carried out.    
 
2.2. Activity of SPC lipid fraction C in wild type and JD18 -/- 
mice 
The activity of SPC fraction C, the only lipid fraction from Brazil nuts 
able to induce the production of anaphylactic antibodies in vivo (Chapter 5), was 
then studied in animals lacking NKT cells in order to rule out the immune 
activation involving the participation of NKT cells.  
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Therefore, the same sensitisation protocol used in the present work 
(Chapter 5) was performed in knockout mice (JD18-/-), which are exclusively 
deficient in the invariant VD14 (iVD14), CD1d-restricted NKT cells. Therefore, 
JD18 -/- and wild type C57BL/6 mice were sensitised with rBer e 1 and SPC 
fraction C and several parameters were observed. 
The groups used are specified below:  
Groups Animals Sensitisation: 
WT Wild type C57BL/6 rBer e 1 (2.5 mg) + 600 µg of SPC 
fraction C 
JD18-/- JD18 knockout C57BL/6 rBer e 1 (2.5 mg) + 600 µg of SPC 
fraction C 
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Figure 6.7. (a-d) shows that NKT cells (TT+ and TCR+) were detected 
in WT animals (Figure 6.5.a), but not in JD18-/- mice (Figure 6.4.d). The plot 
(Figure 6.4.b) and histogram (Figure 6.5.c) showed the expression of CD69 by 
NKT cells from wild type animals, indicating the activation of these cells. Since 
these animals were injected with rBer e 1 and SPC lipid fraction C, it would be 
necessary a group of wild type animals that had not been injected with lipids to 
evaluate whether the NKT cell activation observed was due to the lipids activity. 
However, due to the low availability of animals, the control groups necessary to 
evaluate the activation of NKT cells in WT animals were not carried out.  
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In order to study the activation of CD4+ and CD8+ T cells in WT and 
JD18-/- mice, these markers as well as CD69 were evaluated. Figure 6.8. shows 
the activation of CD4+ and CD8+ T cells; i.e. CD69+ T cells. The gate for the 
analyses of T cells is shown in the Figure 6.8.a for WT animals and in the Figure 
6.8.e for JD18-/- animals. The histograms show the expression of CD69 by CD4 
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T cells (Figure 6.8.c and g) and by CD8 T cells (Figure 6.8.d and h). There is a 
slight increase in the expression of C69 in CD4 and CD8 T cells of JD18-/- 
animals when compared to WT mice, however no statistical differences were 
found comparing the two groups of animals.  
 
 
The activation of TCR+ cells (T cells) and Dx5+ cells (NK cells) was 
studied through the expression of CD69. Figure 6.9. (a-f) indicates that the 
expression of CD69 is increased in JD18-/- T cells (Figure 6.9.e) and NK cells 
(Figure 6.9.f) when compared to WT T cells and NK cells (Figure 6.9.b. and 
6.9.c, respectively). However, no statistic differences (p>0.05) were found 
comparing animals form both groups. Therefore, although there is an indication 
that NK and T cells from JD18 knockout animals are more activated than NK 
and T cells from WT animals, this fact could not be statistically confirmed.  
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It is known that NKT cells, when activated, produce large amounts of 
IL-4 and IFN-J, activate DCs, macrophages and NK cells, and recruit 
neutrophils, expanding the immediate innate immune response. These events 
interfere in the subsequent adaptive T-cell and B-cell responses (Barral e Brenner, 
2007). Therefore, considering this complex network of interactions, the absence 
of NKT cells (in JD18-/- mice) could interfere in the behaviour of other cells of 
the immune system, explaining, for instance, the different activation of T cells 
and NK cells observed in NKT knockout animals.   
In order to compare the results that originated from NKT experiments 
and the role that lipids from Brazil nuts play in the immune response to rBer e 1, 
the next series of experiments aimed to evaluate the antibody profile of WT and 
NKT knockout animals sensitised to rBer e 1. 
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Figure 6.10. shows the immunoglobulins produced by WT and JD18 -/- 
C57BL/6 mice sensitised with rBer e 1 and SPC lipid fraction C. It was possible 
to observe that WT animals produced significantly (p<0.05) increased titers of 
Ber-specific IgG1 (Figure 6.10.a) and total IgE (Figure 6.10.c) when compared to 
JD18 -/- mice. The titers of anaphylactic immunoglobulins detected by PCA were 
also increased in WT mice (Figure 6.10.d). This difference was detected in the 
serum dilutions 1/4 and 1/8, in which serum from WT animals induced 
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significantly stronger PCA reactions than the serum from JD18 -/- mice. These 
data clearly demonstrated that, although NKT cells were not essential for the 
immune activation induced by SPC lipid fraction C, the presence of these cells 
interfered in the development of the allergic response observed.  
After stimulated by lipid ligands, NKT cells rapidly produce IL-4 and 
IFN-J IL-4 induces the differentiation of Th2 cells while IFN-J is related with 
the development of Th1 cells. In animal models of asthma, direct activation of 
NKT cells by glycolipids results in the secretion of extensive amounts of 
cytokines and triggers the development of airway hyperreactivity. Moreover, in 
patients with chronic asthma, significant amounts of NKT cells can be found in 
their bronchoalveolar lavage fluids, suggesting that NKT plays an important role 
in allergy pathogenesis (Stock e Akbari, 2008; Umetsu e Dekruyff, 2010). 
Therefore, the less evident Th2-pattern of antibody production observed in 
JD18-/- animals was probably due to the absence of NKT cells presented by 
these animals.  
These results also confirmed the data obtained in Chapter 5, in which 
rBer e 1 in the presence of SPC lipid fraction C induced a Th2 humoral response, 
with increased titers of Ber-specific IgG1, total IgE, and the production of 
anaphylactic antibodies (Figure 5.3.). The average titers of Ber-specific IgG1 were 
higher in rBer+SPC fraction C sensitised C57BL/6, approximately 800 Pg/mL 
(Figure 6.10.a), compared to rBer+SPC fraction C sensitised BALB/c, 
approximately 30 Pg/mL (Figures 5.3., 5.4. and 5.6.a). However, this could be 
due to strain differences in the production of antibodies. BALB/c and C57BL/6 
mice are known to differ in some aspects related to allergy. In BALB/c mice, for 
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instance, allergic responses are more dominated by IL-4 than IL-5 comparing to 
C57BL/6 mice (Drazen, Arm et al., 1996). 
Altogether, the results presented in this chapter corroborate the 
hypothesis that the recognition of lipids from Brazil nuts by the immune system 
might involve the activation of NKT cells. Firstly, lipid fractions from Brazil nuts 
were shown not to be able to activate humans TLRs. Furthermore, although no 
NKT activation was found using the 2h-protocol performed in BALB/c mice, 
the sensitisation protocol performed in JD18-/- animals showed that these 
animals presented significantly decreased titers of Ber-specific IgG1, total IgE 
and anaphylactic antibodies compared to WT mice. These data indicate that the 
role of natural lipids from Brazil nuts might involve the activation of NKT cells 
and consequently CD1 presentation. Considering the complexity of the immune 
system, which is composed by numerous types of cells and compounds that 
interact with each other as well as with cells and compounds from other systems, 
such as nervous and endocrine systems, it is very likely that other cells participate 
in the role that natural lipids from Brazil nuts play in the development of an 
allergic response to rBer e 1. Moreover, it is important to consider that the 
fraction of lipids that induced the Th2-mediated response (SPC fraction C) is 
composed by a mixture of different classes of lipids and that, the individual 
minor components of this mixture were not able to induce the same pattern of 
immune response. This could be due to a synergistic effect amongst different 
classes of lipids or, alternatively, that the lipid concentration of the active 
compound is important for the development of the immune response. Further 
studies would be then necessary to find out the lipid aspects of immune 
activation, the network of cells and mechanisms involved with the recognition of 
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these active lipids by the immune system and the consequences of it in the 
development of allergy.  
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FINAL DISCUSSION 
The prevalence of allergic diseases has been increased in recent years, 
and the reasons underlying this augmented incidence are still unclear 
(Niederberger, 2009). Extensive research using in vivo and in vitro models has been 
performed, and the general mechanisms, immune cells and molecules involved in 
allergic processes are well described in the literature, although the details are far 
from complete (Gould, Sutton et al., 2003; Prussin e Metcalfe, 2006; Finkelman, 
2007). Questions such as why some people are more prone to develop allergy and 
why only few proteins act as allergens remain unanswered. In fact, several factors 
are suggested to influence the development of allergy as, for instance, the 
structure and functional properties of a protein (Breiteneder, H. e Mills, E. N., 
2005; Cochrane, Beyer et al., 2009; Togias, Fenton et al., 2010). However, not all 
proteins wLWK ¶W\SLFDO DOOHUJHQ· IHDWXUHV are involved in allergy cases and, 
moreover, not everybody develops allergy towards well-established allergens. 
Therefore, it is clear that there is still information missing in order to fully 
understand the networked events involved in allergic processes.  
It has been recently shown that natural lipids play an essential role in the 
development of a Th2-type humoral response towards Ber e 1 (Dearman, 
Alcocer et al., 2007). The present project further investigated the role of natural 
lipids in the sensitisation to Ber e 1, focusing in the Brazil nut lipids 
characterization (Chapter 3), humoral responses observed in animals sensitised 
with Ber e 1 in the presence of different fractions of lipids (Chapter 4 and 5), and 
mechanisms by which natural lipids modulate the sensitisation process (Chapter 
6).  
 193 
Firstly, no immune reaction was observed in animals sensitised with 
rBer e 1 alone, confirming previous findings (Dearman, Alcocer et al., 2007). 
Although the allergenicity of Ber e 1, the major allergen from Brazil nuts, is well 
established (Arshad, Malmberg et al., 1991; Pastorello, Farioli et al., 1998; Bansal, 
Chee et al., 2007) and this 2S albumin protein possesses several allergen-related 
features (Murtagh, Archer et al., 2003; Alcocer, Murtagh et al., 2004), this protein 
alone was not able to induce Th2-biased response in the animal model of 
sensitisation used in the present study.  
Of the several fractions of Brazil nut lipids tested, only one fraction 
(SPC fraction C) consistently induced the production of increased titers of Ber-
specific IgG1 and anaphylactic antibodies (found by PCA) in Ber-sensitised 
animals. These results indicated that particular classes of lipids present in this 
fraction, which is a complex mixture of several lipids, might be involved in the 
role that natural lipids play in the development of Brazil nut allergy. Other 
allergens, such as those from peanuts, were also reported to need the presence of 
the whole food extract in order to induce an immune response in mice (Van 
Wijk, Nierkens et al., 2005).  
As discussed in Chapter 3, both IgE and IgG1 antibody isotypes 
possess anaphylactic properties in mice (Mota, Wong et al., 1968; Becker, 1971; 
Lehrer e Vaughan, 1976; Dombrowicz, Flamand et al., 1997; Blaikie e Basketter, 
1999; Ryan, Kashyap et al., 2007). Although no titers of specific-IgE could be 
detected by ELISA in our protocol of sensitisation using rBer e 1 and the 
immune active lipid fraction (SPC fraction C), the consistent positive passive 
anaphylaxis reactions induced by serum from lipid-Ber sensitised animals indicate 
that the phenomenon observed can indeed be related to an allergic process. IgG1 
is a Th2-type immunoglobulin usually present in murine allergic protocols 
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(Faquim-Mauro, Coffman et al., 1999; Adel-Patient, Bernard et al., 2005; Fujita, 
Teng et al., 2009), and the isotypes equivalent to mouse IgG1 found in humans 
are IgG4 and IgG2 (Unkeless, Scigliano et al., 1988). However, in humans the 
focus in allergic diseases is strongly related to IgE and not to other 
immunoglobulin subclasses (Wang, Lin et al., 2010). 
Sub-fractions extracted from the SPC fraction C containing different 
classes of lipids were tested in vivo in order to find specific lipid classes 
responsible for the immune effect observed, but although one of them induced 
evident immunogenic effect (phospholipid-rich sub-fraction), with increased 
titers of Ber-specific IgG1 and IgG2a, none of them induced anaphylactic 
antibodies. These results indicated that the dose of particular lipid classes might 
be important to modulate the immune respone to rBer e 1. The fact that in the 
present study the whole lipid extract from Brazil nuts was not able to induce the 
production of anaphylactic antibodies also corroborates this hypothesis. 
Dearman et al showed that the total Brazil nut lipid fraction induced anaphylactic 
antibodies when the level of triglycerides, the most abundant lipid class present in 
Brazil nuts, was reduced, altering therefore the proportion of other lipid 
constituents (Dearman, Alcocer et al., 2007).   
Indeed, the immune effect of SPC fraction C was shown to be 
concentration-dependent. Whereas lower doses induced a Th2-type response, 
with the presence of anaphylactic antibodies; higher doses induced evident 
immunogenic effect, with a vigorous increase in the titers of Ber-apecific IgG1 
and IgG2a, but no anaphylactic antibodies. Doses of antigens as well as adjuvants 
are reported to play a role in the development of allergic processes; however, the 
underlying mechanisms are still unknown (Cochrane, Beyer et al., 2009). In this 
vein, the level of LPS exposure is reported to determine the type of inflammatory 
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response towards the antigen, generating Th1- or Th2-skewed responses 
(Eisenbarth, Piggott et al., 2002; Watanabe, Miyazaki et al., 2003; Dong, Li et al., 
2009); although there are controversies regarding the levels necessary to modulate 
the direction of the immune response. The immune response induced by rBer e 1 
in the presence of different doses of LPS was tested in the present study and, 
consistent with this, the LPS effect was demonstrated to be dose-dependent. 
Only higher doses of LPS induced the production of anaphylactic antibodies. 
Here it is relevant to mention that although LPS as well as natural lipids were 
able to induce anaphylactic antibodies in Ber sensitised animals, the humoral 
response induced by these lipids was different. Whereas natural lipids induced a 
more defined Th2 response, with increased IgG1 and low IgG2a, LPS induced 
robust increase in both antibodies isotypes, IgG1 and IgG2a (a Th1 isotype). 
Therefore, the immune response developed towards rBer e 1 was shown to be 
dependent not only on the presence of adjuvant compounds, such as natural 
lipids or LPS, but also dependent on the concentrarion of the adjuvants used.  
The allergenicity of rBer e 1 was investigated in the presence of other 
lipids such as different commercial classes of phospholipids, and lipid fractions 
from sunflower seeds; as well as in the presence of alum, a well-established Th2 
adjuvant. Interestingly, none of these compounds were able to induce detectable 
titers of Ber-specific antibodies in sensitised mice. These results suggest that 
Brazil nut natural lipids present exclusive features that are crucial for the 
development of a specifc immune response. Similar data are observed in the 
immune response induced by schistosome lipids, in which parasite but not 
synthetic lyso-phosphatidylserine presented immunomodulatory funtions (Van 
Der Kleij, Latz et al., 2002). These results and the absence of immune response 
observed when rBer e 1 was injected in the presence of alum, a potent Th2 
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response inducer, bring out the possibility that the immunomodulatory effect is 
dependent on a protein-lipid complex. The fact that lipid binding is a common 
characteristic of major allergens (Thomas, Hales et al., 2005) corroborates this 
hypothesis. For instance, the 2S albumin Sin a 1, the major allergen from mustard 
seeds, was shown to interact with phospholipid vesicles, binding to 
dimyristoylglycerophosphoglycerol vesicles with a dissociation constant of 
approximately 2.4 pM. The number of phospholipid molecules affected by one 
protein molecule was approximately 20 (Onaderra, Monsalve et al., 1994). 
Consistent with this, preliminary results investigating the lipid binding 
properties of rBer e 1 using NMR (nuclear magnetic resonance) spectroscopy 
indicated that the binding of lipid to Ber e 1 did push the protein to populate a 
conformational state that was different from the lipid-free form. Two types of 
lipid interactions were identified, one interaction in fast exchange, probably 
related to weak unspecific interactions with one or more lipid classes; and other 
interaction in slow exchange, probably related to a specific lipid interaction. 
Based on the volume of cross-peaks observed, the NMR results also suggested 
that Ber e 1 specifically interacts with one of the less abundant lipids in the SPC 
lipid fraction C. This study is being carried out in collaboration with Dr. G. 
Larsson at the University of Umea (Sweden), and the final data have not yet been 
published. Other evidences show that Ber e 1 is intrinsically a lipid binding 
protein. Non-specific binding results carried out in our lab and repeated at the 
University of Umea have shown that the hydrophobic site of Ber e 1 can 
accommodate a lipid molecule and the stoichiometric of this interaction is 1:1. It 
is relevant to highlight that the immune effect observed in the present study was 
induced at very low stoichiometry levels, approximately one part of protein to 
four parts of lipids. This fact is important to rule out other potential adjuvant or 
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micelle forming effects. Therefore, the lipid binding properties of Ber e 1 and the 
conformation state assumed by this protein after the lipid binding may be 
determinant factors for its allergenicity.  
The SPC fraction C from Brazil nuts was composed by a mixture of 
different classes of lipids, mainly triglycerides, but also acylsterylglycosides, 
sterylglycosides, sulfolipids, lyso-phosphatidylcholine, phosphatidylcholine, 
phosphatisylinositol, and phosphatidic acid. In the data previously published, the 
lipid fractions able to induce anaphylactic antibodies and increased IgG1 and IgG 
contained (i) sterol, sterol ester and free fatty acids; (ii) all lipids with reduced 
triglyceride level; or (iii) sulfolipid, phosphatidylcholine, phosphatidylinositol and 
phosphatidylethanolamine. However, the lipid fractions used here and in the 
previous study (Dearman, Alcocer et al., 2007) have been extracted by different 
techniques (SPC and TLC, respectively) and, furthermore, since the methods 
available to identify lipid classes are relative, precise identification of all lipid 
classes present in the fractions might not have been achieved. Therefore, in spite 
of lipid analyses have been useful for the development of the present study; the 
direct comparison with published data should be treated with caution.   
In the literature, particular classes of lipids are reported to modulate 
adaptive immune responses. Specifically in Th2 responses, phosphorycholine was 
reported to be responsible for the immunomodulatory effects of ES-62, a 
glycoprotein present in nematodes (Harnett e Harnett, 2006; Harnett, Melendez 
et al., 2009). ES-62 promoted the differentiation of naïve CD4+ T cells with a 
Th2 phenotype (Whelan, Harnett et al., 2000; Goodridge, Mcguiness et al., 2007) 
and suppressed the production IL-12, IL-6 and TNF-DIts activity was shown to 
be TLR-4 and Myd88-dependent (Goodridge, Marshall et al., 2005). Similarly to 
our results, in which Brazil nut lipids had immune effects when attached to SFA-
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8 (protein from sunflower), the immunomodulatory properties of 
phosphorycholine was also shown when conjugated to other proteins, such as 
bovine serum albumin or ovalbumin (Goodridge, Mcguiness et al., 2007; Harnett, 
Kean et al., 2008). Lyso-phosphatidylserine is another example in the parasitology 
area; this lipid extracted from schistosomes contains specific acyl-chains, and it 
was able to polarize the maturation of dendritic cells into Th2-direction. The 
immunomodulatory function of this lipid was via TLR2 activation (Van Der 
Kleij, Latz et al., 2002). The role of LPS, a lipid component of Gram-negative 
bacteria, has also been investigated in Th2-processes. Although controversial 
results are found concerning its participation in allergic processes (Williams, 
Ownby et al., 2005), convincing data show that LPS, signalling through TLR4, 
can down- or up-regulate Th2-mediated allergic responses (Tulic, Knight et al., 
2001; Eisenbarth, Piggott et al., 2002; Delayre-Orthez, De Blay et al., 2004; 
Hollingsworth, Whitehead et al., 2006).  
Therefore, evidences demonstrating the participation of different classes 
of lipids in modulating Th2 immune responses are robust. Since the described 
underlying mechanisms by which the lipids cited above are recognized by the 
immune system involved TLRs (Medzhitov, 2001), we investigated whether the 
Th2 activation induced by Brazil nut lipids also involved TLRs. However, no 
human TLRs (2, 3, 4, 5, 7, 8 and 9) were activated by the SPC fraction C from 
Brazil nuts in the in vitro model used. Based on the possibility that a structural 
attachment of natural lipids and rBer e 1 is necessary for its immune recognition 
and consequent immunomodulation, it can be speculated that this is also a pre-
requisite to TLR activation. And in the in vitro model used herein, lipids were 
tested in the absence of protein. In this vein, the immune activation induced by 
LPS, classically via TLR-4 (Medzhitov, 2001 (Poltorak, He et al., 1998), is 
 199 
preceded by its interaction with plasma lipid binding proteins (Schumann, Leong 
et al., 1990). LPS-lipid binding protein complexes are subsequently recognized by  
CD14 (Wright, Ramos et al., 1990) and cellular signaling is transmitted through 
TLR4 (Poltorak, He et al., 1998). Therefore, although the results of the in vitro test 
indicated that the immune activation induced by lipids from Brazil nuts does not 
involve TLR activation, this possibility can not be completely ruled out.  
Another way by which lipids can be recognized by the immune system 
involves CD1-NKT pathways. CD1 is a MHC class I-like molecule expressed in 
antigen presenting cells that are capable of presenting lipid antigens to NKT cells. 
Stimulated NKT cells rapidly produce both Th1 (IFN-J and Th2 (IL-4) 
cytokines, and also activate several immune cells (Porcelli e Modlin, 1999; Barral 
e Brenner, 2007). Due to its pronounced secretion of IL-4, NKT cells have been 
implicated in Th2 processes (Yoshimoto, Bendelac et al., 1995; Leite-De-Moraes, 
Moreau et al., 1998; Lisbonne, Diem et al., 2003). It has been shown that NKT 
cells are required for airway eosinophilia, Th2 cytokine production, and elevated 
levels of IgE in an animal model of allergic asthma to ovalbumin (Lisbonne, 
Diem et al., 2003). CD1 molecules are also involved in pollen allergy. 
Phospholipids present in the pollen membrane, particularly phosphatidylserine, 
cardiolipin, phosphatidylethanolamine and phosphatidylcholine, were reported to 
be implicated in early pollen grain capture and recognition by CD1 (Russano, 
Agea et al., 2008). The involvement of NKT cells in modulating the Th2-type 
humoral response observed in animals sensitised to rBer e 1 and SPC fraction C 
from Brazil nuts was demonstrated in the present study, since sensitised NKT-
knockout mice presented significantly less IgE, IgG1 and anaphylactic antibodies 
than wild type animals. No significant differences were observed in the cytokine 
production or activation of NKT cells stimulated by Brazil nut lipids; however, 
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this could have been due to the very limited number of animals used for this 
experiment. Therefore, the participation of CD1-NKT pathways was 
demonstrated not be essential for the sensitisation to rBer e 1, but these results 
clearly showed that the immune activity of Brazil nut lipids does involve this 
mechanism. In addition to the hypothesis that the lipid-binding features of rBer e 
1 are essential for its immune recognition, it may be speculated that the CD1 
positive dendritic cells recognize natural lipids from Brazil nuts in the early stages 
of the allergic response and present them to CD1-restricted T cells. As antigen 
presenting cells can express CD1 and MHC class II molecules, two different 
kinds of antigen recognition may coexist. This was observed in pollen, intact 
grain was degraded in the lysosomal compartment where both CD1 and MHC 
class II molecules were present (Van Rhijn, Zajonc et al., 2005).  
In summary, the data presented in this study demonstrated that natural 
lipids from Brazil nuts do play a crucial role in the sensitisation to rBer e 1, the 
major allergen in these nuts. Lipid concentration as well as lipid classes was 
important for the development of the humoral response towards rBer e 1, which 
was characterized by increased titers of Ber-specific IgG1 and Ber-specific 
anaphylactic antibodies. The mechanisms by which natural lipids orchestrate the 
immunomodulation observed herein might involve CD1-NKT related pathways. 
Therefore, although further studies are necessary to fully understand the role that 
natural lipids play in Brazil allergy, this study provided insights into interaction of 
this class of molecules with the immune system and the role they may play in 
immunopathologies.  
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APPENDIX  1 
Brazil nuts, dried, unblanched 
Refuse: 49% (Shells) 
Scientific name:  Bertholletia excelsa 
 
Nutrient Units 
Value per 
100 grams 
Number of Data 
Points 
Std. 
Error 
Proximates     
Water g 3.48 9 0.170 
Energy kcal 656 0   
Energy kJ 2743 0   
Protein g 14.32 7 0.146 
Total lipid (fat) g 66.43 7 0.237 
Ash g 3.51 7 0.033 
Carbohydrate, by 
difference 
g 12.27 0   
Fiber, total dietary g 7.5 3 0.232 
Sugars, total g 2.33 7 0.078 
Sucrose g 2.33 7 0.078 
Glucose (dextrose) g 0.00 7 0.000 
Fructose g 0.00 7 0.000 
Lactose g 0.00 7 0.000 
Maltose g 0.00 7 0.000 
Galactose g 0.00 7 0.000 
Starch g 0.25 7 0.000 
Minerals     
Calcium, Ca mg 160 7 5.660 
Iron, Fe mg 2.43 7 0.030 
Magnesium, Mg mg 376 7 3.746 
Phosphorus, P mg 725 7 5.614 
Potassium, K mg 659 7 8.853 
Sodium, Na mg 3 7 0.252 
Zinc, Zn mg 4.06 7 0.043 
Copper, Cu mg 1.743 7 0.021 
Manganese, Mn mg 1.223 7 0.052 
Selenium, Se mcg 1917.0 15 231.798 
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Vitamins     
Vitamin C, total ascorbic 
acid 
mg 0.7 3 0.000 
Thiamin mg 0.617 7 0.053 
Riboflavin mg 0.035 7 0.001 
Niacin mg 0.295 7 0.019 
Pantothenic acid mg 0.184 7 0.012 
Vitamin B-6 mg 0.101 7 0.004 
Folate, total mcg 22 4 2.316 
Folic acid mcg 0 0   
Folate, food mcg 22 4 2.316 
Folate, DFE mcg_DFE 22 0   
Choline, total mg 28.8 0   
Betaine mg 0.4 2   
Vitamin B-12 mcg 0.00 0   
Vitamin B-12, added mcg 0.00 0   
Vitamin A, RAE mcg_RAE 0 1   
Retinol mcg 0 0   
Carotene, beta mcg 0 1   
Carotene, alpha mcg 0 1   
Cryptoxanthin, beta mcg 0 1   
Vitamin A, IU IU 0 1   
Lycopene mcg 0 1   
Lutein + zeaxanthin mcg 0 1   
Vitamin E (alpha-
tocopherol) 
mg 5.73 6 1.540 
Vitamin E, added mg 0.00 0   
Tocopherol, beta mg 0.00 6 0.000 
Tocopherol, gamma mg 7.87 6 2.148 
Tocopherol, delta mg 0.77 6 0.657 
Vitamin D (D2 + D3) mcg 0.0 0   
Vitamin D IU 0 0   
Vitamin K 
(phylloquinone) 
mcg 0.0 7 0.000 
Lipids     
Fatty acids, total 
saturated 
g 15.137 0   
4:0 g 0.000 0   
6:0 g 0.000 0   
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8:0 g 0.000 3 0.000 
10:0 g 0.000 3 0.000 
12:0 g 0.000 3 0.000 
14:0 g 0.052 3 0.000 
15:0 g 0.000 3 0.000 
16:0 g 9.085 3 0.200 
17:0 g 0.047 3 0.012 
18:0 g 5.794 3 0.145 
20:0 g 0.160 3 0.007 
22:0 g 0.000 3 0.000 
Fatty acids, total 
monounsaturated 
g 24.548 0   
14:1 g 0.000 3 0.000 
15:1 g 0.000 3 0.000 
16:1 undifferentiated g 0.229 3 0.004 
17:1 g 0.044 3 0.009 
18:1 undifferentiated g 24.223 3 0.835 
20:1 g 0.052 3 0.000 
22:1 undifferentiated g 0.000 0   
Fatty acids, total 
polyunsaturated 
g 20.577 0   
18:2 undifferentiated g 20.543 3 0.492 
18:3 undifferentiated g 0.035 0   
18:3 n-3 c,c,c (ALA) g 0.017 3 0.000 
18:3 n-6 c,c,c g 0.017 3 0.000 
18:4 g 0.000 0   
20:2 n-6 c,c g 0.000 3 0.000 
20:3 undifferentiated g 0.000 3 0.000 
20:4 undifferentiated g 0.000 3 0.000 
Amino acids     
Tryptophan g 0.141 0   
Threonine g 0.362 0   
Isoleucine g 0.516 0   
Leucine g 1.155 0   
Lysine g 0.492 0   
Methionine g 1.008 0   
Cystine g 0.367 0   
Phenylalanine g 0.630 0   
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Tyrosine g 0.420 0   
Valine g 0.756 0   
Arginine g 2.148 0   
Histidine g 0.386 0   
Alanine g 0.577 0   
Aspartic acid g 1.346 0   
Glutamic acid g 3.147 0   
Glycine g 0.718 0   
Proline g 0.657 0   
Serine g 0.683 0   
Other     
Alcohol, ethyl g 0.0 0   
Caffeine mg 0 0   
Theobromine mg 0 0   
USDA National Nutrient Database for Standard Reference, 
Release 22 (2009) 
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